Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
type: datablock
references: doi:10.2210/pdb4g6j/pdb
alternative label: 4g6j
link to pdbml: 4g6j.xml.gz
link to pdbml noatom: 4g6j-noatom.xml.gz
link to pdbml extatom: 4g6j-extatom.xml.gz
link to vrpt: 4G6J
datablock name: 4G6J-noatom
has atom sites category: atom sitesCategory
has atom type category: atom typeCategory
has audit author category: audit authorCategory
has audit conform category: audit conformCategory
has cell category: cellCategory
has chem comp category: chem compCategory
has citation category: citationCategory
has citation author category: citation authorCategory
has database 2 category: database 2Category
has database PDB matrix category: database PDB matrixCategory
has diffrn category: diffrnCategory
has diffrn detector category: diffrn detectorCategory
has diffrn radiation category: diffrn radiationCategory
has diffrn radiation wavelength category: diffrn radiation wavelengthCategory
has diffrn source category: diffrn sourceCategory
has entity category: entityCategory
has entity name com category: entity name comCategory
has entity poly category: entity polyCategory
has entity poly seq category: entity poly seqCategory
has entry category: entryCategory
has exptl category: exptlCategory
has exptl crystal category: exptl crystalCategory
has exptl crystal grow category: exptl crystal growCategory
has pdbx audit revision details category: pdbx audit revision detailsCategory
has pdbx audit revision group category: pdbx audit revision groupCategory
has pdbx audit revision history category: pdbx audit revision historyCategory
has pdbx database related category: pdbx database relatedCategory
has pdbx database status category: pdbx database statusCategory
has pdbx entity nonpoly category: pdbx entity nonpolyCategory
has pdbx entity src syn category: pdbx entity src synCategory
has pdbx nonpoly scheme category: pdbx nonpoly schemeCategory
has pdbx poly seq scheme category: pdbx poly seq schemeCategory
has pdbx refine tls category: pdbx refine tlsCategory
has pdbx refine tls group category: pdbx refine tls groupCategory
has pdbx struct assembly category: pdbx struct assemblyCategory
has pdbx struct assembly gen category: pdbx struct assembly genCategory
has pdbx struct oper list category: pdbx struct oper listCategory
has pdbx struct sheet hbond category: pdbx struct sheet hbondCategory
has pdbx unobs or zero occ atoms category: pdbx unobs or zero occ atomsCategory
has pdbx unobs or zero occ residues category: pdbx unobs or zero occ residuesCategory
has pdbx validate torsion category: pdbx validate torsionCategory
has refine category: refineCategory
has refine analyze category: refine analyzeCategory
has refine hist category: refine histCategory
has refine ls restr category: refine ls restrCategory
has refine ls shell category: refine ls shellCategory
has reflns category: reflnsCategory
has reflns shell category: reflns shellCategory
has software category: softwareCategory
has struct category: structCategory
has struct asym category: struct asymCategory
has struct biol category: struct biolCategory
has struct conf category: struct confCategory
has struct conf type category: struct conf typeCategory
has struct conn category: struct connCategory
has struct conn type category: struct conn typeCategory
has struct keywords category: struct keywordsCategory
has struct mon prot cis category: struct mon prot cisCategory
has struct ref category: struct refCategory
has struct ref seq category: struct ref seqCategory
has struct ref seq dif category: struct ref seq difCategory
has struct sheet category: struct sheetCategory
has struct sheet order category: struct sheet orderCategory
has struct sheet range category: struct sheet rangeCategory
has symmetry category: symmetryCategory
has pdbx sifts unp segments category: pdbx sifts unp segmentsCategory
has pdbx sifts xref db segments category: pdbx sifts xref db segmentsCategory

4G6J
type: atom sites
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
atom sites.entry id: 4G6J
atom sites.fract transf matrix11: 0.012336
atom sites.fract transf matrix12: 0.000000
atom sites.fract transf matrix13: 0.000000
atom sites.fract transf matrix21: 0.000000
atom sites.fract transf matrix22: 0.026810
atom sites.fract transf matrix23: 0.000000
atom sites.fract transf matrix31: 0.000000
atom sites.fract transf matrix32: 0.000000
atom sites.fract transf matrix33: 0.005279
atom sites.fract transf vector1: 0.00000
atom sites.fract transf vector2: 0.00000
atom sites.fract transf vector3: 0.00000

http://rdf.wwpdb.org/pdb/4G6J/atom_type/C
type: atom type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
atom type.symbol: C

http://rdf.wwpdb.org/pdb/4G6J/atom_type/N
type: atom type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
atom type.symbol: N

http://rdf.wwpdb.org/pdb/4G6J/atom_type/O
type: atom type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
atom type.symbol: O

http://rdf.wwpdb.org/pdb/4G6J/atom_type/S
type: atom type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
atom type.symbol: S

http://rdf.wwpdb.org/pdb/4G6J/audit_author/1
type: audit author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
audit author.pdbx ordinal: 1
audit author.name: Blech, M.

http://rdf.wwpdb.org/pdb/4G6J/audit_author/2
type: audit author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
audit author.pdbx ordinal: 2
audit author.name: Hoerer, S.

mmcif pdbx.dic,5.281
type: audit conform
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
audit conform.dict name: mmcif_pdbx.dic
audit conform.dict version: 5.281
audit conform.dict location: http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic

4G6J
type: cell
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
cell.entry id: 4G6J
cell.z PDB: 4
cell.angle alpha: 90.00
cell.angle beta: 90.00
cell.angle gamma: 90.00
cell.length a: 81.061
cell.length b: 37.300
cell.length c: 189.418

ALA
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: ALA
link to chem comp: ALA
chem comp.formula: C3 H7 N O2
chem comp.formula weight: 89.093
chem comp.mon nstd flag: y
chem comp.name: ALANINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/2

ARG
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: ARG
link to chem comp: ARG
chem comp.formula: C6 H15 N4 O2 1
chem comp.formula weight: 175.209
chem comp.mon nstd flag: y
chem comp.name: ARGININE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/21
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/22
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/23
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/24
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/25
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/26
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/27
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/28
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/29
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/30
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/5
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/10

ASN
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: ASN
link to chem comp: ASN
chem comp.formula: C4 H8 N2 O3
chem comp.formula weight: 132.118
chem comp.mon nstd flag: y
chem comp.name: ASPARAGINE
chem comp.type: L-peptide linking

ASP
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: ASP
link to chem comp: ASP
chem comp.formula: C4 H7 N O4
chem comp.formula weight: 133.103
chem comp.mon nstd flag: y
chem comp.name: ASPARTIC ACID
chem comp.type: L-peptide linking

CYS
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: CYS
link to chem comp: CYS
chem comp.formula: C3 H7 N O2 S
chem comp.formula weight: 121.158
chem comp.mon nstd flag: y
chem comp.name: CYSTEINE
chem comp.type: L-peptide linking

GLN
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: GLN
link to chem comp: GLN
chem comp.formula: C5 H10 N2 O3
chem comp.formula weight: 146.144
chem comp.mon nstd flag: y
chem comp.name: GLUTAMINE
chem comp.type: L-peptide linking

GLU
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: GLU
link to chem comp: GLU
chem comp.formula: C5 H9 N O4
chem comp.formula weight: 147.129
chem comp.mon nstd flag: y
chem comp.name: GLUTAMIC ACID
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/31

GLY
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: GLY
link to chem comp: GLY
chem comp.formula: C2 H5 N O2
chem comp.formula weight: 75.067
chem comp.mon nstd flag: y
chem comp.name: GLYCINE
chem comp.type: peptide linking
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/11

HIS
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: HIS
link to chem comp: HIS
chem comp.formula: C6 H10 N3 O2 1
chem comp.formula weight: 156.162
chem comp.mon nstd flag: y
chem comp.name: HISTIDINE
chem comp.type: L-peptide linking

HOH
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: HOH
link to chem comp: HOH
chem comp.formula: H2 O
chem comp.formula weight: 18.015
chem comp.name: WATER
chem comp.type: non-polymer

ILE
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: ILE
link to chem comp: ILE
chem comp.formula: C6 H13 N O2
chem comp.formula weight: 131.173
chem comp.mon nstd flag: y
chem comp.name: ISOLEUCINE
chem comp.type: L-peptide linking

LEU
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: LEU
link to chem comp: LEU
chem comp.formula: C6 H13 N O2
chem comp.formula weight: 131.173
chem comp.mon nstd flag: y
chem comp.name: LEUCINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/43
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/44
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/7

LYS
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: LYS
link to chem comp: LYS
chem comp.formula: C6 H15 N2 O2 1
chem comp.formula weight: 147.195
chem comp.mon nstd flag: y
chem comp.name: LYSINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/1
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/2
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/3
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/4
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/5
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/6
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/7
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/8
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/9
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/10
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/12
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/13
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/14
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/15
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/16
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/17
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/18
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/19
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/20
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/32
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/33
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/34
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/35
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/36
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/37
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/38
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/39
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/40
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/41
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/42
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/45
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/46
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/47
referenced by pdbx unobs or zero occ atoms: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/48

MET
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: MET
link to chem comp: MET
chem comp.formula: C5 H11 N O2 S
chem comp.formula weight: 149.211
chem comp.mon nstd flag: y
chem comp.name: METHIONINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/1

PHE
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: PHE
link to chem comp: PHE
chem comp.formula: C9 H11 N O2
chem comp.formula weight: 165.189
chem comp.mon nstd flag: y
chem comp.name: PHENYLALANINE
chem comp.type: L-peptide linking

PRO
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: PRO
link to chem comp: PRO
chem comp.formula: C5 H9 N O2
chem comp.formula weight: 115.130
chem comp.mon nstd flag: y
chem comp.name: PROLINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/3
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/9

SER
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: SER
link to chem comp: SER
chem comp.formula: C3 H7 N O3
chem comp.formula weight: 105.093
chem comp.mon nstd flag: y
chem comp.name: SERINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/6

THR
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: THR
link to chem comp: THR
chem comp.formula: C4 H9 N O3
chem comp.formula weight: 119.119
chem comp.mon nstd flag: y
chem comp.name: THREONINE
chem comp.type: L-peptide linking

TRP
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: TRP
link to chem comp: TRP
chem comp.formula: C11 H12 N2 O2
chem comp.formula weight: 204.225
chem comp.mon nstd flag: y
chem comp.name: TRYPTOPHAN
chem comp.type: L-peptide linking

TYR
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: TYR
link to chem comp: TYR
chem comp.formula: C9 H11 N O3
chem comp.formula weight: 181.189
chem comp.mon nstd flag: y
chem comp.name: TYROSINE
chem comp.type: L-peptide linking

VAL
type: chem comp
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
chem comp.id: VAL
link to chem comp: VAL
chem comp.formula: C5 H11 N O2
chem comp.formula weight: 117.146
chem comp.mon nstd flag: y
chem comp.name: VALINE
chem comp.type: L-peptide linking
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/4
referenced by pdbx unobs or zero occ residues: http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/8

primary
type: citation
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
citation.id: primary
citation.country: UK
citation.journal abbrev: J.Mol.Biol.
citation.journal id ASTM: JMOBAK
citation.journal id CSD: 0070
citation.journal id ISSN: 0022-2836
citation.journal volume: 425
citation.page first: 94
citation.page last: 111
citation.pdbx database id DOI: 10.1016/j.jmb.2012.09.021
citation.pdbx database id pub med: 23041424
citation.title: One traget-two different binding modes: Structural insights into gevokizumab and canakinumab interactions to interleukin-1beta
citation.year: 2013
link to doi: doi:10.1016/j.jmb.2012.09.021
link to pubmed: pubmed:23041424
references: pubmed:23041424

primary,Blech, M.,1
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Blech, M.
citation author.ordinal: 1

primary,Peter, D.,2
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Peter, D.
citation author.ordinal: 2

primary,Fischer, P.,3
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Fischer, P.
citation author.ordinal: 3

primary,Bauer, M.M.,4
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Bauer, M.M.
citation author.ordinal: 4

primary,Hafner, M.,5
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Hafner, M.
citation author.ordinal: 5

primary,Zeeb, M.,6
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Zeeb, M.
citation author.ordinal: 6

primary,Nar, H.,7
type: citation author
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to citation: citation
citation author.citation id: primary
citation author.name: Nar, H.
citation author.ordinal: 7

4G6J,PDB
type: database 2
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
database 2.database code: 4G6J
database 2.database id: PDB

RCSB073800,RCSB
type: database 2
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
database 2.database code: RCSB073800
database 2.database id: RCSB

D 1000073800,WWPDB
type: database 2
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
database 2.database code: D_1000073800
database 2.database id: WWPDB

4G6J
type: database PDB matrix
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
database PDB matrix.entry id: 4G6J
database PDB matrix.origx11: 1.000000
database PDB matrix.origx12: 0.000000
database PDB matrix.origx13: 0.000000
database PDB matrix.origx21: 0.000000
database PDB matrix.origx22: 1.000000
database PDB matrix.origx23: 0.000000
database PDB matrix.origx31: 0.000000
database PDB matrix.origx32: 0.000000
database PDB matrix.origx33: 1.000000
database PDB matrix.origx vector1: 0.00000
database PDB matrix.origx vector2: 0.00000
database PDB matrix.origx vector3: 0.00000

http://rdf.wwpdb.org/pdb/4G6J/diffrn/1
type: diffrn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to exptl crystal: http://rdf.wwpdb.org/pdb/4G6J/exptl_crystal/1
diffrn.id: 1
diffrn.ambient temp: 100
diffrn.crystal id: 1

http://rdf.wwpdb.org/pdb/4G6J/exptl_crystal/1
referenced by diffrn: http://rdf.wwpdb.org/pdb/4G6J/diffrn/1
type: exptl crystal
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
exptl crystal.id: 1
exptl crystal.density matthews: 2.22
exptl crystal.density percent sol: 44.60

http://rdf.wwpdb.org/pdb/4G6J/diffrn_detector/1
type: diffrn detector
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to diffrn: diffrn
diffrn detector.diffrn id: 1
diffrn detector.detector: PIXEL
diffrn detector.pdbx collection date: 2012-03-09
diffrn detector.type: PSI PILATUS 6M

http://rdf.wwpdb.org/pdb/4G6J/diffrn_radiation/1
type: diffrn radiation
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to diffrn: diffrn
diffrn radiation.diffrn id: 1
diffrn radiation.pdbx diffrn protocol: SINGLE WAVELENGTH
diffrn radiation.pdbx monochromatic or laue m l: M
diffrn radiation.pdbx scattering type: x-ray
diffrn radiation.wavelength id: 1

http://rdf.wwpdb.org/pdb/4G6J/diffrn_radiation_wavelength/1
type: diffrn radiation wavelength
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
diffrn radiation wavelength.id: 1
diffrn radiation wavelength.wavelength: 0.91
diffrn radiation wavelength.wt: 1.0

http://rdf.wwpdb.org/pdb/4G6J/diffrn_source/1
type: diffrn source
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to diffrn: diffrn
diffrn source.diffrn id: 1
diffrn source.pdbx synchrotron beamline: X06SA
diffrn source.pdbx synchrotron site: SLS
diffrn source.pdbx wavelength list: 0.91
diffrn source.source: SYNCHROTRON
diffrn source.type: SLS BEAMLINE X06SA

http://rdf.wwpdb.org/pdb/4G6J/entity/1
type: entity
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
entity.id: 1
entity.formula weight: 17993.629
entity.pdbx description: Interleukin-1 beta
entity.pdbx fragment: human interleukin-1beta
entity.pdbx number of molecules: 1
entity.src method: syn
entity.type: polymer
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/A
referenced by struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/1

http://rdf.wwpdb.org/pdb/4G6J/entity/2
type: entity
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
entity.id: 2
entity.formula weight: 23349.152
entity.pdbx description: heavy chain of antibody binding fragment of canakinumab
entity.pdbx fragment: heavy chain of antibody binding fragment of canakinumab
entity.pdbx number of molecules: 1
entity.src method: syn
entity.type: polymer
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/B
referenced by struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/2

http://rdf.wwpdb.org/pdb/4G6J/entity/3
type: entity
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
entity.id: 3
entity.formula weight: 23149.652
entity.pdbx description: light chain of antibody binding fragment of canakinumab
entity.pdbx fragment: light chain of antibody binding fragment of canakinumab
entity.pdbx number of molecules: 1
entity.src method: syn
entity.type: polymer
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/C
referenced by struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/3

http://rdf.wwpdb.org/pdb/4G6J/entity/4
type: entity
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
entity.id: 4
entity.formula weight: 18.015
entity.pdbx description: water
entity.pdbx number of molecules: 303
entity.src method: nat
entity.type: water
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/D
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/E
referenced by struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/F

http://rdf.wwpdb.org/pdb/4G6J/entity_name_com/1
type: entity name com
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
entity name com.entity id: 1
entity name com.name: IL-1 beta, Catabolin

http://rdf.wwpdb.org/pdb/4G6J/entity_poly/1
type: entity poly
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
entity poly.entity id: 1
entity poly.nstd linkage: no
entity poly.nstd monomer: no
entity poly.pdbx seq one letter code: MAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSSLVPR
entity poly.pdbx seq one letter code can: MAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSSLVPR
entity poly.pdbx strand id: A
entity poly.type: polypeptide(L)

http://rdf.wwpdb.org/pdb/4G6J/entity_poly/2
type: entity poly
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
entity poly.entity id: 2
entity poly.nstd linkage: no
entity poly.nstd monomer: no
entity poly.pdbx seq one letter code: QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPAKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVAP
entity poly.pdbx seq one letter code can: QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPAKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVAP
entity poly.pdbx strand id: H
entity poly.type: polypeptide(L)

http://rdf.wwpdb.org/pdb/4G6J/entity_poly/3
type: entity poly
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
entity poly.entity id: 3
entity poly.nstd linkage: no
entity poly.nstd monomer: no
entity poly.pdbx seq one letter code: EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
entity poly.pdbx seq one letter code can: EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG
entity poly.pdbx strand id: L
entity poly.type: polypeptide(L)

1,MET,1
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 1
entity poly seq.hetero: n

1,ALA,2
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ALA
entity poly seq.num: 2
entity poly seq.hetero: n

1,PRO,3
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 3
entity poly seq.hetero: n

1,VAL,4
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 4
entity poly seq.hetero: n

1,ARG,5
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ARG
entity poly seq.num: 5
entity poly seq.hetero: n

1,SER,6
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 6
entity poly seq.hetero: n

1,LEU,7
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 7
entity poly seq.hetero: n

1,ASN,8
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 8
entity poly seq.hetero: n

1,CYS,9
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: CYS
entity poly seq.num: 9
entity poly seq.hetero: n

1,THR,10
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 10
entity poly seq.hetero: n

1,LEU,11
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 11
entity poly seq.hetero: n

1,ARG,12
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ARG
entity poly seq.num: 12
entity poly seq.hetero: n

1,ASP,13
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 13
entity poly seq.hetero: n

1,SER,14
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 14
entity poly seq.hetero: n

1,GLN,15
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 15
entity poly seq.hetero: n

1,GLN,16
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 16
entity poly seq.hetero: n

1,LYS,17
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 17
entity poly seq.hetero: n

1,SER,18
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 18
entity poly seq.hetero: n

1,LEU,19
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 19
entity poly seq.hetero: n

1,VAL,20
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 20
entity poly seq.hetero: n

1,MET,21
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 21
entity poly seq.hetero: n

1,SER,22
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 22
entity poly seq.hetero: n

1,GLY,23
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 23
entity poly seq.hetero: n

1,PRO,24
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 24
entity poly seq.hetero: n

1,TYR,25
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: TYR
entity poly seq.num: 25
entity poly seq.hetero: n

1,GLU,26
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 26
entity poly seq.hetero: n

1,LEU,27
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 27
entity poly seq.hetero: n

1,LYS,28
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 28
entity poly seq.hetero: n

1,ALA,29
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ALA
entity poly seq.num: 29
entity poly seq.hetero: n

1,LEU,30
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 30
entity poly seq.hetero: n

1,HIS,31
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: HIS
entity poly seq.num: 31
entity poly seq.hetero: n

1,LEU,32
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 32
entity poly seq.hetero: n

1,GLN,33
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 33
entity poly seq.hetero: n

1,GLY,34
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 34
entity poly seq.hetero: n

1,GLN,35
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 35
entity poly seq.hetero: n

1,ASP,36
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 36
entity poly seq.hetero: n

1,MET,37
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 37
entity poly seq.hetero: n

1,GLU,38
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 38
entity poly seq.hetero: n

1,GLN,39
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 39
entity poly seq.hetero: n

1,GLN,40
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 40
entity poly seq.hetero: n

1,VAL,41
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 41
entity poly seq.hetero: n

1,VAL,42
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 42
entity poly seq.hetero: n

1,PHE,43
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 43
entity poly seq.hetero: n

1,SER,44
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 44
entity poly seq.hetero: n

1,MET,45
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 45
entity poly seq.hetero: n

1,SER,46
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 46
entity poly seq.hetero: n

1,PHE,47
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 47
entity poly seq.hetero: n

1,VAL,48
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 48
entity poly seq.hetero: n

1,GLN,49
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 49
entity poly seq.hetero: n

1,GLY,50
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 50
entity poly seq.hetero: n

1,GLU,51
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 51
entity poly seq.hetero: n

1,GLU,52
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 52
entity poly seq.hetero: n

1,SER,53
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 53
entity poly seq.hetero: n

1,ASN,54
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 54
entity poly seq.hetero: n

1,ASP,55
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 55
entity poly seq.hetero: n

1,LYS,56
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 56
entity poly seq.hetero: n

1,ILE,57
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ILE
entity poly seq.num: 57
entity poly seq.hetero: n

1,PRO,58
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 58
entity poly seq.hetero: n

1,VAL,59
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 59
entity poly seq.hetero: n

1,ALA,60
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ALA
entity poly seq.num: 60
entity poly seq.hetero: n

1,LEU,61
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 61
entity poly seq.hetero: n

1,GLY,62
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 62
entity poly seq.hetero: n

1,LEU,63
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 63
entity poly seq.hetero: n

1,LYS,64
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 64
entity poly seq.hetero: n

1,GLU,65
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 65
entity poly seq.hetero: n

1,LYS,66
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 66
entity poly seq.hetero: n

1,ASN,67
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 67
entity poly seq.hetero: n

1,LEU,68
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 68
entity poly seq.hetero: n

1,TYR,69
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: TYR
entity poly seq.num: 69
entity poly seq.hetero: n

1,LEU,70
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 70
entity poly seq.hetero: n

1,SER,71
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 71
entity poly seq.hetero: n

1,CYS,72
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: CYS
entity poly seq.num: 72
entity poly seq.hetero: n

1,VAL,73
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 73
entity poly seq.hetero: n

1,LEU,74
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 74
entity poly seq.hetero: n

1,LYS,75
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 75
entity poly seq.hetero: n

1,ASP,76
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 76
entity poly seq.hetero: n

1,ASP,77
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 77
entity poly seq.hetero: n

1,LYS,78
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 78
entity poly seq.hetero: n

1,PRO,79
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 79
entity poly seq.hetero: n

1,THR,80
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 80
entity poly seq.hetero: n

1,LEU,81
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 81
entity poly seq.hetero: n

1,GLN,82
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 82
entity poly seq.hetero: n

1,LEU,83
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 83
entity poly seq.hetero: n

1,GLU,84
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 84
entity poly seq.hetero: n

1,SER,85
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 85
entity poly seq.hetero: n

1,VAL,86
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 86
entity poly seq.hetero: n

1,ASP,87
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 87
entity poly seq.hetero: n

1,PRO,88
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 88
entity poly seq.hetero: n

1,LYS,89
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 89
entity poly seq.hetero: n

1,ASN,90
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 90
entity poly seq.hetero: n

1,TYR,91
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: TYR
entity poly seq.num: 91
entity poly seq.hetero: n

1,PRO,92
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 92
entity poly seq.hetero: n

1,LYS,93
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 93
entity poly seq.hetero: n

1,LYS,94
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 94
entity poly seq.hetero: n

1,LYS,95
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 95
entity poly seq.hetero: n

1,MET,96
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 96
entity poly seq.hetero: n

1,GLU,97
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 97
entity poly seq.hetero: n

1,LYS,98
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 98
entity poly seq.hetero: n

1,ARG,99
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ARG
entity poly seq.num: 99
entity poly seq.hetero: n

1,PHE,100
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 100
entity poly seq.hetero: n

1,VAL,101
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 101
entity poly seq.hetero: n

1,PHE,102
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 102
entity poly seq.hetero: n

1,ASN,103
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 103
entity poly seq.hetero: n

1,LYS,104
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 104
entity poly seq.hetero: n

1,ILE,105
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ILE
entity poly seq.num: 105
entity poly seq.hetero: n

1,GLU,106
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 106
entity poly seq.hetero: n

1,ILE,107
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ILE
entity poly seq.num: 107
entity poly seq.hetero: n

1,ASN,108
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 108
entity poly seq.hetero: n

1,ASN,109
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 109
entity poly seq.hetero: n

1,LYS,110
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 110
entity poly seq.hetero: n

1,LEU,111
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 111
entity poly seq.hetero: n

1,GLU,112
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 112
entity poly seq.hetero: n

1,PHE,113
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 113
entity poly seq.hetero: n

1,GLU,114
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 114
entity poly seq.hetero: n

1,SER,115
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 115
entity poly seq.hetero: n

1,ALA,116
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ALA
entity poly seq.num: 116
entity poly seq.hetero: n

1,GLN,117
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 117
entity poly seq.hetero: n

1,PHE,118
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 118
entity poly seq.hetero: n

1,PRO,119
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 119
entity poly seq.hetero: n

1,ASN,120
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 120
entity poly seq.hetero: n

1,TRP,121
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: TRP
entity poly seq.num: 121
entity poly seq.hetero: n

1,TYR,122
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: TYR
entity poly seq.num: 122
entity poly seq.hetero: n

1,ILE,123
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ILE
entity poly seq.num: 123
entity poly seq.hetero: n

1,SER,124
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 124
entity poly seq.hetero: n

1,THR,125
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 125
entity poly seq.hetero: n

1,SER,126
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 126
entity poly seq.hetero: n

1,GLN,127
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 127
entity poly seq.hetero: n

1,ALA,128
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ALA
entity poly seq.num: 128
entity poly seq.hetero: n

1,GLU,129
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLU
entity poly seq.num: 129
entity poly seq.hetero: n

1,ASN,130
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASN
entity poly seq.num: 130
entity poly seq.hetero: n

1,MET,131
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 131
entity poly seq.hetero: n

1,PRO,132
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 132
entity poly seq.hetero: n

1,VAL,133
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 133
entity poly seq.hetero: n

1,PHE,134
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 134
entity poly seq.hetero: n

1,LEU,135
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 135
entity poly seq.hetero: n

1,GLY,136
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 136
entity poly seq.hetero: n

1,GLY,137
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 137
entity poly seq.hetero: n

1,THR,138
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 138
entity poly seq.hetero: n

1,LYS,139
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LYS
entity poly seq.num: 139
entity poly seq.hetero: n

1,GLY,140
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 140
entity poly seq.hetero: n

1,GLY,141
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLY
entity poly seq.num: 141
entity poly seq.hetero: n

1,GLN,142
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 142
entity poly seq.hetero: n

1,ASP,143
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 143
entity poly seq.hetero: n

1,ILE,144
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ILE
entity poly seq.num: 144
entity poly seq.hetero: n

1,THR,145
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 145
entity poly seq.hetero: n

1,ASP,146
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ASP
entity poly seq.num: 146
entity poly seq.hetero: n

1,PHE,147
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 147
entity poly seq.hetero: n

1,THR,148
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: THR
entity poly seq.num: 148
entity poly seq.hetero: n

1,MET,149
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: MET
entity poly seq.num: 149
entity poly seq.hetero: n

1,GLN,150
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: GLN
entity poly seq.num: 150
entity poly seq.hetero: n

1,PHE,151
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PHE
entity poly seq.num: 151
entity poly seq.hetero: n

1,VAL,152
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 152
entity poly seq.hetero: n

1,SER,153
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 153
entity poly seq.hetero: n

1,SER,154
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: SER
entity poly seq.num: 154
entity poly seq.hetero: n

1,LEU,155
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: LEU
entity poly seq.num: 155
entity poly seq.hetero: n

1,VAL,156
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: VAL
entity poly seq.num: 156
entity poly seq.hetero: n

1,PRO,157
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: PRO
entity poly seq.num: 157
entity poly seq.hetero: n

1,ARG,158
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 1
entity poly seq.mon id: ARG
entity poly seq.num: 158
entity poly seq.hetero: n

2,GLN,1
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 1
entity poly seq.hetero: n

2,VAL,2
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 2
entity poly seq.hetero: n

2,GLN,3
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 3
entity poly seq.hetero: n

2,LEU,4
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 4
entity poly seq.hetero: n

2,VAL,5
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 5
entity poly seq.hetero: n

2,GLU,6
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLU
entity poly seq.num: 6
entity poly seq.hetero: n

2,SER,7
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 7
entity poly seq.hetero: n

2,GLY,8
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 8
entity poly seq.hetero: n

2,GLY,9
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 9
entity poly seq.hetero: n

2,GLY,10
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 10
entity poly seq.hetero: n

2,VAL,11
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 11
entity poly seq.hetero: n

2,VAL,12
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 12
entity poly seq.hetero: n

2,GLN,13
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 13
entity poly seq.hetero: n

2,PRO,14
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 14
entity poly seq.hetero: n

2,GLY,15
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 15
entity poly seq.hetero: n

2,ARG,16
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 16
entity poly seq.hetero: n

2,SER,17
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 17
entity poly seq.hetero: n

2,LEU,18
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 18
entity poly seq.hetero: n

2,ARG,19
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 19
entity poly seq.hetero: n

2,LEU,20
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 20
entity poly seq.hetero: n

2,SER,21
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 21
entity poly seq.hetero: n

2,CYS,22
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: CYS
entity poly seq.num: 22
entity poly seq.hetero: n

2,ALA,23
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 23
entity poly seq.hetero: n

2,ALA,24
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 24
entity poly seq.hetero: n

2,SER,25
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 25
entity poly seq.hetero: n

2,GLY,26
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 26
entity poly seq.hetero: n

2,PHE,27
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 27
entity poly seq.hetero: n

2,THR,28
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 28
entity poly seq.hetero: n

2,PHE,29
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 29
entity poly seq.hetero: n

2,SER,30
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 30
entity poly seq.hetero: n

2,VAL,31
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 31
entity poly seq.hetero: n

2,TYR,32
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 32
entity poly seq.hetero: n

2,GLY,33
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 33
entity poly seq.hetero: n

2,MET,34
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: MET
entity poly seq.num: 34
entity poly seq.hetero: n

2,ASN,35
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 35
entity poly seq.hetero: n

2,TRP,36
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TRP
entity poly seq.num: 36
entity poly seq.hetero: n

2,VAL,37
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 37
entity poly seq.hetero: n

2,ARG,38
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 38
entity poly seq.hetero: n

2,GLN,39
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 39
entity poly seq.hetero: n

2,ALA,40
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 40
entity poly seq.hetero: n

2,PRO,41
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 41
entity poly seq.hetero: n

2,ALA,42
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 42
entity poly seq.hetero: n

2,LYS,43
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 43
entity poly seq.hetero: n

2,GLY,44
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 44
entity poly seq.hetero: n

2,LEU,45
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 45
entity poly seq.hetero: n

2,GLU,46
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLU
entity poly seq.num: 46
entity poly seq.hetero: n

2,TRP,47
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TRP
entity poly seq.num: 47
entity poly seq.hetero: n

2,VAL,48
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 48
entity poly seq.hetero: n

2,ALA,49
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 49
entity poly seq.hetero: n

2,ILE,50
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ILE
entity poly seq.num: 50
entity poly seq.hetero: n

2,ILE,51
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ILE
entity poly seq.num: 51
entity poly seq.hetero: n

2,TRP,52
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TRP
entity poly seq.num: 52
entity poly seq.hetero: n

2,TYR,53
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 53
entity poly seq.hetero: n

2,ASP,54
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 54
entity poly seq.hetero: n

2,GLY,55
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 55
entity poly seq.hetero: n

2,ASP,56
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 56
entity poly seq.hetero: n

2,ASN,57
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 57
entity poly seq.hetero: n

2,GLN,58
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 58
entity poly seq.hetero: n

2,TYR,59
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 59
entity poly seq.hetero: n

2,TYR,60
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 60
entity poly seq.hetero: n

2,ALA,61
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 61
entity poly seq.hetero: n

2,ASP,62
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 62
entity poly seq.hetero: n

2,SER,63
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 63
entity poly seq.hetero: n

2,VAL,64
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 64
entity poly seq.hetero: n

2,LYS,65
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 65
entity poly seq.hetero: n

2,GLY,66
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 66
entity poly seq.hetero: n

2,ARG,67
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 67
entity poly seq.hetero: n

2,PHE,68
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 68
entity poly seq.hetero: n

2,THR,69
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 69
entity poly seq.hetero: n

2,ILE,70
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ILE
entity poly seq.num: 70
entity poly seq.hetero: n

2,SER,71
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 71
entity poly seq.hetero: n

2,ARG,72
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 72
entity poly seq.hetero: n

2,ASP,73
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 73
entity poly seq.hetero: n

2,ASN,74
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 74
entity poly seq.hetero: n

2,SER,75
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 75
entity poly seq.hetero: n

2,LYS,76
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 76
entity poly seq.hetero: n

2,ASN,77
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 77
entity poly seq.hetero: n

2,THR,78
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 78
entity poly seq.hetero: n

2,LEU,79
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 79
entity poly seq.hetero: n

2,TYR,80
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 80
entity poly seq.hetero: n

2,LEU,81
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 81
entity poly seq.hetero: n

2,GLN,82
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 82
entity poly seq.hetero: n

2,MET,83
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: MET
entity poly seq.num: 83
entity poly seq.hetero: n

2,ASN,84
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 84
entity poly seq.hetero: n

2,GLY,85
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 85
entity poly seq.hetero: n

2,LEU,86
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 86
entity poly seq.hetero: n

2,ARG,87
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 87
entity poly seq.hetero: n

2,ALA,88
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 88
entity poly seq.hetero: n

2,GLU,89
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLU
entity poly seq.num: 89
entity poly seq.hetero: n

2,ASP,90
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 90
entity poly seq.hetero: n

2,THR,91
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 91
entity poly seq.hetero: n

2,ALA,92
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 92
entity poly seq.hetero: n

2,VAL,93
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 93
entity poly seq.hetero: n

2,TYR,94
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 94
entity poly seq.hetero: n

2,TYR,95
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 95
entity poly seq.hetero: n

2,CYS,96
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: CYS
entity poly seq.num: 96
entity poly seq.hetero: n

2,ALA,97
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 97
entity poly seq.hetero: n

2,ARG,98
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 98
entity poly seq.hetero: n

2,ASP,99
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 99
entity poly seq.hetero: n

2,LEU,100
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 100
entity poly seq.hetero: n

2,ARG,101
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 101
entity poly seq.hetero: n

2,THR,102
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 102
entity poly seq.hetero: n

2,GLY,103
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 103
entity poly seq.hetero: n

2,PRO,104
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 104
entity poly seq.hetero: n

2,PHE,105
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 105
entity poly seq.hetero: n

2,ASP,106
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 106
entity poly seq.hetero: n

2,TYR,107
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 107
entity poly seq.hetero: n

2,TRP,108
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TRP
entity poly seq.num: 108
entity poly seq.hetero: n

2,GLY,109
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 109
entity poly seq.hetero: n

2,GLN,110
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 110
entity poly seq.hetero: n

2,GLY,111
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 111
entity poly seq.hetero: n

2,THR,112
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 112
entity poly seq.hetero: n

2,LEU,113
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 113
entity poly seq.hetero: n

2,VAL,114
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 114
entity poly seq.hetero: n

2,THR,115
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 115
entity poly seq.hetero: n

2,VAL,116
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 116
entity poly seq.hetero: n

2,SER,117
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 117
entity poly seq.hetero: n

2,SER,118
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 118
entity poly seq.hetero: n

2,ALA,119
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 119
entity poly seq.hetero: n

2,SER,120
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 120
entity poly seq.hetero: n

2,THR,121
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 121
entity poly seq.hetero: n

2,LYS,122
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 122
entity poly seq.hetero: n

2,GLY,123
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 123
entity poly seq.hetero: n

2,PRO,124
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 124
entity poly seq.hetero: n

2,SER,125
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 125
entity poly seq.hetero: n

2,VAL,126
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 126
entity poly seq.hetero: n

2,PHE,127
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 127
entity poly seq.hetero: n

2,PRO,128
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 128
entity poly seq.hetero: n

2,LEU,129
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 129
entity poly seq.hetero: n

2,ALA,130
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 130
entity poly seq.hetero: n

2,PRO,131
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 131
entity poly seq.hetero: n

2,SER,132
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 132
entity poly seq.hetero: n

2,SER,133
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 133
entity poly seq.hetero: n

2,LYS,134
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 134
entity poly seq.hetero: n

2,SER,135
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 135
entity poly seq.hetero: n

2,THR,136
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 136
entity poly seq.hetero: n

2,SER,137
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 137
entity poly seq.hetero: n

2,GLY,138
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 138
entity poly seq.hetero: n

2,GLY,139
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 139
entity poly seq.hetero: n

2,THR,140
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 140
entity poly seq.hetero: n

2,ALA,141
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 141
entity poly seq.hetero: n

2,ALA,142
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 142
entity poly seq.hetero: n

2,LEU,143
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 143
entity poly seq.hetero: n

2,GLY,144
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 144
entity poly seq.hetero: n

2,CYS,145
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: CYS
entity poly seq.num: 145
entity poly seq.hetero: n

2,LEU,146
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 146
entity poly seq.hetero: n

2,VAL,147
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 147
entity poly seq.hetero: n

2,LYS,148
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 148
entity poly seq.hetero: n

2,ASP,149
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 149
entity poly seq.hetero: n

2,TYR,150
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 150
entity poly seq.hetero: n

2,PHE,151
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 151
entity poly seq.hetero: n

2,PRO,152
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 152
entity poly seq.hetero: n

2,GLU,153
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLU
entity poly seq.num: 153
entity poly seq.hetero: n

2,PRO,154
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 154
entity poly seq.hetero: n

2,VAL,155
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 155
entity poly seq.hetero: n

2,THR,156
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 156
entity poly seq.hetero: n

2,VAL,157
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 157
entity poly seq.hetero: n

2,SER,158
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 158
entity poly seq.hetero: n

2,TRP,159
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TRP
entity poly seq.num: 159
entity poly seq.hetero: n

2,ASN,160
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 160
entity poly seq.hetero: n

2,SER,161
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 161
entity poly seq.hetero: n

2,GLY,162
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 162
entity poly seq.hetero: n

2,ALA,163
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 163
entity poly seq.hetero: n

2,LEU,164
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 164
entity poly seq.hetero: n

2,THR,165
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 165
entity poly seq.hetero: n

2,SER,166
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 166
entity poly seq.hetero: n

2,GLY,167
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 167
entity poly seq.hetero: n

2,VAL,168
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 168
entity poly seq.hetero: n

2,HIS,169
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: HIS
entity poly seq.num: 169
entity poly seq.hetero: n

2,THR,170
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 170
entity poly seq.hetero: n

2,PHE,171
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PHE
entity poly seq.num: 171
entity poly seq.hetero: n

2,PRO,172
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 172
entity poly seq.hetero: n

2,ALA,173
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 173
entity poly seq.hetero: n

2,VAL,174
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 174
entity poly seq.hetero: n

2,LEU,175
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 175
entity poly seq.hetero: n

2,GLN,176
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 176
entity poly seq.hetero: n

2,SER,177
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 177
entity poly seq.hetero: n

2,SER,178
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 178
entity poly seq.hetero: n

2,GLY,179
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 179
entity poly seq.hetero: n

2,LEU,180
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 180
entity poly seq.hetero: n

2,TYR,181
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 181
entity poly seq.hetero: n

2,SER,182
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 182
entity poly seq.hetero: n

2,LEU,183
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 183
entity poly seq.hetero: n

2,SER,184
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 184
entity poly seq.hetero: n

2,SER,185
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 185
entity poly seq.hetero: n

2,VAL,186
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 186
entity poly seq.hetero: n

2,VAL,187
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 187
entity poly seq.hetero: n

2,THR,188
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 188
entity poly seq.hetero: n

2,VAL,189
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 189
entity poly seq.hetero: n

2,PRO,190
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 190
entity poly seq.hetero: n

2,SER,191
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 191
entity poly seq.hetero: n

2,SER,192
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 192
entity poly seq.hetero: n

2,SER,193
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 193
entity poly seq.hetero: n

2,LEU,194
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LEU
entity poly seq.num: 194
entity poly seq.hetero: n

2,GLY,195
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLY
entity poly seq.num: 195
entity poly seq.hetero: n

2,THR,196
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 196
entity poly seq.hetero: n

2,GLN,197
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: GLN
entity poly seq.num: 197
entity poly seq.hetero: n

2,THR,198
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 198
entity poly seq.hetero: n

2,TYR,199
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: TYR
entity poly seq.num: 199
entity poly seq.hetero: n

2,ILE,200
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ILE
entity poly seq.num: 200
entity poly seq.hetero: n

2,CYS,201
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: CYS
entity poly seq.num: 201
entity poly seq.hetero: n

2,ASN,202
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 202
entity poly seq.hetero: n

2,VAL,203
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 203
entity poly seq.hetero: n

2,ASN,204
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 204
entity poly seq.hetero: n

2,HIS,205
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: HIS
entity poly seq.num: 205
entity poly seq.hetero: n

2,LYS,206
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 206
entity poly seq.hetero: n

2,PRO,207
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 207
entity poly seq.hetero: n

2,SER,208
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: SER
entity poly seq.num: 208
entity poly seq.hetero: n

2,ASN,209
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASN
entity poly seq.num: 209
entity poly seq.hetero: n

2,THR,210
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: THR
entity poly seq.num: 210
entity poly seq.hetero: n

2,LYS,211
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 211
entity poly seq.hetero: n

2,VAL,212
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 212
entity poly seq.hetero: n

2,ASP,213
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ASP
entity poly seq.num: 213
entity poly seq.hetero: n

2,LYS,214
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: LYS
entity poly seq.num: 214
entity poly seq.hetero: n

2,ARG,215
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ARG
entity poly seq.num: 215
entity poly seq.hetero: n

2,VAL,216
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: VAL
entity poly seq.num: 216
entity poly seq.hetero: n

2,ALA,217
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: ALA
entity poly seq.num: 217
entity poly seq.hetero: n

2,PRO,218
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 2
entity poly seq.mon id: PRO
entity poly seq.num: 218
entity poly seq.hetero: n

3,GLU,1
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 1
entity poly seq.hetero: n

3,ILE,2
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 2
entity poly seq.hetero: n

3,VAL,3
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 3
entity poly seq.hetero: n

3,LEU,4
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 4
entity poly seq.hetero: n

3,THR,5
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 5
entity poly seq.hetero: n

3,GLN,6
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 6
entity poly seq.hetero: n

3,SER,7
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 7
entity poly seq.hetero: n

3,PRO,8
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 8
entity poly seq.hetero: n

3,ASP,9
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 9
entity poly seq.hetero: n

3,PHE,10
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 10
entity poly seq.hetero: n

3,GLN,11
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 11
entity poly seq.hetero: n

3,SER,12
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 12
entity poly seq.hetero: n

3,VAL,13
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 13
entity poly seq.hetero: n

3,THR,14
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 14
entity poly seq.hetero: n

3,PRO,15
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 15
entity poly seq.hetero: n

3,LYS,16
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 16
entity poly seq.hetero: n

3,GLU,17
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 17
entity poly seq.hetero: n

3,LYS,18
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 18
entity poly seq.hetero: n

3,VAL,19
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 19
entity poly seq.hetero: n

3,THR,20
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 20
entity poly seq.hetero: n

3,ILE,21
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 21
entity poly seq.hetero: n

3,THR,22
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 22
entity poly seq.hetero: n

3,CYS,23
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: CYS
entity poly seq.num: 23
entity poly seq.hetero: n

3,ARG,24
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ARG
entity poly seq.num: 24
entity poly seq.hetero: n

3,ALA,25
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 25
entity poly seq.hetero: n

3,SER,26
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 26
entity poly seq.hetero: n

3,GLN,27
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 27
entity poly seq.hetero: n

3,SER,28
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 28
entity poly seq.hetero: n

3,ILE,29
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 29
entity poly seq.hetero: n

3,GLY,30
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 30
entity poly seq.hetero: n

3,SER,31
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 31
entity poly seq.hetero: n

3,SER,32
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 32
entity poly seq.hetero: n

3,LEU,33
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 33
entity poly seq.hetero: n

3,HIS,34
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: HIS
entity poly seq.num: 34
entity poly seq.hetero: n

3,TRP,35
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TRP
entity poly seq.num: 35
entity poly seq.hetero: n

3,TYR,36
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 36
entity poly seq.hetero: n

3,GLN,37
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 37
entity poly seq.hetero: n

3,GLN,38
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 38
entity poly seq.hetero: n

3,LYS,39
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 39
entity poly seq.hetero: n

3,PRO,40
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 40
entity poly seq.hetero: n

3,ASP,41
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 41
entity poly seq.hetero: n

3,GLN,42
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 42
entity poly seq.hetero: n

3,SER,43
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 43
entity poly seq.hetero: n

3,PRO,44
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 44
entity poly seq.hetero: n

3,LYS,45
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 45
entity poly seq.hetero: n

3,LEU,46
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 46
entity poly seq.hetero: n

3,LEU,47
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 47
entity poly seq.hetero: n

3,ILE,48
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 48
entity poly seq.hetero: n

3,LYS,49
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 49
entity poly seq.hetero: n

3,TYR,50
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 50
entity poly seq.hetero: n

3,ALA,51
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 51
entity poly seq.hetero: n

3,SER,52
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 52
entity poly seq.hetero: n

3,GLN,53
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 53
entity poly seq.hetero: n

3,SER,54
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 54
entity poly seq.hetero: n

3,PHE,55
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 55
entity poly seq.hetero: n

3,SER,56
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 56
entity poly seq.hetero: n

3,GLY,57
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 57
entity poly seq.hetero: n

3,VAL,58
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 58
entity poly seq.hetero: n

3,PRO,59
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 59
entity poly seq.hetero: n

3,SER,60
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 60
entity poly seq.hetero: n

3,ARG,61
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ARG
entity poly seq.num: 61
entity poly seq.hetero: n

3,PHE,62
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 62
entity poly seq.hetero: n

3,SER,63
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 63
entity poly seq.hetero: n

3,GLY,64
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 64
entity poly seq.hetero: n

3,SER,65
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 65
entity poly seq.hetero: n

3,GLY,66
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 66
entity poly seq.hetero: n

3,SER,67
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 67
entity poly seq.hetero: n

3,GLY,68
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 68
entity poly seq.hetero: n

3,THR,69
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 69
entity poly seq.hetero: n

3,ASP,70
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 70
entity poly seq.hetero: n

3,PHE,71
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 71
entity poly seq.hetero: n

3,THR,72
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 72
entity poly seq.hetero: n

3,LEU,73
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 73
entity poly seq.hetero: n

3,THR,74
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 74
entity poly seq.hetero: n

3,ILE,75
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 75
entity poly seq.hetero: n

3,ASN,76
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 76
entity poly seq.hetero: n

3,SER,77
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 77
entity poly seq.hetero: n

3,LEU,78
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 78
entity poly seq.hetero: n

3,GLU,79
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 79
entity poly seq.hetero: n

3,ALA,80
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 80
entity poly seq.hetero: n

3,GLU,81
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 81
entity poly seq.hetero: n

3,ASP,82
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 82
entity poly seq.hetero: n

3,ALA,83
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 83
entity poly seq.hetero: n

3,ALA,84
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 84
entity poly seq.hetero: n

3,ALA,85
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 85
entity poly seq.hetero: n

3,TYR,86
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 86
entity poly seq.hetero: n

3,TYR,87
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 87
entity poly seq.hetero: n

3,CYS,88
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: CYS
entity poly seq.num: 88
entity poly seq.hetero: n

3,HIS,89
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: HIS
entity poly seq.num: 89
entity poly seq.hetero: n

3,GLN,90
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 90
entity poly seq.hetero: n

3,SER,91
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 91
entity poly seq.hetero: n

3,SER,92
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 92
entity poly seq.hetero: n

3,SER,93
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 93
entity poly seq.hetero: n

3,LEU,94
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 94
entity poly seq.hetero: n

3,PRO,95
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 95
entity poly seq.hetero: n

3,PHE,96
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 96
entity poly seq.hetero: n

3,THR,97
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 97
entity poly seq.hetero: n

3,PHE,98
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 98
entity poly seq.hetero: n

3,GLY,99
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 99
entity poly seq.hetero: n

3,PRO,100
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 100
entity poly seq.hetero: n

3,GLY,101
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 101
entity poly seq.hetero: n

3,THR,102
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 102
entity poly seq.hetero: n

3,LYS,103
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 103
entity poly seq.hetero: n

3,VAL,104
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 104
entity poly seq.hetero: n

3,ASP,105
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 105
entity poly seq.hetero: n

3,ILE,106
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 106
entity poly seq.hetero: n

3,LYS,107
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 107
entity poly seq.hetero: n

3,ARG,108
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ARG
entity poly seq.num: 108
entity poly seq.hetero: n

3,THR,109
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 109
entity poly seq.hetero: n

3,VAL,110
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 110
entity poly seq.hetero: n

3,ALA,111
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 111
entity poly seq.hetero: n

3,ALA,112
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 112
entity poly seq.hetero: n

3,PRO,113
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 113
entity poly seq.hetero: n

3,SER,114
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 114
entity poly seq.hetero: n

3,VAL,115
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 115
entity poly seq.hetero: n

3,PHE,116
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 116
entity poly seq.hetero: n

3,ILE,117
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ILE
entity poly seq.num: 117
entity poly seq.hetero: n

3,PHE,118
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 118
entity poly seq.hetero: n

3,PRO,119
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 119
entity poly seq.hetero: n

3,PRO,120
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 120
entity poly seq.hetero: n

3,SER,121
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 121
entity poly seq.hetero: n

3,ASP,122
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 122
entity poly seq.hetero: n

3,GLU,123
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 123
entity poly seq.hetero: n

3,GLN,124
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 124
entity poly seq.hetero: n

3,LEU,125
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 125
entity poly seq.hetero: n

3,LYS,126
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 126
entity poly seq.hetero: n

3,SER,127
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 127
entity poly seq.hetero: n

3,GLY,128
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 128
entity poly seq.hetero: n

3,THR,129
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 129
entity poly seq.hetero: n

3,ALA,130
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 130
entity poly seq.hetero: n

3,SER,131
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 131
entity poly seq.hetero: n

3,VAL,132
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 132
entity poly seq.hetero: n

3,VAL,133
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 133
entity poly seq.hetero: n

3,CYS,134
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: CYS
entity poly seq.num: 134
entity poly seq.hetero: n

3,LEU,135
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 135
entity poly seq.hetero: n

3,LEU,136
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 136
entity poly seq.hetero: n

3,ASN,137
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 137
entity poly seq.hetero: n

3,ASN,138
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 138
entity poly seq.hetero: n

3,PHE,139
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 139
entity poly seq.hetero: n

3,TYR,140
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 140
entity poly seq.hetero: n

3,PRO,141
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 141
entity poly seq.hetero: n

3,ARG,142
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ARG
entity poly seq.num: 142
entity poly seq.hetero: n

3,GLU,143
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 143
entity poly seq.hetero: n

3,ALA,144
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 144
entity poly seq.hetero: n

3,LYS,145
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 145
entity poly seq.hetero: n

3,VAL,146
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 146
entity poly seq.hetero: n

3,GLN,147
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 147
entity poly seq.hetero: n

3,TRP,148
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TRP
entity poly seq.num: 148
entity poly seq.hetero: n

3,LYS,149
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 149
entity poly seq.hetero: n

3,VAL,150
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 150
entity poly seq.hetero: n

3,ASP,151
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 151
entity poly seq.hetero: n

3,ASN,152
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 152
entity poly seq.hetero: n

3,ALA,153
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 153
entity poly seq.hetero: n

3,LEU,154
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 154
entity poly seq.hetero: n

3,GLN,155
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 155
entity poly seq.hetero: n

3,SER,156
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 156
entity poly seq.hetero: n

3,GLY,157
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 157
entity poly seq.hetero: n

3,ASN,158
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 158
entity poly seq.hetero: n

3,SER,159
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 159
entity poly seq.hetero: n

3,GLN,160
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 160
entity poly seq.hetero: n

3,GLU,161
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 161
entity poly seq.hetero: n

3,SER,162
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 162
entity poly seq.hetero: n

3,VAL,163
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 163
entity poly seq.hetero: n

3,THR,164
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 164
entity poly seq.hetero: n

3,GLU,165
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 165
entity poly seq.hetero: n

3,GLN,166
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 166
entity poly seq.hetero: n

3,ASP,167
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 167
entity poly seq.hetero: n

3,SER,168
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 168
entity poly seq.hetero: n

3,LYS,169
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 169
entity poly seq.hetero: n

3,ASP,170
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 170
entity poly seq.hetero: n

3,SER,171
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 171
entity poly seq.hetero: n

3,THR,172
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 172
entity poly seq.hetero: n

3,TYR,173
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 173
entity poly seq.hetero: n

3,SER,174
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 174
entity poly seq.hetero: n

3,LEU,175
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 175
entity poly seq.hetero: n

3,SER,176
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 176
entity poly seq.hetero: n

3,SER,177
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 177
entity poly seq.hetero: n

3,THR,178
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 178
entity poly seq.hetero: n

3,LEU,179
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 179
entity poly seq.hetero: n

3,THR,180
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 180
entity poly seq.hetero: n

3,LEU,181
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 181
entity poly seq.hetero: n

3,SER,182
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 182
entity poly seq.hetero: n

3,LYS,183
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 183
entity poly seq.hetero: n

3,ALA,184
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 184
entity poly seq.hetero: n

3,ASP,185
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASP
entity poly seq.num: 185
entity poly seq.hetero: n

3,TYR,186
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 186
entity poly seq.hetero: n

3,GLU,187
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 187
entity poly seq.hetero: n

3,LYS,188
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 188
entity poly seq.hetero: n

3,HIS,189
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: HIS
entity poly seq.num: 189
entity poly seq.hetero: n

3,LYS,190
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 190
entity poly seq.hetero: n

3,VAL,191
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 191
entity poly seq.hetero: n

3,TYR,192
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: TYR
entity poly seq.num: 192
entity poly seq.hetero: n

3,ALA,193
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ALA
entity poly seq.num: 193
entity poly seq.hetero: n

3,CYS,194
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: CYS
entity poly seq.num: 194
entity poly seq.hetero: n

3,GLU,195
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLU
entity poly seq.num: 195
entity poly seq.hetero: n

3,VAL,196
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 196
entity poly seq.hetero: n

3,THR,197
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 197
entity poly seq.hetero: n

3,HIS,198
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: HIS
entity poly seq.num: 198
entity poly seq.hetero: n

3,GLN,199
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLN
entity poly seq.num: 199
entity poly seq.hetero: n

3,GLY,200
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 200
entity poly seq.hetero: n

3,LEU,201
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LEU
entity poly seq.num: 201
entity poly seq.hetero: n

3,SER,202
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 202
entity poly seq.hetero: n

3,SER,203
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 203
entity poly seq.hetero: n

3,PRO,204
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PRO
entity poly seq.num: 204
entity poly seq.hetero: n

3,VAL,205
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: VAL
entity poly seq.num: 205
entity poly seq.hetero: n

3,THR,206
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: THR
entity poly seq.num: 206
entity poly seq.hetero: n

3,LYS,207
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: LYS
entity poly seq.num: 207
entity poly seq.hetero: n

3,SER,208
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: SER
entity poly seq.num: 208
entity poly seq.hetero: n

3,PHE,209
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: PHE
entity poly seq.num: 209
entity poly seq.hetero: n

3,ASN,210
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ASN
entity poly seq.num: 210
entity poly seq.hetero: n

3,ARG,211
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: ARG
entity poly seq.num: 211
entity poly seq.hetero: n

3,GLY,212
type: entity poly seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: chem comp
reference to entity poly: entity poly
entity poly seq.entity id: 3
entity poly seq.mon id: GLY
entity poly seq.num: 212
entity poly seq.hetero: n

4G6J
type: entry
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
entry.id: 4G6J
referenced by reflns: http://rdf.wwpdb.org/pdb/4G6J/reflns/1

4G6J,X-RAY DIFFRACTION
type: exptl
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
exptl.entry id: 4G6J
exptl.method: X-RAY DIFFRACTION
exptl.crystals number: 1

http://rdf.wwpdb.org/pdb/4G6J/exptl_crystal_grow/1
type: exptl crystal grow
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to exptl crystal: exptl crystal
exptl crystal grow.crystal id: 1
exptl crystal grow.method: VAPOR DIFFUSION, SITTING DROP
exptl crystal grow.p h: 4.5
exptl crystal grow.pdbx details: 17.2% w/v PEG 3350 and 0.14M tri-sodium citrate, 24% w/v PEG 3350, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
exptl crystal grow.temp: 293

Structure model,1,1
type: pdbx audit revision details
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx audit revision history: http://rdf.wwpdb.org/pdb/4G6J/pdbx_audit_revision_history/,
pdbx audit revision details.data content type: Structure model
pdbx audit revision details.ordinal: 1
pdbx audit revision details.revision ordinal: 1
pdbx audit revision details.provider: repository
pdbx audit revision details.type: Initial release

Structure model,1,2
type: pdbx audit revision group
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx audit revision history: http://rdf.wwpdb.org/pdb/4G6J/pdbx_audit_revision_history/,
pdbx audit revision group.data content type: Structure model
pdbx audit revision group.ordinal: 1
pdbx audit revision group.revision ordinal: 2
pdbx audit revision group.group: Database references

Structure model,1
type: pdbx audit revision history
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx audit revision history.data content type: Structure model
pdbx audit revision history.ordinal: 1
pdbx audit revision history.major revision: 1
pdbx audit revision history.minor revision: 0
pdbx audit revision history.revision date: 2012-12-19

Structure model,2
type: pdbx audit revision history
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx audit revision history.data content type: Structure model
pdbx audit revision history.ordinal: 2
pdbx audit revision history.major revision: 1
pdbx audit revision history.minor revision: 1
pdbx audit revision history.revision date: 2013-07-17

unspecified,4G5Z,PDB
type: pdbx database related
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx database related.content type: unspecified
pdbx database related.db id: 4G5Z
pdbx database related.db name: PDB
link to pdb: 4G5Z
pdbx database related.details: antibody binding fragment in its unbound state

4G6J
type: pdbx database status
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
pdbx database status.entry id: 4G6J
pdbx database status.deposit site: RCSB
pdbx database status.pdb format compatible: Y
pdbx database status.process site: RCSB
pdbx database status.recvd initial deposition date: 2012-07-19
pdbx database status.status code: REL
pdbx database status.status code sf: REL

http://rdf.wwpdb.org/pdb/4G6J/pdbx_entity_nonpoly/4
type: pdbx entity nonpoly
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
pdbx entity nonpoly.entity id: 4
pdbx entity nonpoly.comp id: HOH
pdbx entity nonpoly.name: water

1,1
type: pdbx entity src syn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
pdbx entity src syn.entity id: 1
pdbx entity src syn.pdbx src id: 1
pdbx entity src syn.ncbi taxonomy id: 9606
pdbx entity src syn.organism common name: human
pdbx entity src syn.organism scientific: Homo sapiens
pdbx entity src syn.pdbx alt source flag: sample

2,1
type: pdbx entity src syn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
pdbx entity src syn.entity id: 2
pdbx entity src syn.pdbx src id: 1
pdbx entity src syn.ncbi taxonomy id: 9606
pdbx entity src syn.organism common name: human
pdbx entity src syn.organism scientific: Homo sapiens
pdbx entity src syn.pdbx alt source flag: sample

3,1
type: pdbx entity src syn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: entity
pdbx entity src syn.entity id: 3
pdbx entity src syn.pdbx src id: 1
pdbx entity src syn.ncbi taxonomy id: 9606
pdbx entity src syn.organism common name: human
pdbx entity src syn.organism scientific: Homo sapiens
pdbx entity src syn.pdbx alt source flag: sample

D,1
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 1
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 1
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 201
pdbx nonpoly scheme.pdb strand id: A

D,2
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 2
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 4
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 202
pdbx nonpoly scheme.pdb strand id: A

D,3
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 3
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 7
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 203
pdbx nonpoly scheme.pdb strand id: A

D,4
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 4
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 8
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 204
pdbx nonpoly scheme.pdb strand id: A

D,5
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 5
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 10
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 205
pdbx nonpoly scheme.pdb strand id: A

D,6
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 6
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 13
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 206
pdbx nonpoly scheme.pdb strand id: A

D,7
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 7
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 14
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 207
pdbx nonpoly scheme.pdb strand id: A

D,8
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 8
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 18
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 208
pdbx nonpoly scheme.pdb strand id: A

D,9
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 9
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 20
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 209
pdbx nonpoly scheme.pdb strand id: A

D,10
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 10
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 22
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 210
pdbx nonpoly scheme.pdb strand id: A

D,11
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 11
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 23
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 211
pdbx nonpoly scheme.pdb strand id: A

D,12
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 12
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 24
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 212
pdbx nonpoly scheme.pdb strand id: A

D,13
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 13
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 27
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 213
pdbx nonpoly scheme.pdb strand id: A

D,14
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 14
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 42
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 214
pdbx nonpoly scheme.pdb strand id: A

D,15
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 15
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 43
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 215
pdbx nonpoly scheme.pdb strand id: A

D,16
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 16
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 52
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 216
pdbx nonpoly scheme.pdb strand id: A

D,17
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 17
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 56
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 217
pdbx nonpoly scheme.pdb strand id: A

D,18
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 18
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 62
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 218
pdbx nonpoly scheme.pdb strand id: A

D,19
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 19
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 65
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 219
pdbx nonpoly scheme.pdb strand id: A

D,20
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 20
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 67
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 220
pdbx nonpoly scheme.pdb strand id: A

D,21
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 21
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 70
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 221
pdbx nonpoly scheme.pdb strand id: A

D,22
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 22
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 76
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 222
pdbx nonpoly scheme.pdb strand id: A

D,23
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 23
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 79
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 223
pdbx nonpoly scheme.pdb strand id: A

D,24
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 24
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 103
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 224
pdbx nonpoly scheme.pdb strand id: A

D,25
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 25
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 112
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 225
pdbx nonpoly scheme.pdb strand id: A

D,26
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 26
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 119
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 226
pdbx nonpoly scheme.pdb strand id: A

D,27
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 27
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 124
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 227
pdbx nonpoly scheme.pdb strand id: A

D,28
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 28
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 125
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 228
pdbx nonpoly scheme.pdb strand id: A

D,29
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 29
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 127
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 229
pdbx nonpoly scheme.pdb strand id: A

D,30
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 30
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 131
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 230
pdbx nonpoly scheme.pdb strand id: A

D,31
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 31
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 133
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 231
pdbx nonpoly scheme.pdb strand id: A

D,32
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 32
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 138
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 232
pdbx nonpoly scheme.pdb strand id: A

D,33
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 33
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 146
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 233
pdbx nonpoly scheme.pdb strand id: A

D,34
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 34
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 155
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 234
pdbx nonpoly scheme.pdb strand id: A

D,35
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 35
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 157
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 235
pdbx nonpoly scheme.pdb strand id: A

D,36
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 36
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 159
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 236
pdbx nonpoly scheme.pdb strand id: A

D,37
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 37
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 162
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 237
pdbx nonpoly scheme.pdb strand id: A

D,38
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 38
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 164
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 238
pdbx nonpoly scheme.pdb strand id: A

D,39
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 39
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 166
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 239
pdbx nonpoly scheme.pdb strand id: A

D,40
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 40
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 172
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 240
pdbx nonpoly scheme.pdb strand id: A

D,41
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 41
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 181
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 241
pdbx nonpoly scheme.pdb strand id: A

D,42
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 42
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 186
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 242
pdbx nonpoly scheme.pdb strand id: A

D,43
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 43
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 194
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 243
pdbx nonpoly scheme.pdb strand id: A

D,44
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 44
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 202
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 244
pdbx nonpoly scheme.pdb strand id: A

D,45
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 45
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 214
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 245
pdbx nonpoly scheme.pdb strand id: A

D,46
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 46
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 217
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 246
pdbx nonpoly scheme.pdb strand id: A

D,47
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 47
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 227
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 247
pdbx nonpoly scheme.pdb strand id: A

D,48
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 48
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 230
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 248
pdbx nonpoly scheme.pdb strand id: A

D,49
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 49
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 240
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 249
pdbx nonpoly scheme.pdb strand id: A

D,50
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 50
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 244
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 250
pdbx nonpoly scheme.pdb strand id: A

D,51
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 51
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 247
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 251
pdbx nonpoly scheme.pdb strand id: A

D,52
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 52
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 248
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 252
pdbx nonpoly scheme.pdb strand id: A

D,53
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 53
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 253
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 253
pdbx nonpoly scheme.pdb strand id: A

D,54
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 54
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 254
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 254
pdbx nonpoly scheme.pdb strand id: A

D,55
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 55
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 257
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 255
pdbx nonpoly scheme.pdb strand id: A

D,56
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 56
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 260
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 256
pdbx nonpoly scheme.pdb strand id: A

D,57
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 57
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 263
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 257
pdbx nonpoly scheme.pdb strand id: A

D,58
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 58
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 264
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 258
pdbx nonpoly scheme.pdb strand id: A

D,59
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 59
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 267
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 259
pdbx nonpoly scheme.pdb strand id: A

D,60
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 60
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 268
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 260
pdbx nonpoly scheme.pdb strand id: A

D,61
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 61
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 270
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 261
pdbx nonpoly scheme.pdb strand id: A

D,62
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 62
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 275
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 262
pdbx nonpoly scheme.pdb strand id: A

D,63
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 63
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 286
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 263
pdbx nonpoly scheme.pdb strand id: A

D,64
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 64
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 292
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 264
pdbx nonpoly scheme.pdb strand id: A

D,65
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: D
pdbx nonpoly scheme.ndb seq num: 65
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 303
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 265
pdbx nonpoly scheme.pdb strand id: A

E,1
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 1
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 6
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 301
pdbx nonpoly scheme.pdb strand id: H

E,2
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 2
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 11
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 302
pdbx nonpoly scheme.pdb strand id: H

E,3
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 3
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 15
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 303
pdbx nonpoly scheme.pdb strand id: H

E,4
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 4
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 16
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 304
pdbx nonpoly scheme.pdb strand id: H

E,5
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 5
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 19
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 305
pdbx nonpoly scheme.pdb strand id: H

E,6
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 6
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 25
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 306
pdbx nonpoly scheme.pdb strand id: H

E,7
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 7
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 30
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 307
pdbx nonpoly scheme.pdb strand id: H

E,8
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 8
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 31
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 308
pdbx nonpoly scheme.pdb strand id: H

E,9
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 9
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 33
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 309
pdbx nonpoly scheme.pdb strand id: H

E,10
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 10
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 34
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 310
pdbx nonpoly scheme.pdb strand id: H

E,11
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 11
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 35
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 311
pdbx nonpoly scheme.pdb strand id: H

E,12
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 12
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 36
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 312
pdbx nonpoly scheme.pdb strand id: H

E,13
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 13
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 38
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 313
pdbx nonpoly scheme.pdb strand id: H

E,14
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 14
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 39
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 314
pdbx nonpoly scheme.pdb strand id: H

E,15
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 15
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 41
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 315
pdbx nonpoly scheme.pdb strand id: H

E,16
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 16
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 44
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 316
pdbx nonpoly scheme.pdb strand id: H

E,17
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 17
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 45
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 317
pdbx nonpoly scheme.pdb strand id: H

E,18
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 18
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 46
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 318
pdbx nonpoly scheme.pdb strand id: H

E,19
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 19
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 48
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 319
pdbx nonpoly scheme.pdb strand id: H

E,20
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 20
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 50
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 320
pdbx nonpoly scheme.pdb strand id: H

E,21
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 21
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 51
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 321
pdbx nonpoly scheme.pdb strand id: H

E,22
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 22
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 55
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 322
pdbx nonpoly scheme.pdb strand id: H

E,23
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 23
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 57
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 323
pdbx nonpoly scheme.pdb strand id: H

E,24
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 24
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 58
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 324
pdbx nonpoly scheme.pdb strand id: H

E,25
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 25
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 60
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 325
pdbx nonpoly scheme.pdb strand id: H

E,26
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 26
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 61
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 326
pdbx nonpoly scheme.pdb strand id: H

E,27
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 27
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 63
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 327
pdbx nonpoly scheme.pdb strand id: H

E,28
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 28
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 64
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 328
pdbx nonpoly scheme.pdb strand id: H

E,29
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 29
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 68
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 329
pdbx nonpoly scheme.pdb strand id: H

E,30
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 30
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 71
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 330
pdbx nonpoly scheme.pdb strand id: H

E,31
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 31
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 72
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 331
pdbx nonpoly scheme.pdb strand id: H

E,32
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 32
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 80
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 332
pdbx nonpoly scheme.pdb strand id: H

E,33
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 33
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 83
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 333
pdbx nonpoly scheme.pdb strand id: H

E,34
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 34
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 87
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 334
pdbx nonpoly scheme.pdb strand id: H

E,35
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 35
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 88
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 335
pdbx nonpoly scheme.pdb strand id: H

E,36
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 36
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 89
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 336
pdbx nonpoly scheme.pdb strand id: H

E,37
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 37
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 90
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 337
pdbx nonpoly scheme.pdb strand id: H

E,38
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 38
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 91
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 338
pdbx nonpoly scheme.pdb strand id: H

E,39
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 39
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 92
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 339
pdbx nonpoly scheme.pdb strand id: H

E,40
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 40
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 93
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 340
pdbx nonpoly scheme.pdb strand id: H

E,41
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 41
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 95
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 341
pdbx nonpoly scheme.pdb strand id: H

E,42
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 42
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 96
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 342
pdbx nonpoly scheme.pdb strand id: H

E,43
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 43
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 97
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 343
pdbx nonpoly scheme.pdb strand id: H

E,44
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 44
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 100
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 344
pdbx nonpoly scheme.pdb strand id: H

E,45
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 45
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 102
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 345
pdbx nonpoly scheme.pdb strand id: H

E,46
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 46
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 105
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 346
pdbx nonpoly scheme.pdb strand id: H

E,47
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 47
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 107
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 347
pdbx nonpoly scheme.pdb strand id: H

E,48
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 48
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 113
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 348
pdbx nonpoly scheme.pdb strand id: H

E,49
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 49
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 114
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 349
pdbx nonpoly scheme.pdb strand id: H

E,50
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 50
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 115
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 350
pdbx nonpoly scheme.pdb strand id: H

E,51
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 51
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 116
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 351
pdbx nonpoly scheme.pdb strand id: H

E,52
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 52
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 117
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 352
pdbx nonpoly scheme.pdb strand id: H

E,53
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 53
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 120
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 353
pdbx nonpoly scheme.pdb strand id: H

E,54
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 54
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 121
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 354
pdbx nonpoly scheme.pdb strand id: H

E,55
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 55
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 122
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 355
pdbx nonpoly scheme.pdb strand id: H

E,56
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 56
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 123
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 356
pdbx nonpoly scheme.pdb strand id: H

E,57
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 57
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 126
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 357
pdbx nonpoly scheme.pdb strand id: H

E,58
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 58
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 128
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 358
pdbx nonpoly scheme.pdb strand id: H

E,59
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 59
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 132
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 359
pdbx nonpoly scheme.pdb strand id: H

E,60
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 60
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 134
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 360
pdbx nonpoly scheme.pdb strand id: H

E,61
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 61
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 135
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 361
pdbx nonpoly scheme.pdb strand id: H

E,62
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 62
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 136
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 362
pdbx nonpoly scheme.pdb strand id: H

E,63
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 63
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 139
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 363
pdbx nonpoly scheme.pdb strand id: H

E,64
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 64
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 141
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 364
pdbx nonpoly scheme.pdb strand id: H

E,65
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 65
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 144
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 365
pdbx nonpoly scheme.pdb strand id: H

E,66
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 66
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 147
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 366
pdbx nonpoly scheme.pdb strand id: H

E,67
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 67
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 148
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 367
pdbx nonpoly scheme.pdb strand id: H

E,68
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 68
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 149
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 368
pdbx nonpoly scheme.pdb strand id: H

E,69
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 69
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 151
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 369
pdbx nonpoly scheme.pdb strand id: H

E,70
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 70
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 154
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 370
pdbx nonpoly scheme.pdb strand id: H

E,71
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 71
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 158
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 371
pdbx nonpoly scheme.pdb strand id: H

E,72
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 72
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 165
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 372
pdbx nonpoly scheme.pdb strand id: H

E,73
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 73
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 170
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 373
pdbx nonpoly scheme.pdb strand id: H

E,74
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 74
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 174
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 374
pdbx nonpoly scheme.pdb strand id: H

E,75
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 75
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 175
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 375
pdbx nonpoly scheme.pdb strand id: H

E,76
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 76
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 176
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 376
pdbx nonpoly scheme.pdb strand id: H

E,77
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 77
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 178
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 377
pdbx nonpoly scheme.pdb strand id: H

E,78
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 78
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 180
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 378
pdbx nonpoly scheme.pdb strand id: H

E,79
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 79
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 191
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 379
pdbx nonpoly scheme.pdb strand id: H

E,80
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 80
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 192
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 380
pdbx nonpoly scheme.pdb strand id: H

E,81
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 81
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 193
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 381
pdbx nonpoly scheme.pdb strand id: H

E,82
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 82
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 197
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 382
pdbx nonpoly scheme.pdb strand id: H

E,83
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 83
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 200
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 383
pdbx nonpoly scheme.pdb strand id: H

E,84
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 84
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 201
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 384
pdbx nonpoly scheme.pdb strand id: H

E,85
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 85
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 206
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 385
pdbx nonpoly scheme.pdb strand id: H

E,86
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 86
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 207
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 386
pdbx nonpoly scheme.pdb strand id: H

E,87
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 87
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 210
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 387
pdbx nonpoly scheme.pdb strand id: H

E,88
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 88
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 218
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 388
pdbx nonpoly scheme.pdb strand id: H

E,89
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 89
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 220
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 389
pdbx nonpoly scheme.pdb strand id: H

E,90
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 90
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 224
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 390
pdbx nonpoly scheme.pdb strand id: H

E,91
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 91
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 228
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 391
pdbx nonpoly scheme.pdb strand id: H

E,92
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 92
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 231
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 392
pdbx nonpoly scheme.pdb strand id: H

E,93
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 93
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 232
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 393
pdbx nonpoly scheme.pdb strand id: H

E,94
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 94
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 236
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 394
pdbx nonpoly scheme.pdb strand id: H

E,95
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 95
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 237
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 395
pdbx nonpoly scheme.pdb strand id: H

E,96
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 96
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 238
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 396
pdbx nonpoly scheme.pdb strand id: H

E,97
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 97
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 239
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 397
pdbx nonpoly scheme.pdb strand id: H

E,98
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 98
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 241
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 398
pdbx nonpoly scheme.pdb strand id: H

E,99
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 99
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 243
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 399
pdbx nonpoly scheme.pdb strand id: H

E,100
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 100
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 258
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 400
pdbx nonpoly scheme.pdb strand id: H

E,101
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 101
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 259
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 401
pdbx nonpoly scheme.pdb strand id: H

E,102
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 102
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 265
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 402
pdbx nonpoly scheme.pdb strand id: H

E,103
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 103
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 269
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 403
pdbx nonpoly scheme.pdb strand id: H

E,104
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 104
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 271
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 404
pdbx nonpoly scheme.pdb strand id: H

E,105
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 105
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 272
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 405
pdbx nonpoly scheme.pdb strand id: H

E,106
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 106
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 273
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 406
pdbx nonpoly scheme.pdb strand id: H

E,107
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 107
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 274
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 407
pdbx nonpoly scheme.pdb strand id: H

E,108
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 108
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 276
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 408
pdbx nonpoly scheme.pdb strand id: H

E,109
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 109
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 277
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 409
pdbx nonpoly scheme.pdb strand id: H

E,110
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 110
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 280
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 410
pdbx nonpoly scheme.pdb strand id: H

E,111
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 111
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 283
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 411
pdbx nonpoly scheme.pdb strand id: H

E,112
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 112
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 287
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 412
pdbx nonpoly scheme.pdb strand id: H

E,113
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 113
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 288
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 413
pdbx nonpoly scheme.pdb strand id: H

E,114
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 114
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 289
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 414
pdbx nonpoly scheme.pdb strand id: H

E,115
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 115
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 290
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 415
pdbx nonpoly scheme.pdb strand id: H

E,116
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 116
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 293
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 416
pdbx nonpoly scheme.pdb strand id: H

E,117
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 117
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 294
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 417
pdbx nonpoly scheme.pdb strand id: H

E,118
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 118
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 295
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 418
pdbx nonpoly scheme.pdb strand id: H

E,119
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 119
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 296
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 419
pdbx nonpoly scheme.pdb strand id: H

E,120
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 120
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 297
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 420
pdbx nonpoly scheme.pdb strand id: H

E,121
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 121
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 298
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 421
pdbx nonpoly scheme.pdb strand id: H

E,122
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: E
pdbx nonpoly scheme.ndb seq num: 122
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 299
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 422
pdbx nonpoly scheme.pdb strand id: H

F,1
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 1
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 2
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 301
pdbx nonpoly scheme.pdb strand id: L

F,2
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 2
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 3
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 302
pdbx nonpoly scheme.pdb strand id: L

F,3
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 3
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 5
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 303
pdbx nonpoly scheme.pdb strand id: L

F,4
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 4
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 9
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 304
pdbx nonpoly scheme.pdb strand id: L

F,5
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 5
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 12
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 305
pdbx nonpoly scheme.pdb strand id: L

F,6
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 6
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 17
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 306
pdbx nonpoly scheme.pdb strand id: L

F,7
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 7
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 21
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 307
pdbx nonpoly scheme.pdb strand id: L

F,8
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 8
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 26
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 308
pdbx nonpoly scheme.pdb strand id: L

F,9
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 9
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 28
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 309
pdbx nonpoly scheme.pdb strand id: L

F,10
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 10
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 29
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 310
pdbx nonpoly scheme.pdb strand id: L

F,11
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 11
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 32
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 311
pdbx nonpoly scheme.pdb strand id: L

F,12
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 12
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 37
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 312
pdbx nonpoly scheme.pdb strand id: L

F,13
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 13
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 40
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 313
pdbx nonpoly scheme.pdb strand id: L

F,14
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 14
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 47
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 314
pdbx nonpoly scheme.pdb strand id: L

F,15
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 15
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 49
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 315
pdbx nonpoly scheme.pdb strand id: L

F,16
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 16
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 53
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 316
pdbx nonpoly scheme.pdb strand id: L

F,17
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 17
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 54
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 317
pdbx nonpoly scheme.pdb strand id: L

F,18
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 18
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 59
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 318
pdbx nonpoly scheme.pdb strand id: L

F,19
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 19
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 66
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 319
pdbx nonpoly scheme.pdb strand id: L

F,20
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 20
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 69
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 320
pdbx nonpoly scheme.pdb strand id: L

F,21
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 21
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 73
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 321
pdbx nonpoly scheme.pdb strand id: L

F,22
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 22
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 74
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 322
pdbx nonpoly scheme.pdb strand id: L

F,23
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 23
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 75
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 323
pdbx nonpoly scheme.pdb strand id: L

F,24
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 24
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 77
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 324
pdbx nonpoly scheme.pdb strand id: L

F,25
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 25
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 78
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 325
pdbx nonpoly scheme.pdb strand id: L

F,26
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 26
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 81
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 326
pdbx nonpoly scheme.pdb strand id: L

F,27
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 27
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 82
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 327
pdbx nonpoly scheme.pdb strand id: L

F,28
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 28
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 84
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 328
pdbx nonpoly scheme.pdb strand id: L

F,29
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 29
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 85
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 329
pdbx nonpoly scheme.pdb strand id: L

F,30
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 30
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 86
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 330
pdbx nonpoly scheme.pdb strand id: L

F,31
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 31
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 94
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 331
pdbx nonpoly scheme.pdb strand id: L

F,32
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 32
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 98
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 332
pdbx nonpoly scheme.pdb strand id: L

F,33
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 33
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 99
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 333
pdbx nonpoly scheme.pdb strand id: L

F,34
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 34
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 101
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 334
pdbx nonpoly scheme.pdb strand id: L

F,35
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 35
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 104
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 335
pdbx nonpoly scheme.pdb strand id: L

F,36
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 36
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 106
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 336
pdbx nonpoly scheme.pdb strand id: L

F,37
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 37
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 108
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 337
pdbx nonpoly scheme.pdb strand id: L

F,38
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 38
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 109
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 338
pdbx nonpoly scheme.pdb strand id: L

F,39
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 39
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 110
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 339
pdbx nonpoly scheme.pdb strand id: L

F,40
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 40
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 111
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 340
pdbx nonpoly scheme.pdb strand id: L

F,41
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 41
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 118
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 341
pdbx nonpoly scheme.pdb strand id: L

F,42
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 42
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 129
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 342
pdbx nonpoly scheme.pdb strand id: L

F,43
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 43
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 130
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 343
pdbx nonpoly scheme.pdb strand id: L

F,44
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 44
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 137
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 344
pdbx nonpoly scheme.pdb strand id: L

F,45
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 45
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 140
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 345
pdbx nonpoly scheme.pdb strand id: L

F,46
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 46
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 142
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 346
pdbx nonpoly scheme.pdb strand id: L

F,47
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 47
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 143
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 347
pdbx nonpoly scheme.pdb strand id: L

F,48
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 48
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 145
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 348
pdbx nonpoly scheme.pdb strand id: L

F,49
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 49
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 150
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 349
pdbx nonpoly scheme.pdb strand id: L

F,50
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 50
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 152
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 350
pdbx nonpoly scheme.pdb strand id: L

F,51
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 51
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 153
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 351
pdbx nonpoly scheme.pdb strand id: L

F,52
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 52
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 156
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 352
pdbx nonpoly scheme.pdb strand id: L

F,53
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 53
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 160
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 353
pdbx nonpoly scheme.pdb strand id: L

F,54
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 54
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 161
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 354
pdbx nonpoly scheme.pdb strand id: L

F,55
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 55
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 163
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 355
pdbx nonpoly scheme.pdb strand id: L

F,56
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 56
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 167
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 356
pdbx nonpoly scheme.pdb strand id: L

F,57
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 57
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 168
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 357
pdbx nonpoly scheme.pdb strand id: L

F,58
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 58
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 169
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 358
pdbx nonpoly scheme.pdb strand id: L

F,59
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 59
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 171
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 359
pdbx nonpoly scheme.pdb strand id: L

F,60
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 60
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 173
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 360
pdbx nonpoly scheme.pdb strand id: L

F,61
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 61
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 177
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 361
pdbx nonpoly scheme.pdb strand id: L

F,62
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 62
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 179
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 362
pdbx nonpoly scheme.pdb strand id: L

F,63
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 63
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 182
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 363
pdbx nonpoly scheme.pdb strand id: L

F,64
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 64
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 183
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 364
pdbx nonpoly scheme.pdb strand id: L

F,65
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 65
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 184
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 365
pdbx nonpoly scheme.pdb strand id: L

F,66
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 66
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 185
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 366
pdbx nonpoly scheme.pdb strand id: L

F,67
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 67
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 187
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 367
pdbx nonpoly scheme.pdb strand id: L

F,68
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 68
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 188
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 368
pdbx nonpoly scheme.pdb strand id: L

F,69
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 69
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 189
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 369
pdbx nonpoly scheme.pdb strand id: L

F,70
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 70
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 190
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 370
pdbx nonpoly scheme.pdb strand id: L

F,71
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 71
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 195
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 371
pdbx nonpoly scheme.pdb strand id: L

F,72
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 72
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 196
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 372
pdbx nonpoly scheme.pdb strand id: L

F,73
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 73
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 198
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 373
pdbx nonpoly scheme.pdb strand id: L

F,74
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 74
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 199
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 374
pdbx nonpoly scheme.pdb strand id: L

F,75
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 75
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 203
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 375
pdbx nonpoly scheme.pdb strand id: L

F,76
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 76
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 204
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 376
pdbx nonpoly scheme.pdb strand id: L

F,77
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 77
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 205
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 377
pdbx nonpoly scheme.pdb strand id: L

F,78
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 78
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 208
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 378
pdbx nonpoly scheme.pdb strand id: L

F,79
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 79
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 209
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 379
pdbx nonpoly scheme.pdb strand id: L

F,80
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 80
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 211
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 380
pdbx nonpoly scheme.pdb strand id: L

F,81
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 81
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 212
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 381
pdbx nonpoly scheme.pdb strand id: L

F,82
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 82
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 213
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 382
pdbx nonpoly scheme.pdb strand id: L

F,83
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 83
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 215
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 383
pdbx nonpoly scheme.pdb strand id: L

F,84
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 84
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 216
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 384
pdbx nonpoly scheme.pdb strand id: L

F,85
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 85
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 219
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 385
pdbx nonpoly scheme.pdb strand id: L

F,86
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 86
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 221
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 386
pdbx nonpoly scheme.pdb strand id: L

F,87
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 87
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 222
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 387
pdbx nonpoly scheme.pdb strand id: L

F,88
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 88
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 223
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 388
pdbx nonpoly scheme.pdb strand id: L

F,89
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 89
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 225
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 389
pdbx nonpoly scheme.pdb strand id: L

F,90
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 90
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 226
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 390
pdbx nonpoly scheme.pdb strand id: L

F,91
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 91
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 229
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 391
pdbx nonpoly scheme.pdb strand id: L

F,92
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 92
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 233
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 392
pdbx nonpoly scheme.pdb strand id: L

F,93
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 93
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 234
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 393
pdbx nonpoly scheme.pdb strand id: L

F,94
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 94
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 235
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 394
pdbx nonpoly scheme.pdb strand id: L

F,95
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 95
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 242
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 395
pdbx nonpoly scheme.pdb strand id: L

F,96
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 96
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 245
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 396
pdbx nonpoly scheme.pdb strand id: L

F,97
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 97
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 246
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 397
pdbx nonpoly scheme.pdb strand id: L

F,98
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 98
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 249
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 398
pdbx nonpoly scheme.pdb strand id: L

F,99
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 99
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 250
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 399
pdbx nonpoly scheme.pdb strand id: L

F,100
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 100
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 251
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 400
pdbx nonpoly scheme.pdb strand id: L

F,101
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 101
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 252
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 401
pdbx nonpoly scheme.pdb strand id: L

F,102
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 102
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 255
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 402
pdbx nonpoly scheme.pdb strand id: L

F,103
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 103
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 256
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 403
pdbx nonpoly scheme.pdb strand id: L

F,104
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 104
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 261
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 404
pdbx nonpoly scheme.pdb strand id: L

F,105
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 105
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 262
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 405
pdbx nonpoly scheme.pdb strand id: L

F,106
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 106
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 266
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 406
pdbx nonpoly scheme.pdb strand id: L

F,107
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 107
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 278
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 407
pdbx nonpoly scheme.pdb strand id: L

F,108
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 108
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 279
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 408
pdbx nonpoly scheme.pdb strand id: L

F,109
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 109
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 281
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 409
pdbx nonpoly scheme.pdb strand id: L

F,110
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 110
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 282
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 410
pdbx nonpoly scheme.pdb strand id: L

F,111
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 111
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 284
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 411
pdbx nonpoly scheme.pdb strand id: L

F,112
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 112
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 285
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 412
pdbx nonpoly scheme.pdb strand id: L

F,113
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 113
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 291
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 413
pdbx nonpoly scheme.pdb strand id: L

F,114
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 114
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 300
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 414
pdbx nonpoly scheme.pdb strand id: L

F,115
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 115
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 301
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 415
pdbx nonpoly scheme.pdb strand id: L

F,116
type: pdbx nonpoly scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx nonpoly scheme.asym id: F
pdbx nonpoly scheme.ndb seq num: 116
pdbx nonpoly scheme.auth mon id: HOH
pdbx nonpoly scheme.auth seq num: 302
pdbx nonpoly scheme.entity id: 4
pdbx nonpoly scheme.mon id: HOH
pdbx nonpoly scheme.pdb mon id: HOH
pdbx nonpoly scheme.pdb seq num: 416
pdbx nonpoly scheme.pdb strand id: L

A,1,MET,1
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 1
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 1
pdbx poly seq scheme.pdb seq num: 0
pdbx poly seq scheme.pdb strand id: A

A,1,ALA,2
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 2
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 2
pdbx poly seq scheme.pdb seq num: 1
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,3
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 3
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 3
pdbx poly seq scheme.pdb seq num: 2
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,4
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 4
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 4
pdbx poly seq scheme.pdb seq num: 3
pdbx poly seq scheme.pdb strand id: A

A,1,ARG,5
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 5
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 4
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 5
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 4
pdbx poly seq scheme.pdb strand id: A

A,1,SER,6
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 6
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 5
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 6
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 5
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,7
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 7
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 6
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 7
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 6
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,8
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 8
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 7
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 8
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 7
pdbx poly seq scheme.pdb strand id: A

A,1,CYS,9
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 9
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 8
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 9
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 8
pdbx poly seq scheme.pdb strand id: A

A,1,THR,10
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 10
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 9
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 10
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 9
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,11
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 11
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 10
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 11
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 10
pdbx poly seq scheme.pdb strand id: A

A,1,ARG,12
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 12
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 11
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 12
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 11
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,13
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 13
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 12
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 13
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 12
pdbx poly seq scheme.pdb strand id: A

A,1,SER,14
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 14
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 13
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 14
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 13
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,15
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 15
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 14
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 15
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 14
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,16
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 16
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 15
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 16
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 15
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,17
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 17
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 16
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 17
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 16
pdbx poly seq scheme.pdb strand id: A

A,1,SER,18
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 18
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 17
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 18
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 17
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,19
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 19
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 18
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 19
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 18
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,20
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 20
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 19
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 20
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 19
pdbx poly seq scheme.pdb strand id: A

A,1,MET,21
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 21
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 20
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 21
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 20
pdbx poly seq scheme.pdb strand id: A

A,1,SER,22
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 22
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 21
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 22
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 21
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,23
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 23
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 22
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 23
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 22
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,24
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 24
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 23
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 24
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 23
pdbx poly seq scheme.pdb strand id: A

A,1,TYR,25
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 25
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 24
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 25
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 24
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,26
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 26
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 25
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 26
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 25
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,27
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 27
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 26
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 27
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 26
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,28
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 28
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 27
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 28
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 27
pdbx poly seq scheme.pdb strand id: A

A,1,ALA,29
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 29
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 28
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 29
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 28
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,30
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 30
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 29
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 30
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 29
pdbx poly seq scheme.pdb strand id: A

A,1,HIS,31
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 31
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 30
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 31
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 30
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,32
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 32
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 31
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 32
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 31
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,33
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 33
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 32
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 33
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 32
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,34
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 34
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 33
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 34
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 33
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,35
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 35
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 34
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 35
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 34
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,36
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 36
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 35
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 36
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 35
pdbx poly seq scheme.pdb strand id: A

A,1,MET,37
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 37
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 36
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 37
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 36
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,38
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 38
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 37
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 38
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 37
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,39
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 39
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 38
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 39
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 38
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,40
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 40
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 39
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 40
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 39
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,41
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 41
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 40
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 41
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 40
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,42
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 42
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 41
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 42
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 41
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,43
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 43
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 42
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 43
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 42
pdbx poly seq scheme.pdb strand id: A

A,1,SER,44
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 44
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 43
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 44
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 43
pdbx poly seq scheme.pdb strand id: A

A,1,MET,45
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 45
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 44
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 45
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 44
pdbx poly seq scheme.pdb strand id: A

A,1,SER,46
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 46
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 45
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 46
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 45
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,47
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 47
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 46
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 47
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 46
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,48
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 48
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 47
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 48
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 47
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,49
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 49
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 48
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 49
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 48
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,50
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 50
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 49
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 50
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 49
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,51
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 51
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 50
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 51
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 50
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,52
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 52
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 51
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 52
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 51
pdbx poly seq scheme.pdb strand id: A

A,1,SER,53
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 53
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 52
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 53
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 52
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,54
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 54
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 53
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 54
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 53
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,55
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 55
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 54
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 55
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 54
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,56
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 56
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 55
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 56
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 55
pdbx poly seq scheme.pdb strand id: A

A,1,ILE,57
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 57
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 56
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 57
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 56
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,58
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 58
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 57
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 58
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 57
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,59
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 59
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 58
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 59
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 58
pdbx poly seq scheme.pdb strand id: A

A,1,ALA,60
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 60
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 59
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 60
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 59
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,61
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 61
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 60
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 61
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 60
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,62
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 62
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 61
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 62
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 61
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,63
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 63
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 62
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 63
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 62
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,64
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 64
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 63
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 64
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 63
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,65
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 65
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 64
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 65
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 64
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,66
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 66
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 65
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 66
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 65
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,67
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 67
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 66
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 67
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 66
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,68
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 68
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 67
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 68
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 67
pdbx poly seq scheme.pdb strand id: A

A,1,TYR,69
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 69
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 68
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 69
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 68
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,70
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 70
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 69
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 70
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 69
pdbx poly seq scheme.pdb strand id: A

A,1,SER,71
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 71
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 70
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 71
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 70
pdbx poly seq scheme.pdb strand id: A

A,1,CYS,72
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 72
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 71
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 72
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 71
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,73
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 73
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 72
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 73
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 72
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,74
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 74
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 73
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 74
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 73
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,75
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 75
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 74
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 75
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 74
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,76
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 76
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 75
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 76
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 75
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,77
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 77
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 76
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 77
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 76
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,78
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 78
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 77
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 78
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 77
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,79
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 79
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 78
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 79
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 78
pdbx poly seq scheme.pdb strand id: A

A,1,THR,80
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 80
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 79
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 80
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 79
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,81
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 81
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 80
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 81
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 80
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,82
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 82
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 81
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 82
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 81
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,83
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 83
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 82
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 83
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 82
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,84
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 84
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 83
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 84
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 83
pdbx poly seq scheme.pdb strand id: A

A,1,SER,85
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 85
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 84
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 85
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 84
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,86
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 86
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 85
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 86
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 85
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,87
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 87
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 86
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 87
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 86
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,88
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 88
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 87
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 88
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 87
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,89
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 89
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 88
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 89
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 88
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,90
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 90
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 89
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 90
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 89
pdbx poly seq scheme.pdb strand id: A

A,1,TYR,91
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 91
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 90
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 91
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 90
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,92
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 92
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 91
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 92
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 91
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,93
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 93
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 92
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 93
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 92
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,94
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 94
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 93
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 94
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 93
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,95
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 95
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 94
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 95
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 94
pdbx poly seq scheme.pdb strand id: A

A,1,MET,96
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 96
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 95
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 96
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 95
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,97
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 97
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 96
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 97
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 96
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,98
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 98
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 97
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 98
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 97
pdbx poly seq scheme.pdb strand id: A

A,1,ARG,99
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 99
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 98
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 99
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 98
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,100
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 100
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 99
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 100
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 99
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,101
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 101
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 100
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 101
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 100
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,102
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 102
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 101
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 102
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 101
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,103
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 103
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 102
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 103
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 102
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,104
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 104
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 103
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 104
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 103
pdbx poly seq scheme.pdb strand id: A

A,1,ILE,105
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 105
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 104
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 105
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 104
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,106
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 106
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 105
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 106
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 105
pdbx poly seq scheme.pdb strand id: A

A,1,ILE,107
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 107
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 106
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 107
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 106
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,108
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 108
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 107
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 108
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 107
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,109
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 109
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 108
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 109
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 108
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,110
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 110
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 109
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 110
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 109
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,111
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 111
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 110
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 111
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 110
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,112
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 112
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 111
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 112
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 111
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,113
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 113
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 112
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 113
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 112
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,114
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 114
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 113
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 114
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 113
pdbx poly seq scheme.pdb strand id: A

A,1,SER,115
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 115
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 114
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 115
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 114
pdbx poly seq scheme.pdb strand id: A

A,1,ALA,116
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 116
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 115
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 116
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 115
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,117
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 117
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 116
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 117
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 116
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,118
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 118
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 117
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 118
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 117
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,119
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 119
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 118
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 119
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 118
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,120
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 120
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 119
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 120
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 119
pdbx poly seq scheme.pdb strand id: A

A,1,TRP,121
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 121
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 120
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 121
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 120
pdbx poly seq scheme.pdb strand id: A

A,1,TYR,122
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 122
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 121
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 122
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 121
pdbx poly seq scheme.pdb strand id: A

A,1,ILE,123
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 123
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 122
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 123
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 122
pdbx poly seq scheme.pdb strand id: A

A,1,SER,124
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 124
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 123
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 124
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 123
pdbx poly seq scheme.pdb strand id: A

A,1,THR,125
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 125
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 124
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 125
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 124
pdbx poly seq scheme.pdb strand id: A

A,1,SER,126
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 126
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 125
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 126
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 125
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,127
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 127
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 126
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 127
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 126
pdbx poly seq scheme.pdb strand id: A

A,1,ALA,128
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 128
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 127
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 128
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 127
pdbx poly seq scheme.pdb strand id: A

A,1,GLU,129
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 129
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 128
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 129
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 128
pdbx poly seq scheme.pdb strand id: A

A,1,ASN,130
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 130
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 129
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 130
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 129
pdbx poly seq scheme.pdb strand id: A

A,1,MET,131
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 131
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 130
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 131
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 130
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,132
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 132
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 131
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 132
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 131
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,133
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 133
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 132
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 133
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 132
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,134
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 134
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 133
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 134
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 133
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,135
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 135
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 134
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 135
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 134
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,136
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 136
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 135
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 136
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 135
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,137
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 137
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 136
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 137
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 136
pdbx poly seq scheme.pdb strand id: A

A,1,THR,138
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 138
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 137
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 138
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 137
pdbx poly seq scheme.pdb strand id: A

A,1,LYS,139
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 139
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 138
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 139
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 138
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,140
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 140
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 139
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 140
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 139
pdbx poly seq scheme.pdb strand id: A

A,1,GLY,141
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 141
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 140
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 141
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 140
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,142
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 142
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 141
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 142
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 141
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,143
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 143
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 142
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 143
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 142
pdbx poly seq scheme.pdb strand id: A

A,1,ILE,144
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 144
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 143
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 144
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 143
pdbx poly seq scheme.pdb strand id: A

A,1,THR,145
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 145
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 144
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 145
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 144
pdbx poly seq scheme.pdb strand id: A

A,1,ASP,146
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 146
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 145
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 146
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 145
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,147
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 147
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 146
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 147
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 146
pdbx poly seq scheme.pdb strand id: A

A,1,THR,148
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 148
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 147
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 148
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 147
pdbx poly seq scheme.pdb strand id: A

A,1,MET,149
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 149
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 148
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 149
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 148
pdbx poly seq scheme.pdb strand id: A

A,1,GLN,150
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 150
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 149
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 150
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 149
pdbx poly seq scheme.pdb strand id: A

A,1,PHE,151
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 151
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 150
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 151
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 150
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,152
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 152
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 151
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 152
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 151
pdbx poly seq scheme.pdb strand id: A

A,1,SER,153
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 153
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 152
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 153
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 152
pdbx poly seq scheme.pdb strand id: A

A,1,SER,154
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 154
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 154
pdbx poly seq scheme.pdb seq num: 153
pdbx poly seq scheme.pdb strand id: A

A,1,LEU,155
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 155
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 155
pdbx poly seq scheme.pdb seq num: 154
pdbx poly seq scheme.pdb strand id: A

A,1,VAL,156
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 156
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 156
pdbx poly seq scheme.pdb seq num: 155
pdbx poly seq scheme.pdb strand id: A

A,1,PRO,157
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 157
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 157
pdbx poly seq scheme.pdb seq num: 156
pdbx poly seq scheme.pdb strand id: A

A,1,ARG,158
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: A
pdbx poly seq scheme.entity id: 1
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 158
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 158
pdbx poly seq scheme.pdb seq num: 157
pdbx poly seq scheme.pdb strand id: A

B,2,GLN,1
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 1
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 1
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 1
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 1
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,2
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 2
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 2
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 2
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 2
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,3
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 3
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 3
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 3
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 3
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,4
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 4
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 4
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 4
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 4
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,5
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 5
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 5
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 5
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 5
pdbx poly seq scheme.pdb strand id: H

B,2,GLU,6
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 6
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 6
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 6
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 6
pdbx poly seq scheme.pdb strand id: H

B,2,SER,7
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 7
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 7
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 7
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 7
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,8
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 8
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 8
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 8
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 8
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,9
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 9
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 9
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 9
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 9
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,10
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 10
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 10
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 10
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 10
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,11
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 11
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 11
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 11
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 11
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,12
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 12
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 12
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 12
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 12
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,13
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 13
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 13
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 13
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 13
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,14
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 14
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 14
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 14
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 14
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,15
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 15
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 15
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 15
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 15
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,16
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 16
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 16
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 16
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 16
pdbx poly seq scheme.pdb strand id: H

B,2,SER,17
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 17
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 17
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 17
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 17
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,18
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 18
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 18
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 18
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 18
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,19
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 19
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 19
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 19
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 19
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,20
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 20
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 20
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 20
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 20
pdbx poly seq scheme.pdb strand id: H

B,2,SER,21
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 21
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 21
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 21
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 21
pdbx poly seq scheme.pdb strand id: H

B,2,CYS,22
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 22
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 22
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 22
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 22
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,23
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 23
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 23
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 23
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 23
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,24
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 24
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 24
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 24
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 24
pdbx poly seq scheme.pdb strand id: H

B,2,SER,25
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 25
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 25
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 25
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 25
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,26
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 26
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 26
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 26
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 26
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,27
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 27
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 27
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 27
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 27
pdbx poly seq scheme.pdb strand id: H

B,2,THR,28
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 28
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 28
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 28
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 28
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,29
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 29
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 29
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 29
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 29
pdbx poly seq scheme.pdb strand id: H

B,2,SER,30
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 30
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 30
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 30
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 30
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,31
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 31
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 31
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 31
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 31
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,32
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 32
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 32
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 32
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 32
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,33
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 33
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 33
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 33
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 33
pdbx poly seq scheme.pdb strand id: H

B,2,MET,34
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 34
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 34
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 34
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 34
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,35
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 35
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 35
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 35
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 35
pdbx poly seq scheme.pdb strand id: H

B,2,TRP,36
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 36
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 36
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 36
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 36
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,37
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 37
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 37
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 37
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 37
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,38
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 38
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 38
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 38
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 38
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,39
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 39
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 39
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 39
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 39
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,40
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 40
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 40
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 40
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 40
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,41
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 41
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 41
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 41
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 41
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,42
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 42
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 42
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 42
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 42
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,43
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 43
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 43
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 43
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 43
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,44
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 44
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 44
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 44
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 44
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,45
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 45
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 45
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 45
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 45
pdbx poly seq scheme.pdb strand id: H

B,2,GLU,46
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 46
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 46
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 46
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 46
pdbx poly seq scheme.pdb strand id: H

B,2,TRP,47
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 47
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 47
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 47
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 47
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,48
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 48
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 48
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 48
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 48
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,49
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 49
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 49
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 49
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 49
pdbx poly seq scheme.pdb strand id: H

B,2,ILE,50
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 50
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 50
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 50
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 50
pdbx poly seq scheme.pdb strand id: H

B,2,ILE,51
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 51
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 51
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 51
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 51
pdbx poly seq scheme.pdb strand id: H

B,2,TRP,52
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 52
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 52
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 52
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 52
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,53
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 53
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 53
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 53
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 53
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,54
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 54
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 54
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 54
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 54
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,55
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 55
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 55
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 55
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 55
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,56
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 56
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 56
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 56
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 56
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,57
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 57
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 57
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 57
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 57
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,58
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 58
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 58
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 58
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 58
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,59
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 59
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 59
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 59
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 59
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,60
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 60
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 60
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 60
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 60
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,61
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 61
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 61
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 61
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 61
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,62
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 62
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 62
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 62
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 62
pdbx poly seq scheme.pdb strand id: H

B,2,SER,63
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 63
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 63
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 63
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 63
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,64
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 64
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 64
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 64
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 64
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,65
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 65
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 65
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 65
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 65
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,66
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 66
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 66
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 66
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 66
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,67
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 67
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 67
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 67
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 67
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,68
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 68
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 68
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 68
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 68
pdbx poly seq scheme.pdb strand id: H

B,2,THR,69
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 69
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 69
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 69
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 69
pdbx poly seq scheme.pdb strand id: H

B,2,ILE,70
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 70
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 70
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 70
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 70
pdbx poly seq scheme.pdb strand id: H

B,2,SER,71
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 71
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 71
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 71
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 71
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,72
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 72
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 72
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 72
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 72
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,73
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 73
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 73
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 73
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 73
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,74
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 74
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 74
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 74
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 74
pdbx poly seq scheme.pdb strand id: H

B,2,SER,75
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 75
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 75
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 75
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 75
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,76
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 76
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 76
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 76
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 76
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,77
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 77
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 77
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 77
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 77
pdbx poly seq scheme.pdb strand id: H

B,2,THR,78
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 78
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 78
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 78
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 78
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,79
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 79
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 79
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 79
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 79
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,80
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 80
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 80
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 80
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 80
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,81
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 81
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 81
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 81
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 81
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,82
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 82
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 82
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 82
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 82
pdbx poly seq scheme.pdb strand id: H

B,2,MET,83
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: MET
pdbx poly seq scheme.seq id: 83
pdbx poly seq scheme.auth mon id: MET
pdbx poly seq scheme.auth seq num: 83
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 83
pdbx poly seq scheme.pdb mon id: MET
pdbx poly seq scheme.pdb seq num: 83
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,84
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 84
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 84
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 84
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 84
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,85
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 85
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 85
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 85
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 85
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,86
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 86
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 86
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 86
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 86
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,87
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 87
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 87
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 87
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 87
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,88
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 88
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 88
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 88
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 88
pdbx poly seq scheme.pdb strand id: H

B,2,GLU,89
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 89
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 89
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 89
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 89
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,90
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 90
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 90
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 90
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 90
pdbx poly seq scheme.pdb strand id: H

B,2,THR,91
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 91
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 91
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 91
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 91
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,92
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 92
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 92
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 92
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 92
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,93
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 93
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 93
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 93
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 93
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,94
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 94
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 94
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 94
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 94
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,95
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 95
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 95
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 95
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 95
pdbx poly seq scheme.pdb strand id: H

B,2,CYS,96
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 96
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 96
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 96
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 96
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,97
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 97
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 97
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 97
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 97
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,98
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 98
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 98
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 98
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 98
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,99
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 99
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 99
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 99
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 99
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,100
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 100
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 100
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 100
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 100
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,101
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 101
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 101
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 101
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 101
pdbx poly seq scheme.pdb strand id: H

B,2,THR,102
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 102
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 102
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 102
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 102
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,103
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 103
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 103
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 103
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 103
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,104
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 104
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 104
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 104
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 104
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,105
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 105
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 105
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 105
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 105
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,106
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 106
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 106
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 106
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 106
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,107
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 107
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 107
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 107
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 107
pdbx poly seq scheme.pdb strand id: H

B,2,TRP,108
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 108
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 108
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 108
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 108
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,109
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 109
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 109
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 109
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 109
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,110
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 110
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 110
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 110
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 110
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,111
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 111
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 111
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 111
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 111
pdbx poly seq scheme.pdb strand id: H

B,2,THR,112
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 112
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 112
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 112
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 112
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,113
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 113
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 113
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 113
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 113
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,114
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 114
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 114
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 114
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 114
pdbx poly seq scheme.pdb strand id: H

B,2,THR,115
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 115
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 115
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 115
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 115
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,116
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 116
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 116
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 116
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 116
pdbx poly seq scheme.pdb strand id: H

B,2,SER,117
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 117
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 117
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 117
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 117
pdbx poly seq scheme.pdb strand id: H

B,2,SER,118
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 118
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 118
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 118
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 118
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,119
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 119
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 119
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 119
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 119
pdbx poly seq scheme.pdb strand id: H

B,2,SER,120
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 120
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 120
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 120
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 120
pdbx poly seq scheme.pdb strand id: H

B,2,THR,121
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 121
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 121
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 121
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 121
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,122
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 122
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 122
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 122
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 122
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,123
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 123
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 123
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 123
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 123
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,124
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 124
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 124
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 124
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 124
pdbx poly seq scheme.pdb strand id: H

B,2,SER,125
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 125
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 125
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 125
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 125
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,126
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 126
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 126
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 126
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 126
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,127
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 127
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 127
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 127
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 127
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,128
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 128
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 128
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 128
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 128
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,129
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 129
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 129
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 129
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 129
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,130
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 130
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 130
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 130
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 130
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,131
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 131
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 131
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 131
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 131
pdbx poly seq scheme.pdb strand id: H

B,2,SER,132
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 132
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 132
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 132
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 132
pdbx poly seq scheme.pdb strand id: H

B,2,SER,133
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 133
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 133
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 133
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 133
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,134
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 134
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 134
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 134
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 134
pdbx poly seq scheme.pdb strand id: H

B,2,SER,135
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 135
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 135
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 135
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 135
pdbx poly seq scheme.pdb strand id: H

B,2,THR,136
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 136
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 136
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 136
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 136
pdbx poly seq scheme.pdb strand id: H

B,2,SER,137
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 137
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 137
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 137
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 137
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,138
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 138
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 138
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 138
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 138
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,139
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 139
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 139
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 139
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 139
pdbx poly seq scheme.pdb strand id: H

B,2,THR,140
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 140
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 140
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 140
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 140
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,141
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 141
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 141
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 141
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 141
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,142
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 142
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 142
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 142
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 142
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,143
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 143
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 143
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 143
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 143
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,144
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 144
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 144
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 144
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 144
pdbx poly seq scheme.pdb strand id: H

B,2,CYS,145
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 145
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 145
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 145
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 145
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,146
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 146
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 146
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 146
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 146
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,147
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 147
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 147
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 147
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 147
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,148
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 148
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 148
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 148
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 148
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,149
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 149
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 149
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 149
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 149
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,150
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 150
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 150
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 150
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 150
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,151
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 151
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 151
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 151
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 151
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,152
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 152
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 152
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 152
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 152
pdbx poly seq scheme.pdb strand id: H

B,2,GLU,153
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 153
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 153
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 153
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 153
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,154
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 154
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 154
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 154
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 154
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,155
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 155
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 155
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 155
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 155
pdbx poly seq scheme.pdb strand id: H

B,2,THR,156
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 156
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 156
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 156
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 156
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,157
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 157
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 157
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 157
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 157
pdbx poly seq scheme.pdb strand id: H

B,2,SER,158
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 158
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 158
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 158
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 158
pdbx poly seq scheme.pdb strand id: H

B,2,TRP,159
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 159
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 159
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 159
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 159
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,160
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 160
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 160
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 160
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 160
pdbx poly seq scheme.pdb strand id: H

B,2,SER,161
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 161
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 161
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 161
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 161
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,162
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 162
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 162
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 162
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 162
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,163
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 163
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 163
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 163
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 163
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,164
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 164
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 164
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 164
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 164
pdbx poly seq scheme.pdb strand id: H

B,2,THR,165
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 165
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 165
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 165
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 165
pdbx poly seq scheme.pdb strand id: H

B,2,SER,166
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 166
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 166
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 166
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 166
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,167
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 167
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 167
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 167
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 167
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,168
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 168
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 168
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 168
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 168
pdbx poly seq scheme.pdb strand id: H

B,2,HIS,169
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 169
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 169
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 169
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 169
pdbx poly seq scheme.pdb strand id: H

B,2,THR,170
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 170
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 170
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 170
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 170
pdbx poly seq scheme.pdb strand id: H

B,2,PHE,171
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 171
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 171
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 171
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 171
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,172
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 172
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 172
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 172
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 172
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,173
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 173
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 173
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 173
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 173
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,174
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 174
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 174
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 174
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 174
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,175
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 175
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 175
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 175
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 175
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,176
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 176
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 176
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 176
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 176
pdbx poly seq scheme.pdb strand id: H

B,2,SER,177
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 177
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 177
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 177
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 177
pdbx poly seq scheme.pdb strand id: H

B,2,SER,178
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 178
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 178
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 178
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 178
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,179
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 179
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 179
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 179
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 179
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,180
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 180
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 180
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 180
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 180
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,181
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 181
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 181
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 181
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 181
pdbx poly seq scheme.pdb strand id: H

B,2,SER,182
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 182
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 182
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 182
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 182
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,183
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 183
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 183
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 183
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 183
pdbx poly seq scheme.pdb strand id: H

B,2,SER,184
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 184
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 184
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 184
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 184
pdbx poly seq scheme.pdb strand id: H

B,2,SER,185
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 185
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 185
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 185
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 185
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,186
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 186
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 186
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 186
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 186
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,187
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 187
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 187
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 187
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 187
pdbx poly seq scheme.pdb strand id: H

B,2,THR,188
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 188
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 188
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 188
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 188
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,189
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 189
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 189
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 189
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 189
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,190
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 190
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 190
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 190
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 190
pdbx poly seq scheme.pdb strand id: H

B,2,SER,191
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 191
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 191
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 191
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 191
pdbx poly seq scheme.pdb strand id: H

B,2,SER,192
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 192
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 192
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 192
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 192
pdbx poly seq scheme.pdb strand id: H

B,2,SER,193
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 193
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 193
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 193
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 193
pdbx poly seq scheme.pdb strand id: H

B,2,LEU,194
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 194
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 194
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 194
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 194
pdbx poly seq scheme.pdb strand id: H

B,2,GLY,195
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 195
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 195
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 195
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 195
pdbx poly seq scheme.pdb strand id: H

B,2,THR,196
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 196
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 196
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 196
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 196
pdbx poly seq scheme.pdb strand id: H

B,2,GLN,197
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 197
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 197
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 197
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 197
pdbx poly seq scheme.pdb strand id: H

B,2,THR,198
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 198
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 198
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 198
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 198
pdbx poly seq scheme.pdb strand id: H

B,2,TYR,199
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 199
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 199
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 199
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 199
pdbx poly seq scheme.pdb strand id: H

B,2,ILE,200
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 200
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 200
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 200
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 200
pdbx poly seq scheme.pdb strand id: H

B,2,CYS,201
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 201
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 201
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 201
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 201
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,202
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 202
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 202
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 202
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 202
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,203
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 203
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 203
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 203
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 203
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,204
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 204
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 204
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 204
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 204
pdbx poly seq scheme.pdb strand id: H

B,2,HIS,205
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 205
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 205
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 205
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 205
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,206
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 206
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 206
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 206
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 206
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,207
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 207
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 207
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 207
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 207
pdbx poly seq scheme.pdb strand id: H

B,2,SER,208
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 208
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 208
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 208
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 208
pdbx poly seq scheme.pdb strand id: H

B,2,ASN,209
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 209
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 209
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 209
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 209
pdbx poly seq scheme.pdb strand id: H

B,2,THR,210
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 210
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 210
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 210
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 210
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,211
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 211
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 211
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 211
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 211
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,212
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 212
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 212
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 212
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 212
pdbx poly seq scheme.pdb strand id: H

B,2,ASP,213
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 213
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 213
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 213
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 213
pdbx poly seq scheme.pdb strand id: H

B,2,LYS,214
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 214
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 214
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 214
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 214
pdbx poly seq scheme.pdb strand id: H

B,2,ARG,215
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 215
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 215
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 215
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 215
pdbx poly seq scheme.pdb strand id: H

B,2,VAL,216
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 216
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 216
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 216
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 216
pdbx poly seq scheme.pdb strand id: H

B,2,ALA,217
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 217
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 217
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 217
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 217
pdbx poly seq scheme.pdb strand id: H

B,2,PRO,218
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: B
pdbx poly seq scheme.entity id: 2
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 218
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 218
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 218
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 218
pdbx poly seq scheme.pdb strand id: H

C,3,GLU,1
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 1
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 1
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 1
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 1
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,2
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 2
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 2
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 2
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 2
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,3
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 3
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 3
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 3
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 3
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,4
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 4
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 4
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 4
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 4
pdbx poly seq scheme.pdb strand id: L

C,3,THR,5
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 5
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 5
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 5
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 5
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,6
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 6
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 6
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 6
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 6
pdbx poly seq scheme.pdb strand id: L

C,3,SER,7
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 7
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 7
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 7
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 7
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,8
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 8
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 8
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 8
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 8
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,9
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 9
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 9
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 9
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 9
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,10
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 10
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 10
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 10
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 10
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,11
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 11
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 11
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 11
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 11
pdbx poly seq scheme.pdb strand id: L

C,3,SER,12
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 12
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 12
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 12
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 12
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,13
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 13
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 13
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 13
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 13
pdbx poly seq scheme.pdb strand id: L

C,3,THR,14
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 14
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 14
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 14
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 14
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,15
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 15
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 15
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 15
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 15
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,16
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 16
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 16
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 16
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 16
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,17
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 17
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 17
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 17
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 17
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,18
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 18
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 18
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 18
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 18
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,19
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 19
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 19
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 19
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 19
pdbx poly seq scheme.pdb strand id: L

C,3,THR,20
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 20
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 20
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 20
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 20
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,21
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 21
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 21
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 21
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 21
pdbx poly seq scheme.pdb strand id: L

C,3,THR,22
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 22
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 22
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 22
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 22
pdbx poly seq scheme.pdb strand id: L

C,3,CYS,23
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 23
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 23
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 23
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 23
pdbx poly seq scheme.pdb strand id: L

C,3,ARG,24
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 24
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 24
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 24
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 24
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,25
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 25
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 25
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 25
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 25
pdbx poly seq scheme.pdb strand id: L

C,3,SER,26
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 26
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 26
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 26
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 26
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,27
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 27
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 27
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 27
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 27
pdbx poly seq scheme.pdb strand id: L

C,3,SER,28
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 28
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 28
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 28
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 28
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,29
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 29
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 29
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 29
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 29
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,30
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 30
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 30
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 30
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 30
pdbx poly seq scheme.pdb strand id: L

C,3,SER,31
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 31
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 31
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 31
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 31
pdbx poly seq scheme.pdb strand id: L

C,3,SER,32
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 32
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 32
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 32
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 32
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,33
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 33
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 33
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 33
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 33
pdbx poly seq scheme.pdb strand id: L

C,3,HIS,34
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 34
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 34
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 34
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 34
pdbx poly seq scheme.pdb strand id: L

C,3,TRP,35
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 35
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 35
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 35
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 35
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,36
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 36
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 36
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 36
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 36
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,37
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 37
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 37
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 37
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 37
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,38
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 38
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 38
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 38
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 38
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,39
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 39
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 39
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 39
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 39
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,40
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 40
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 40
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 40
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 40
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,41
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 41
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 41
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 41
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 41
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,42
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 42
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 42
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 42
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 42
pdbx poly seq scheme.pdb strand id: L

C,3,SER,43
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 43
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 43
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 43
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 43
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,44
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 44
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 44
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 44
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 44
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,45
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 45
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 45
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 45
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 45
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,46
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 46
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 46
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 46
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 46
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,47
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 47
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 47
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 47
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 47
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,48
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 48
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 48
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 48
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 48
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,49
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 49
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 49
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 49
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 49
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,50
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 50
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 50
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 50
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 50
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,51
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 51
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 51
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 51
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 51
pdbx poly seq scheme.pdb strand id: L

C,3,SER,52
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 52
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 52
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 52
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 52
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,53
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 53
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 53
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 53
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 53
pdbx poly seq scheme.pdb strand id: L

C,3,SER,54
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 54
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 54
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 54
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 54
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,55
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 55
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 55
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 55
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 55
pdbx poly seq scheme.pdb strand id: L

C,3,SER,56
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 56
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 56
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 56
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 56
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,57
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 57
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 57
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 57
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 57
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,58
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 58
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 58
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 58
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 58
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,59
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 59
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 59
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 59
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 59
pdbx poly seq scheme.pdb strand id: L

C,3,SER,60
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 60
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 60
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 60
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 60
pdbx poly seq scheme.pdb strand id: L

C,3,ARG,61
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 61
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 61
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 61
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 61
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,62
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 62
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 62
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 62
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 62
pdbx poly seq scheme.pdb strand id: L

C,3,SER,63
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 63
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 63
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 63
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 63
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,64
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 64
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 64
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 64
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 64
pdbx poly seq scheme.pdb strand id: L

C,3,SER,65
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 65
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 65
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 65
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 65
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,66
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 66
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 66
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 66
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 66
pdbx poly seq scheme.pdb strand id: L

C,3,SER,67
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 67
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 67
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 67
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 67
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,68
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 68
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 68
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 68
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 68
pdbx poly seq scheme.pdb strand id: L

C,3,THR,69
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 69
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 69
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 69
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 69
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,70
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 70
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 70
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 70
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 70
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,71
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 71
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 71
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 71
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 71
pdbx poly seq scheme.pdb strand id: L

C,3,THR,72
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 72
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 72
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 72
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 72
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,73
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 73
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 73
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 73
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 73
pdbx poly seq scheme.pdb strand id: L

C,3,THR,74
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 74
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 74
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 74
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 74
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,75
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 75
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 75
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 75
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 75
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,76
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 76
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 76
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 76
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 76
pdbx poly seq scheme.pdb strand id: L

C,3,SER,77
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 77
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 77
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 77
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 77
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,78
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 78
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 78
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 78
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 78
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,79
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 79
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 79
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 79
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 79
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,80
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 80
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 80
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 80
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 80
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,81
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 81
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 81
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 81
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 81
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,82
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 82
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 82
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 82
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 82
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,83
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 83
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 83
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 83
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 83
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,84
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 84
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 84
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 84
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 84
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,85
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 85
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 85
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 85
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 85
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,86
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 86
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 86
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 86
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 86
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,87
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 87
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 87
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 87
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 87
pdbx poly seq scheme.pdb strand id: L

C,3,CYS,88
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 88
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 88
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 88
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 88
pdbx poly seq scheme.pdb strand id: L

C,3,HIS,89
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 89
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 89
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 89
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 89
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,90
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 90
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 90
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 90
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 90
pdbx poly seq scheme.pdb strand id: L

C,3,SER,91
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 91
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 91
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 91
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 91
pdbx poly seq scheme.pdb strand id: L

C,3,SER,92
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 92
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 92
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 92
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 92
pdbx poly seq scheme.pdb strand id: L

C,3,SER,93
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 93
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 93
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 93
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 93
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,94
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 94
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 94
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 94
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 94
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,95
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 95
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 95
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 95
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 95
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,96
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 96
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 96
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 96
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 96
pdbx poly seq scheme.pdb strand id: L

C,3,THR,97
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 97
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 97
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 97
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 97
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,98
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 98
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 98
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 98
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 98
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,99
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 99
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 99
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 99
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 99
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,100
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 100
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 100
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 100
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 100
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,101
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 101
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 101
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 101
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 101
pdbx poly seq scheme.pdb strand id: L

C,3,THR,102
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 102
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 102
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 102
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 102
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,103
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 103
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 103
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 103
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 103
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,104
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 104
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 104
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 104
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 104
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,105
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 105
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 105
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 105
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 105
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,106
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 106
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 106
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 106
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 106
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,107
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 107
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 107
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 107
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 107
pdbx poly seq scheme.pdb strand id: L

C,3,ARG,108
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 108
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 108
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 108
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 108
pdbx poly seq scheme.pdb strand id: L

C,3,THR,109
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 109
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 109
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 109
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 109
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,110
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 110
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 110
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 110
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 110
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,111
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 111
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 111
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 111
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 111
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,112
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 112
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 112
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 112
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 112
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,113
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 113
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 113
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 113
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 113
pdbx poly seq scheme.pdb strand id: L

C,3,SER,114
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 114
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 114
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 114
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 114
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,115
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 115
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 115
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 115
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 115
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,116
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 116
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 116
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 116
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 116
pdbx poly seq scheme.pdb strand id: L

C,3,ILE,117
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ILE
pdbx poly seq scheme.seq id: 117
pdbx poly seq scheme.auth mon id: ILE
pdbx poly seq scheme.auth seq num: 117
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 117
pdbx poly seq scheme.pdb mon id: ILE
pdbx poly seq scheme.pdb seq num: 117
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,118
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 118
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 118
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 118
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 118
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,119
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 119
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 119
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 119
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 119
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,120
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 120
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 120
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 120
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 120
pdbx poly seq scheme.pdb strand id: L

C,3,SER,121
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 121
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 121
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 121
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 121
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,122
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 122
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 122
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 122
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 122
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,123
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 123
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 123
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 123
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 123
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,124
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 124
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 124
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 124
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 124
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,125
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 125
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 125
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 125
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 125
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,126
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 126
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 126
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 126
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 126
pdbx poly seq scheme.pdb strand id: L

C,3,SER,127
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 127
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 127
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 127
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 127
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,128
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 128
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 128
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 128
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 128
pdbx poly seq scheme.pdb strand id: L

C,3,THR,129
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 129
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 129
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 129
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 129
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,130
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 130
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 130
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 130
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 130
pdbx poly seq scheme.pdb strand id: L

C,3,SER,131
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 131
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 131
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 131
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 131
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,132
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 132
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 132
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 132
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 132
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,133
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 133
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 133
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 133
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 133
pdbx poly seq scheme.pdb strand id: L

C,3,CYS,134
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 134
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 134
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 134
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 134
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,135
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 135
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 135
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 135
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 135
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,136
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 136
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 136
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 136
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 136
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,137
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 137
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 137
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 137
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 137
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,138
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 138
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 138
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 138
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 138
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,139
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 139
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 139
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 139
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 139
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,140
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 140
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 140
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 140
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 140
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,141
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 141
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 141
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 141
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 141
pdbx poly seq scheme.pdb strand id: L

C,3,ARG,142
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 142
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 142
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 142
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 142
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,143
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 143
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 143
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 143
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 143
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,144
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 144
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 144
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 144
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 144
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,145
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 145
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 145
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 145
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 145
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,146
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 146
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 146
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 146
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 146
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,147
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 147
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 147
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 147
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 147
pdbx poly seq scheme.pdb strand id: L

C,3,TRP,148
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TRP
pdbx poly seq scheme.seq id: 148
pdbx poly seq scheme.auth mon id: TRP
pdbx poly seq scheme.auth seq num: 148
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 148
pdbx poly seq scheme.pdb mon id: TRP
pdbx poly seq scheme.pdb seq num: 148
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,149
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 149
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 149
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 149
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 149
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,150
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 150
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 150
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 150
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 150
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,151
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 151
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 151
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 151
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 151
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,152
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 152
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 152
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 152
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 152
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,153
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 153
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 153
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 153
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 153
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,154
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 154
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 154
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 154
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 154
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,155
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 155
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 155
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 155
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 155
pdbx poly seq scheme.pdb strand id: L

C,3,SER,156
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 156
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 156
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 156
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 156
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,157
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 157
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 157
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 157
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 157
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,158
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 158
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 158
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 158
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 158
pdbx poly seq scheme.pdb strand id: L

C,3,SER,159
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 159
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 159
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 159
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 159
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,160
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 160
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 160
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 160
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 160
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,161
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 161
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 161
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 161
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 161
pdbx poly seq scheme.pdb strand id: L

C,3,SER,162
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 162
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 162
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 162
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 162
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,163
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 163
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 163
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 163
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 163
pdbx poly seq scheme.pdb strand id: L

C,3,THR,164
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 164
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 164
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 164
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 164
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,165
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 165
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 165
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 165
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 165
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,166
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 166
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 166
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 166
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 166
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,167
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 167
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 167
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 167
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 167
pdbx poly seq scheme.pdb strand id: L

C,3,SER,168
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 168
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 168
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 168
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 168
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,169
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 169
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 169
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 169
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 169
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,170
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 170
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 170
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 170
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 170
pdbx poly seq scheme.pdb strand id: L

C,3,SER,171
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 171
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 171
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 171
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 171
pdbx poly seq scheme.pdb strand id: L

C,3,THR,172
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 172
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 172
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 172
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 172
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,173
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 173
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 173
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 173
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 173
pdbx poly seq scheme.pdb strand id: L

C,3,SER,174
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 174
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 174
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 174
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 174
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,175
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 175
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 175
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 175
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 175
pdbx poly seq scheme.pdb strand id: L

C,3,SER,176
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 176
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 176
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 176
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 176
pdbx poly seq scheme.pdb strand id: L

C,3,SER,177
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 177
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 177
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 177
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 177
pdbx poly seq scheme.pdb strand id: L

C,3,THR,178
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 178
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 178
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 178
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 178
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,179
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 179
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 179
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 179
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 179
pdbx poly seq scheme.pdb strand id: L

C,3,THR,180
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 180
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 180
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 180
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 180
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,181
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 181
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 181
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 181
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 181
pdbx poly seq scheme.pdb strand id: L

C,3,SER,182
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 182
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 182
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 182
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 182
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,183
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 183
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 183
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 183
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 183
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,184
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 184
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 184
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 184
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 184
pdbx poly seq scheme.pdb strand id: L

C,3,ASP,185
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASP
pdbx poly seq scheme.seq id: 185
pdbx poly seq scheme.auth mon id: ASP
pdbx poly seq scheme.auth seq num: 185
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 185
pdbx poly seq scheme.pdb mon id: ASP
pdbx poly seq scheme.pdb seq num: 185
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,186
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 186
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 186
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 186
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 186
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,187
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 187
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 187
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 187
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 187
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,188
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 188
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 188
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 188
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 188
pdbx poly seq scheme.pdb strand id: L

C,3,HIS,189
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 189
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 189
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 189
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 189
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,190
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 190
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 190
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 190
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 190
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,191
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 191
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 191
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 191
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 191
pdbx poly seq scheme.pdb strand id: L

C,3,TYR,192
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: TYR
pdbx poly seq scheme.seq id: 192
pdbx poly seq scheme.auth mon id: TYR
pdbx poly seq scheme.auth seq num: 192
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 192
pdbx poly seq scheme.pdb mon id: TYR
pdbx poly seq scheme.pdb seq num: 192
pdbx poly seq scheme.pdb strand id: L

C,3,ALA,193
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ALA
pdbx poly seq scheme.seq id: 193
pdbx poly seq scheme.auth mon id: ALA
pdbx poly seq scheme.auth seq num: 193
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 193
pdbx poly seq scheme.pdb mon id: ALA
pdbx poly seq scheme.pdb seq num: 193
pdbx poly seq scheme.pdb strand id: L

C,3,CYS,194
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: CYS
pdbx poly seq scheme.seq id: 194
pdbx poly seq scheme.auth mon id: CYS
pdbx poly seq scheme.auth seq num: 194
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 194
pdbx poly seq scheme.pdb mon id: CYS
pdbx poly seq scheme.pdb seq num: 194
pdbx poly seq scheme.pdb strand id: L

C,3,GLU,195
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLU
pdbx poly seq scheme.seq id: 195
pdbx poly seq scheme.auth mon id: GLU
pdbx poly seq scheme.auth seq num: 195
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 195
pdbx poly seq scheme.pdb mon id: GLU
pdbx poly seq scheme.pdb seq num: 195
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,196
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 196
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 196
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 196
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 196
pdbx poly seq scheme.pdb strand id: L

C,3,THR,197
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 197
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 197
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 197
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 197
pdbx poly seq scheme.pdb strand id: L

C,3,HIS,198
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: HIS
pdbx poly seq scheme.seq id: 198
pdbx poly seq scheme.auth mon id: HIS
pdbx poly seq scheme.auth seq num: 198
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 198
pdbx poly seq scheme.pdb mon id: HIS
pdbx poly seq scheme.pdb seq num: 198
pdbx poly seq scheme.pdb strand id: L

C,3,GLN,199
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLN
pdbx poly seq scheme.seq id: 199
pdbx poly seq scheme.auth mon id: GLN
pdbx poly seq scheme.auth seq num: 199
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 199
pdbx poly seq scheme.pdb mon id: GLN
pdbx poly seq scheme.pdb seq num: 199
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,200
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 200
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 200
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 200
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 200
pdbx poly seq scheme.pdb strand id: L

C,3,LEU,201
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LEU
pdbx poly seq scheme.seq id: 201
pdbx poly seq scheme.auth mon id: LEU
pdbx poly seq scheme.auth seq num: 201
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 201
pdbx poly seq scheme.pdb mon id: LEU
pdbx poly seq scheme.pdb seq num: 201
pdbx poly seq scheme.pdb strand id: L

C,3,SER,202
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 202
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 202
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 202
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 202
pdbx poly seq scheme.pdb strand id: L

C,3,SER,203
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 203
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 203
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 203
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 203
pdbx poly seq scheme.pdb strand id: L

C,3,PRO,204
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PRO
pdbx poly seq scheme.seq id: 204
pdbx poly seq scheme.auth mon id: PRO
pdbx poly seq scheme.auth seq num: 204
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 204
pdbx poly seq scheme.pdb mon id: PRO
pdbx poly seq scheme.pdb seq num: 204
pdbx poly seq scheme.pdb strand id: L

C,3,VAL,205
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: VAL
pdbx poly seq scheme.seq id: 205
pdbx poly seq scheme.auth mon id: VAL
pdbx poly seq scheme.auth seq num: 205
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 205
pdbx poly seq scheme.pdb mon id: VAL
pdbx poly seq scheme.pdb seq num: 205
pdbx poly seq scheme.pdb strand id: L

C,3,THR,206
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: THR
pdbx poly seq scheme.seq id: 206
pdbx poly seq scheme.auth mon id: THR
pdbx poly seq scheme.auth seq num: 206
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 206
pdbx poly seq scheme.pdb mon id: THR
pdbx poly seq scheme.pdb seq num: 206
pdbx poly seq scheme.pdb strand id: L

C,3,LYS,207
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: LYS
pdbx poly seq scheme.seq id: 207
pdbx poly seq scheme.auth mon id: LYS
pdbx poly seq scheme.auth seq num: 207
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 207
pdbx poly seq scheme.pdb mon id: LYS
pdbx poly seq scheme.pdb seq num: 207
pdbx poly seq scheme.pdb strand id: L

C,3,SER,208
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: SER
pdbx poly seq scheme.seq id: 208
pdbx poly seq scheme.auth mon id: SER
pdbx poly seq scheme.auth seq num: 208
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 208
pdbx poly seq scheme.pdb mon id: SER
pdbx poly seq scheme.pdb seq num: 208
pdbx poly seq scheme.pdb strand id: L

C,3,PHE,209
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: PHE
pdbx poly seq scheme.seq id: 209
pdbx poly seq scheme.auth mon id: PHE
pdbx poly seq scheme.auth seq num: 209
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 209
pdbx poly seq scheme.pdb mon id: PHE
pdbx poly seq scheme.pdb seq num: 209
pdbx poly seq scheme.pdb strand id: L

C,3,ASN,210
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ASN
pdbx poly seq scheme.seq id: 210
pdbx poly seq scheme.auth mon id: ASN
pdbx poly seq scheme.auth seq num: 210
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 210
pdbx poly seq scheme.pdb mon id: ASN
pdbx poly seq scheme.pdb seq num: 210
pdbx poly seq scheme.pdb strand id: L

C,3,ARG,211
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: ARG
pdbx poly seq scheme.seq id: 211
pdbx poly seq scheme.auth mon id: ARG
pdbx poly seq scheme.auth seq num: 211
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 211
pdbx poly seq scheme.pdb mon id: ARG
pdbx poly seq scheme.pdb seq num: 211
pdbx poly seq scheme.pdb strand id: L

C,3,GLY,212
type: pdbx poly seq scheme
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity poly seq: ,,
reference to struct asym: http://rdf.wwpdb.org/pdb/4G6J/struct_asym/,
pdbx poly seq scheme.asym id: C
pdbx poly seq scheme.entity id: 3
pdbx poly seq scheme.mon id: GLY
pdbx poly seq scheme.seq id: 212
pdbx poly seq scheme.auth mon id: GLY
pdbx poly seq scheme.auth seq num: 212
pdbx poly seq scheme.hetero: n
pdbx poly seq scheme.ndb seq num: 212
pdbx poly seq scheme.pdb mon id: GLY
pdbx poly seq scheme.pdb seq num: 212
pdbx poly seq scheme.pdb strand id: L

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/1
type: pdbx refine tls
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx refine tls.id: 1
pdbx refine tls.l11: 2.0583
pdbx refine tls.l12: 0.8840
pdbx refine tls.l13: -0.4522
pdbx refine tls.l22: 1.5259
pdbx refine tls.l23: -0.7633
pdbx refine tls.l33: 1.6968
pdbx refine tls.s11: 0.0075
pdbx refine tls.s12: -0.1359
pdbx refine tls.s13: 0.0177
pdbx refine tls.s21: 0.2270
pdbx refine tls.s22: 0.0706
pdbx refine tls.s23: 0.0632
pdbx refine tls.s31: -0.0396
pdbx refine tls.s32: -0.3307
pdbx refine tls.s33: -0.0781
pdbx refine tls.t11: 0.0451
pdbx refine tls.t12: -0.0311
pdbx refine tls.t13: 0.0225
pdbx refine tls.t22: 0.0139
pdbx refine tls.t23: 0.0324
pdbx refine tls.t33: -0.1711
pdbx refine tls.method: refined
pdbx refine tls.origin x: 18.5512
pdbx refine tls.origin y: -12.2017
pdbx refine tls.origin z: -36.2569
pdbx refine tls.pdbx refine id: X-RAY DIFFRACTION
referenced by pdbx refine tls group: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/1

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/2
type: pdbx refine tls
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx refine tls.id: 2
pdbx refine tls.l11: 0.1688
pdbx refine tls.l12: 0.1613
pdbx refine tls.l13: -0.3350
pdbx refine tls.l22: 0.5104
pdbx refine tls.l23: -0.0073
pdbx refine tls.l33: 2.4357
pdbx refine tls.s11: 0.0509
pdbx refine tls.s12: -0.0232
pdbx refine tls.s13: -0.0058
pdbx refine tls.s21: -0.0306
pdbx refine tls.s22: 0.0455
pdbx refine tls.s23: -0.0485
pdbx refine tls.s31: -0.0070
pdbx refine tls.s32: 0.1515
pdbx refine tls.s33: -0.0965
pdbx refine tls.t11: -0.0235
pdbx refine tls.t12: 0.0175
pdbx refine tls.t13: -0.0106
pdbx refine tls.t22: -0.0980
pdbx refine tls.t23: -0.0125
pdbx refine tls.t33: -0.0495
pdbx refine tls.method: refined
pdbx refine tls.origin x: 37.6745
pdbx refine tls.origin y: -8.8056
pdbx refine tls.origin z: -76.0438
pdbx refine tls.pdbx refine id: X-RAY DIFFRACTION
referenced by pdbx refine tls group: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/2

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/3
type: pdbx refine tls
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx refine tls.id: 3
pdbx refine tls.l11: 0.7887
pdbx refine tls.l12: -0.1068
pdbx refine tls.l13: -0.1399
pdbx refine tls.l22: 0.2833
pdbx refine tls.l23: -0.2771
pdbx refine tls.l33: 2.1385
pdbx refine tls.s11: 0.0423
pdbx refine tls.s12: 0.0500
pdbx refine tls.s13: -0.0655
pdbx refine tls.s21: -0.1021
pdbx refine tls.s22: 0.0240
pdbx refine tls.s23: 0.0440
pdbx refine tls.s31: -0.0665
pdbx refine tls.s32: -0.2651
pdbx refine tls.s33: -0.0663
pdbx refine tls.t11: -0.0178
pdbx refine tls.t12: 0.0025
pdbx refine tls.t13: -0.0193
pdbx refine tls.t22: -0.1218
pdbx refine tls.t23: -0.0026
pdbx refine tls.t33: -0.0820
pdbx refine tls.method: refined
pdbx refine tls.origin x: 21.9125
pdbx refine tls.origin y: -5.6650
pdbx refine tls.origin z: -84.9250
pdbx refine tls.pdbx refine id: X-RAY DIFFRACTION
referenced by pdbx refine tls group: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/3

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/1
type: pdbx refine tls group
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx refine tls: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/1
pdbx refine tls group.id: 1
pdbx refine tls group.beg auth asym id: A
pdbx refine tls group.beg auth seq id: 4
pdbx refine tls group.end auth asym id: A
pdbx refine tls group.end auth seq id: 152
pdbx refine tls group.pdbx refine id: X-RAY DIFFRACTION
pdbx refine tls group.refine tls id: 1
pdbx refine tls group.selection details: { A|4 - A|152 }

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/2
type: pdbx refine tls group
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx refine tls: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/2
pdbx refine tls group.id: 2
pdbx refine tls group.beg auth asym id: H
pdbx refine tls group.beg auth seq id: 1
pdbx refine tls group.end auth asym id: H
pdbx refine tls group.end auth seq id: 218
pdbx refine tls group.pdbx refine id: X-RAY DIFFRACTION
pdbx refine tls group.refine tls id: 2
pdbx refine tls group.selection details: { H|1 - H|218 }

http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls_group/3
type: pdbx refine tls group
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx refine tls: http://rdf.wwpdb.org/pdb/4G6J/pdbx_refine_tls/3
pdbx refine tls group.id: 3
pdbx refine tls group.beg auth asym id: L
pdbx refine tls group.beg auth seq id: 1
pdbx refine tls group.end auth asym id: L
pdbx refine tls group.end auth seq id: 212
pdbx refine tls group.pdbx refine id: X-RAY DIFFRACTION
pdbx refine tls group.refine tls id: 3
pdbx refine tls group.selection details: { L|1 - L|212 }

http://rdf.wwpdb.org/pdb/4G6J/pdbx_struct_assembly/1
type: pdbx struct assembly
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx struct assembly.id: 1
pdbx struct assembly.details: author_defined_assembly
pdbx struct assembly.oligomeric count: 3
pdbx struct assembly.oligomeric details: trimeric

1,A,B,C,D,E,F,1
type: pdbx struct assembly gen
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to pdbx struct assembly: pdbx struct assembly
pdbx struct assembly gen.assembly id: 1
pdbx struct assembly gen.asym id list: A,B,C,D,E,F
pdbx struct assembly gen.oper expression: 1

http://rdf.wwpdb.org/pdb/4G6J/pdbx_struct_oper_list/1
type: pdbx struct oper list
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx struct oper list.id: 1
pdbx struct oper list.matrix11: 1.0000000000
pdbx struct oper list.matrix12: 0.0000000000
pdbx struct oper list.matrix13: 0.0000000000
pdbx struct oper list.matrix21: 0.0000000000
pdbx struct oper list.matrix22: 1.0000000000
pdbx struct oper list.matrix23: 0.0000000000
pdbx struct oper list.matrix31: 0.0000000000
pdbx struct oper list.matrix32: 0.0000000000
pdbx struct oper list.matrix33: 1.0000000000
pdbx struct oper list.name: 1_555
pdbx struct oper list.symmetry operation: x,y,z
pdbx struct oper list.type: identity operation
pdbx struct oper list.vector1: 0.0000000000
pdbx struct oper list.vector2: 0.0000000000
pdbx struct oper list.vector3: 0.0000000000

1,2,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: CYS
pdbx struct sheet hbond.range 1 auth seq id: 8
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: CYS
pdbx struct sheet hbond.range 1 label seq id: 9
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: PHE
pdbx struct sheet hbond.range 2 auth seq id: 42
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: PHE
pdbx struct sheet hbond.range 2 label seq id: 43

2,3,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 43
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 44
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLY
pdbx struct sheet hbond.range 2 auth seq id: 61
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLY
pdbx struct sheet hbond.range 2 label seq id: 62

3,4,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: VAL
pdbx struct sheet hbond.range 1 auth seq id: 58
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: VAL
pdbx struct sheet hbond.range 1 label seq id: 59
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: PHE
pdbx struct sheet hbond.range 2 auth seq id: 101
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: PHE
pdbx struct sheet hbond.range 2 label seq id: 102

4,5,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 4
pdbx struct sheet hbond.range id 2: 5
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: ASN
pdbx struct sheet hbond.range 1 auth seq id: 102
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: ASN
pdbx struct sheet hbond.range 1 label seq id: 103
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLU
pdbx struct sheet hbond.range 2 auth seq id: 113
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLU
pdbx struct sheet hbond.range 2 label seq id: 114

5,6,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 5
pdbx struct sheet hbond.range id 2: 6
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: LEU
pdbx struct sheet hbond.range 1 auth seq id: 110
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: LEU
pdbx struct sheet hbond.range 1 label seq id: 111
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: PHE
pdbx struct sheet hbond.range 2 auth seq id: 146
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: PHE
pdbx struct sheet hbond.range 2 label seq id: 147

6,7,A
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 6
pdbx struct sheet hbond.range id 2: 7
pdbx struct sheet hbond.sheet id: A
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 147
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 148
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: ARG
pdbx struct sheet hbond.range 2 auth seq id: 11
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: ARG
pdbx struct sheet hbond.range 2 label seq id: 12

1,2,B
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: B
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 21
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 22
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLU
pdbx struct sheet hbond.range 2 auth seq id: 25
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLU
pdbx struct sheet hbond.range 2 label seq id: 26

2,3,B
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: B
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: ALA
pdbx struct sheet hbond.range 1 auth seq id: 28
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: ALA
pdbx struct sheet hbond.range 1 label seq id: 29
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: MET
pdbx struct sheet hbond.range 2 auth seq id: 130
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: MET
pdbx struct sheet hbond.range 2 label seq id: 131

1,2,C
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: C
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 70
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 71
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLN
pdbx struct sheet hbond.range 2 auth seq id: 81
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLN
pdbx struct sheet hbond.range 2 label seq id: 82

1,2,D
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: D
pdbx struct sheet hbond.range 1 auth asym id: A
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 123
pdbx struct sheet hbond.range 1 label asym id: A
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 124
pdbx struct sheet hbond.range 2 auth asym id: A
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: PHE
pdbx struct sheet hbond.range 2 auth seq id: 133
pdbx struct sheet hbond.range 2 label asym id: A
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: PHE
pdbx struct sheet hbond.range 2 label seq id: 134

1,2,E
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: E
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: VAL
pdbx struct sheet hbond.range 1 auth seq id: 5
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: VAL
pdbx struct sheet hbond.range 1 label seq id: 5
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ALA
pdbx struct sheet hbond.range 2 auth seq id: 23
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ALA
pdbx struct sheet hbond.range 2 label seq id: 23

2,3,E
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: E
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: LEU
pdbx struct sheet hbond.range 1 auth seq id: 20
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: LEU
pdbx struct sheet hbond.range 1 label seq id: 20
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: LEU
pdbx struct sheet hbond.range 2 auth seq id: 81
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: LEU
pdbx struct sheet hbond.range 2 label seq id: 81

3,4,E
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: E
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: TYR
pdbx struct sheet hbond.range 1 auth seq id: 80
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: TYR
pdbx struct sheet hbond.range 1 label seq id: 80
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: SER
pdbx struct sheet hbond.range 2 auth seq id: 71
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: SER
pdbx struct sheet hbond.range 2 label seq id: 71

1,2,F
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: F
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: GLY
pdbx struct sheet hbond.range 1 auth seq id: 10
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: GLY
pdbx struct sheet hbond.range 1 label seq id: 10
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: THR
pdbx struct sheet hbond.range 2 auth seq id: 115
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: THR
pdbx struct sheet hbond.range 2 label seq id: 115

2,3,F
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: F
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 112
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 112
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 94
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 94

3,4,F
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: F
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: TYR
pdbx struct sheet hbond.range 1 auth seq id: 95
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: TYR
pdbx struct sheet hbond.range 1 label seq id: 95
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: VAL
pdbx struct sheet hbond.range 2 auth seq id: 37
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: VAL
pdbx struct sheet hbond.range 2 label seq id: 37

4,5,F
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 4
pdbx struct sheet hbond.range id 2: 5
pdbx struct sheet hbond.sheet id: F
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: ARG
pdbx struct sheet hbond.range 1 auth seq id: 38
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: ARG
pdbx struct sheet hbond.range 1 label seq id: 38
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLU
pdbx struct sheet hbond.range 2 auth seq id: 46
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLU
pdbx struct sheet hbond.range 2 label seq id: 46

5,6,F
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 5
pdbx struct sheet hbond.range id 2: 6
pdbx struct sheet hbond.sheet id: F
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: ILE
pdbx struct sheet hbond.range 1 auth seq id: 50
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: ILE
pdbx struct sheet hbond.range 1 label seq id: 50
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 59
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 59

1,2,G
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: G
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: GLY
pdbx struct sheet hbond.range 1 auth seq id: 10
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: GLY
pdbx struct sheet hbond.range 1 label seq id: 10
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: THR
pdbx struct sheet hbond.range 2 auth seq id: 115
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: THR
pdbx struct sheet hbond.range 2 label seq id: 115

2,3,G
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: G
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 112
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 112
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 94
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 94

3,4,G
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: G
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: ARG
pdbx struct sheet hbond.range 1 auth seq id: 98
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: ARG
pdbx struct sheet hbond.range 1 label seq id: 98
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 107
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 107

1,2,H
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: H
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: PHE
pdbx struct sheet hbond.range 1 auth seq id: 127
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: PHE
pdbx struct sheet hbond.range 1 label seq id: 127
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: LEU
pdbx struct sheet hbond.range 2 auth seq id: 146
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: LEU
pdbx struct sheet hbond.range 2 label seq id: 146

2,3,H
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: H
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: TYR
pdbx struct sheet hbond.range 1 auth seq id: 150
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: TYR
pdbx struct sheet hbond.range 1 label seq id: 150
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 181
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 181

3,4,H
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: H
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: VAL
pdbx struct sheet hbond.range 1 auth seq id: 186
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: VAL
pdbx struct sheet hbond.range 1 label seq id: 186
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: HIS
pdbx struct sheet hbond.range 2 auth seq id: 169
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: HIS
pdbx struct sheet hbond.range 2 label seq id: 169

1,2,I
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: I
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 137
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 137
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: THR
pdbx struct sheet hbond.range 2 auth seq id: 140
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: THR
pdbx struct sheet hbond.range 2 label seq id: 140

2,3,I
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: I
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: TYR
pdbx struct sheet hbond.range 1 auth seq id: 150
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: TYR
pdbx struct sheet hbond.range 1 label seq id: 150
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 181
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 181

3,4,I
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: I
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 182
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 182
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: VAL
pdbx struct sheet hbond.range 2 auth seq id: 174
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: VAL
pdbx struct sheet hbond.range 2 label seq id: 174

1,2,J
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: J
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: SER
pdbx struct sheet hbond.range 1 auth seq id: 158
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: SER
pdbx struct sheet hbond.range 1 label seq id: 158
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ASN
pdbx struct sheet hbond.range 2 auth seq id: 202
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ASN
pdbx struct sheet hbond.range 2 label seq id: 202

2,3,J
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: J
pdbx struct sheet hbond.range 1 auth asym id: H
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: VAL
pdbx struct sheet hbond.range 1 auth seq id: 203
pdbx struct sheet hbond.range 1 label asym id: B
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: VAL
pdbx struct sheet hbond.range 1 label seq id: 203
pdbx struct sheet hbond.range 2 auth asym id: H
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: VAL
pdbx struct sheet hbond.range 2 auth seq id: 212
pdbx struct sheet hbond.range 2 label asym id: B
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: VAL
pdbx struct sheet hbond.range 2 label seq id: 212

1,2,K
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: K
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 5
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 5
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ARG
pdbx struct sheet hbond.range 2 auth seq id: 24
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ARG
pdbx struct sheet hbond.range 2 label seq id: 24

2,3,K
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: K
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: CYS
pdbx struct sheet hbond.range 1 auth seq id: 23
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: CYS
pdbx struct sheet hbond.range 1 label seq id: 23
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: PHE
pdbx struct sheet hbond.range 2 auth seq id: 71
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: PHE
pdbx struct sheet hbond.range 2 label seq id: 71

3,4,K
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: K
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 74
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 74
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: SER
pdbx struct sheet hbond.range 2 auth seq id: 63
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: SER
pdbx struct sheet hbond.range 2 label seq id: 63

1,2,L
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: L
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: GLN
pdbx struct sheet hbond.range 1 auth seq id: 11
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: GLN
pdbx struct sheet hbond.range 1 label seq id: 11
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ASP
pdbx struct sheet hbond.range 2 auth seq id: 105
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ASP
pdbx struct sheet hbond.range 2 label seq id: 105

2,3,L
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: L
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 102
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 102
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 86
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 86

3,4,L
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: L
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: ALA
pdbx struct sheet hbond.range 1 auth seq id: 85
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: ALA
pdbx struct sheet hbond.range 1 label seq id: 85
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: GLN
pdbx struct sheet hbond.range 2 auth seq id: 38
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: GLN
pdbx struct sheet hbond.range 2 label seq id: 38

4,5,L
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 4
pdbx struct sheet hbond.range id 2: 5
pdbx struct sheet hbond.sheet id: L
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: TRP
pdbx struct sheet hbond.range 1 auth seq id: 35
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: TRP
pdbx struct sheet hbond.range 1 label seq id: 35
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: LEU
pdbx struct sheet hbond.range 2 auth seq id: 47
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: LEU
pdbx struct sheet hbond.range 2 label seq id: 47

5,6,L
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 5
pdbx struct sheet hbond.range id 2: 6
pdbx struct sheet hbond.sheet id: L
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: LYS
pdbx struct sheet hbond.range 1 auth seq id: 49
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: LYS
pdbx struct sheet hbond.range 1 label seq id: 49
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: GLN
pdbx struct sheet hbond.range 2 auth seq id: 53
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: GLN
pdbx struct sheet hbond.range 2 label seq id: 53

1,2,M
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: M
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: GLN
pdbx struct sheet hbond.range 1 auth seq id: 11
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: GLN
pdbx struct sheet hbond.range 1 label seq id: 11
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ASP
pdbx struct sheet hbond.range 2 auth seq id: 105
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ASP
pdbx struct sheet hbond.range 2 label seq id: 105

2,3,M
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: M
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 102
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 102
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: TYR
pdbx struct sheet hbond.range 2 auth seq id: 86
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: TYR
pdbx struct sheet hbond.range 2 label seq id: 86

3,4,M
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: M
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: GLN
pdbx struct sheet hbond.range 1 auth seq id: 90
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: GLN
pdbx struct sheet hbond.range 1 label seq id: 90
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: THR
pdbx struct sheet hbond.range 2 auth seq id: 97
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: THR
pdbx struct sheet hbond.range 2 label seq id: 97

1,2,N
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: N
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: PHE
pdbx struct sheet hbond.range 1 auth seq id: 116
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: PHE
pdbx struct sheet hbond.range 1 label seq id: 116
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: LEU
pdbx struct sheet hbond.range 2 auth seq id: 135
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: LEU
pdbx struct sheet hbond.range 2 label seq id: 135

2,3,N
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: N
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: LEU
pdbx struct sheet hbond.range 1 auth seq id: 136
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: LEU
pdbx struct sheet hbond.range 1 label seq id: 136
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: LEU
pdbx struct sheet hbond.range 2 auth seq id: 175
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: LEU
pdbx struct sheet hbond.range 2 label seq id: 175

3,4,N
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: N
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: THR
pdbx struct sheet hbond.range 1 auth seq id: 178
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: THR
pdbx struct sheet hbond.range 1 label seq id: 178
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: GLN
pdbx struct sheet hbond.range 2 auth seq id: 160
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: GLN
pdbx struct sheet hbond.range 2 label seq id: 160

1,2,O
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 1
pdbx struct sheet hbond.range id 2: 2
pdbx struct sheet hbond.sheet id: O
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: O
pdbx struct sheet hbond.range 1 auth comp id: ALA
pdbx struct sheet hbond.range 1 auth seq id: 153
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: O
pdbx struct sheet hbond.range 1 label comp id: ALA
pdbx struct sheet hbond.range 1 label seq id: 153
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: N
pdbx struct sheet hbond.range 2 auth comp id: VAL
pdbx struct sheet hbond.range 2 auth seq id: 150
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: N
pdbx struct sheet hbond.range 2 label comp id: VAL
pdbx struct sheet hbond.range 2 label seq id: 150

2,3,O
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 2
pdbx struct sheet hbond.range id 2: 3
pdbx struct sheet hbond.sheet id: O
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: LYS
pdbx struct sheet hbond.range 1 auth seq id: 149
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: LYS
pdbx struct sheet hbond.range 1 label seq id: 149
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: ALA
pdbx struct sheet hbond.range 2 auth seq id: 193
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: ALA
pdbx struct sheet hbond.range 2 label seq id: 193

3,4,O
type: pdbx struct sheet hbond
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
pdbx struct sheet hbond.range id 1: 3
pdbx struct sheet hbond.range id 2: 4
pdbx struct sheet hbond.sheet id: O
pdbx struct sheet hbond.range 1 auth asym id: L
pdbx struct sheet hbond.range 1 auth atom id: N
pdbx struct sheet hbond.range 1 auth comp id: VAL
pdbx struct sheet hbond.range 1 auth seq id: 196
pdbx struct sheet hbond.range 1 label asym id: C
pdbx struct sheet hbond.range 1 label atom id: N
pdbx struct sheet hbond.range 1 label comp id: VAL
pdbx struct sheet hbond.range 1 label seq id: 196
pdbx struct sheet hbond.range 2 auth asym id: L
pdbx struct sheet hbond.range 2 auth atom id: O
pdbx struct sheet hbond.range 2 auth comp id: VAL
pdbx struct sheet hbond.range 2 auth seq id: 205
pdbx struct sheet hbond.range 2 label asym id: C
pdbx struct sheet hbond.range 2 label atom id: O
pdbx struct sheet hbond.range 2 label comp id: VAL
pdbx struct sheet hbond.range 2 label seq id: 205

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/1
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 1
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CB
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 88
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CB
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 89
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/2
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 2
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 88
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 89
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/3
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 3
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 88
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 89
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/4
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 4
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 88
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 89
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/5
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 5
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 88
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 89
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/6
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 6
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CB
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 93
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CB
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 94
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/7
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 7
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 93
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 94
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/8
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 8
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 93
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 94
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/9
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 9
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 93
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 94
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/10
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 10
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: A
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 93
pdbx unobs or zero occ atoms.label asym id: A
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 94
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/11
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: GLY
pdbx unobs or zero occ atoms.id: 11
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CA
pdbx unobs or zero occ atoms.auth comp id: GLY
pdbx unobs or zero occ atoms.auth seq id: 195
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CA
pdbx unobs or zero occ atoms.label comp id: GLY
pdbx unobs or zero occ atoms.label seq id: 195
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/12
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 12
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CB
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 206
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CB
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 206
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/13
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 13
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 206
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 206
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/14
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 14
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 206
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 206
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/15
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 15
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 206
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 206
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/16
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 16
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 206
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 206
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/17
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 17
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 211
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 211
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/18
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 18
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 211
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 211
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/19
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 19
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 211
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 211
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/20
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 20
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 211
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 211
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/21
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 21
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: N
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: N
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/22
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 22
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: C
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: C
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/23
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 23
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: O
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: O
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/24
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 24
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CB
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CB
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/25
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 25
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/26
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 26
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/27
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 27
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: NE
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: NE
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/28
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 28
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: CZ
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: CZ
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/29
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 29
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: NH1
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: NH1
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/30
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ atoms.id: 30
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: H
pdbx unobs or zero occ atoms.auth atom id: NH2
pdbx unobs or zero occ atoms.auth comp id: ARG
pdbx unobs or zero occ atoms.auth seq id: 215
pdbx unobs or zero occ atoms.label asym id: B
pdbx unobs or zero occ atoms.label atom id: NH2
pdbx unobs or zero occ atoms.label comp id: ARG
pdbx unobs or zero occ atoms.label seq id: 215
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/31
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: GLU
pdbx unobs or zero occ atoms.id: 31
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: GLU
pdbx unobs or zero occ atoms.auth seq id: 17
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: GLU
pdbx unobs or zero occ atoms.label seq id: 17
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/32
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 32
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: N
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: N
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/33
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 33
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: C
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: C
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/34
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 34
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: O
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: O
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/35
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 35
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CB
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CB
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/36
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 36
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/37
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 37
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/38
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 38
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/39
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 39
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 126
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 126
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/40
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 40
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 145
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 145
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/41
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 41
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 145
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 145
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/42
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 42
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 145
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 145
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/43
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LEU
pdbx unobs or zero occ atoms.id: 43
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CD1
pdbx unobs or zero occ atoms.auth comp id: LEU
pdbx unobs or zero occ atoms.auth seq id: 154
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CD1
pdbx unobs or zero occ atoms.label comp id: LEU
pdbx unobs or zero occ atoms.label seq id: 154
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/44
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LEU
pdbx unobs or zero occ atoms.id: 44
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CD2
pdbx unobs or zero occ atoms.auth comp id: LEU
pdbx unobs or zero occ atoms.auth seq id: 154
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CD2
pdbx unobs or zero occ atoms.label comp id: LEU
pdbx unobs or zero occ atoms.label seq id: 154
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/45
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 45
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CG
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 190
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CG
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 190
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/46
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 46
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CD
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 190
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CD
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 190
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/47
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 47
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: CE
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 190
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: CE
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 190
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_atoms/48
type: pdbx unobs or zero occ atoms
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LYS
pdbx unobs or zero occ atoms.id: 48
pdbx unobs or zero occ atoms.pdb model num: 1
pdbx unobs or zero occ atoms.auth asym id: L
pdbx unobs or zero occ atoms.auth atom id: NZ
pdbx unobs or zero occ atoms.auth comp id: LYS
pdbx unobs or zero occ atoms.auth seq id: 190
pdbx unobs or zero occ atoms.label asym id: C
pdbx unobs or zero occ atoms.label atom id: NZ
pdbx unobs or zero occ atoms.label comp id: LYS
pdbx unobs or zero occ atoms.label seq id: 190
pdbx unobs or zero occ atoms.occupancy flag: 0
pdbx unobs or zero occ atoms.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/1
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: MET
pdbx unobs or zero occ residues.id: 1
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: MET
pdbx unobs or zero occ residues.auth seq id: 0
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: MET
pdbx unobs or zero occ residues.label seq id: 1
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/2
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ALA
pdbx unobs or zero occ residues.id: 2
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: ALA
pdbx unobs or zero occ residues.auth seq id: 1
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: ALA
pdbx unobs or zero occ residues.label seq id: 2
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/3
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: PRO
pdbx unobs or zero occ residues.id: 3
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: PRO
pdbx unobs or zero occ residues.auth seq id: 2
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: PRO
pdbx unobs or zero occ residues.label seq id: 3
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/4
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: VAL
pdbx unobs or zero occ residues.id: 4
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: VAL
pdbx unobs or zero occ residues.auth seq id: 3
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: VAL
pdbx unobs or zero occ residues.label seq id: 4
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/5
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ residues.id: 5
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: ARG
pdbx unobs or zero occ residues.auth seq id: 4
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: ARG
pdbx unobs or zero occ residues.label seq id: 5
pdbx unobs or zero occ residues.occupancy flag: 0
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/6
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: SER
pdbx unobs or zero occ residues.id: 6
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: SER
pdbx unobs or zero occ residues.auth seq id: 153
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: SER
pdbx unobs or zero occ residues.label seq id: 154
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/7
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: LEU
pdbx unobs or zero occ residues.id: 7
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: LEU
pdbx unobs or zero occ residues.auth seq id: 154
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: LEU
pdbx unobs or zero occ residues.label seq id: 155
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/8
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: VAL
pdbx unobs or zero occ residues.id: 8
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: VAL
pdbx unobs or zero occ residues.auth seq id: 155
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: VAL
pdbx unobs or zero occ residues.label seq id: 156
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/9
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: PRO
pdbx unobs or zero occ residues.id: 9
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: PRO
pdbx unobs or zero occ residues.auth seq id: 156
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: PRO
pdbx unobs or zero occ residues.label seq id: 157
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_unobs_or_zero_occ_residues/10
type: pdbx unobs or zero occ residues
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to chem comp: ARG
pdbx unobs or zero occ residues.id: 10
pdbx unobs or zero occ residues.pdb model num: 1
pdbx unobs or zero occ residues.auth asym id: A
pdbx unobs or zero occ residues.auth comp id: ARG
pdbx unobs or zero occ residues.auth seq id: 157
pdbx unobs or zero occ residues.label asym id: A
pdbx unobs or zero occ residues.label comp id: ARG
pdbx unobs or zero occ residues.label seq id: 158
pdbx unobs or zero occ residues.occupancy flag: 1
pdbx unobs or zero occ residues.polymer flag: Y

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/1
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 1
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: A
pdbx validate torsion.auth comp id: LYS
pdbx validate torsion.auth seq id: 63
pdbx validate torsion.phi: 55.76
pdbx validate torsion.psi: -55.94

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/2
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 2
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: A
pdbx validate torsion.auth comp id: ASN
pdbx validate torsion.auth seq id: 66
pdbx validate torsion.phi: -84.71
pdbx validate torsion.psi: 43.00

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/3
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 3
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: A
pdbx validate torsion.auth comp id: ILE
pdbx validate torsion.auth seq id: 106
pdbx validate torsion.phi: -99.01
pdbx validate torsion.psi: -105.50

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/4
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 4
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: A
pdbx validate torsion.auth comp id: ASN
pdbx validate torsion.auth seq id: 107
pdbx validate torsion.phi: -112.08
pdbx validate torsion.psi: 73.91

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/5
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 5
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: H
pdbx validate torsion.auth comp id: VAL
pdbx validate torsion.auth seq id: 48
pdbx validate torsion.phi: -95.72
pdbx validate torsion.psi: -63.23

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/6
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 6
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: H
pdbx validate torsion.auth comp id: LEU
pdbx validate torsion.auth seq id: 129
pdbx validate torsion.phi: -113.21
pdbx validate torsion.psi: 79.62

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/7
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 7
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: H
pdbx validate torsion.auth comp id: ASP
pdbx validate torsion.auth seq id: 213
pdbx validate torsion.phi: -114.61
pdbx validate torsion.psi: 76.31

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/8
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 8
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: LYS
pdbx validate torsion.auth seq id: 16
pdbx validate torsion.phi: 74.08
pdbx validate torsion.psi: -5.82

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/9
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 9
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: LEU
pdbx validate torsion.auth seq id: 47
pdbx validate torsion.phi: -107.76
pdbx validate torsion.psi: -60.83

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/10
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 10
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: ALA
pdbx validate torsion.auth seq id: 51
pdbx validate torsion.phi: 63.93
pdbx validate torsion.psi: -45.54

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/11
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 11
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: SER
pdbx validate torsion.auth seq id: 77
pdbx validate torsion.phi: 37.95
pdbx validate torsion.psi: 68.70

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/12
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 12
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: ALA
pdbx validate torsion.auth seq id: 83
pdbx validate torsion.phi: -67.13
pdbx validate torsion.psi: 97.36

http://rdf.wwpdb.org/pdb/4G6J/pdbx_validate_torsion/13
type: pdbx validate torsion
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
pdbx validate torsion.id: 13
pdbx validate torsion.pdb model num: 1
pdbx validate torsion.auth asym id: L
pdbx validate torsion.auth comp id: GLU
pdbx validate torsion.auth seq id: 143
pdbx validate torsion.phi: -58.97
pdbx validate torsion.psi: 104.96

4G6J,X-RAY DIFFRACTION
type: refine
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
refine.entry id: 4G6J
refine.pdbx refine id: X-RAY DIFFRACTION
refine.b iso mean: 35.92
refine.aniso B11: -7.0896
refine.aniso B12: 0.0000
refine.aniso B13: 0.0000
refine.aniso B22: -0.8482
refine.aniso B23: 0.0000
refine.aniso B33: 7.9378
refine.correlation coeff fo to fc: 0.9065
refine.correlation coeff fo to fc free: 0.8926
refine.ls r factor r free: 0.2519
refine.ls r factor r work: 0.2257
refine.ls r factor obs: 0.2270
refine.ls d res high: 2.03
refine.ls d res low: 39.36
refine.ls number reflns r free: 1891
refine.ls number reflns all: 37806
refine.ls number reflns obs: 37684
refine.ls percent reflns r free: 5.02
refine.ls percent reflns obs: 98.59
refine.overall SU r cruickshank DPI: 0.231
refine.pdbx r free selection details: RANDOM
refine.pdbx diffrn id: 1
refine.pdbx ls cross valid method: THROUGHOUT
refine.pdbx ls sigma f: 0.0
refine.pdbx ls sigma i: 2.0
refine.pdbx method to determine struct: MOLECULAR REPLACEMENT
refine.pdbx starting model: 1PZ5, 3BKJ, 1TOO

4G6J,X-RAY DIFFRACTION
type: refine analyze
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
refine analyze.entry id: 4G6J
refine analyze.pdbx refine id: X-RAY DIFFRACTION
refine analyze.luzzati coordinate error obs: 0.300

LAST,X-RAY DIFFRACTION
type: refine hist
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine hist.cycle id: LAST
refine hist.pdbx refine id: X-RAY DIFFRACTION
refine hist.d res high: 2.03
refine hist.d res low: 39.36
refine hist.number atoms solvent: 303
refine hist.number atoms total: 4769
refine hist.pdbx number atoms ligand: 0
refine hist.pdbx number atoms nucleic acid: 0
refine hist.pdbx number atoms protein: 4466

X-RAY DIFFRACTION,t bond d
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_bond_d
refine ls restr.dev ideal: 0.007
refine ls restr.number: 4575
refine ls restr.pdbx restraint function: HARMONIC
refine ls restr.weight: 2.00

X-RAY DIFFRACTION,t angle deg
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_angle_deg
refine ls restr.dev ideal: 1.02
refine ls restr.number: 6211
refine ls restr.pdbx restraint function: HARMONIC
refine ls restr.weight: 2.00

X-RAY DIFFRACTION,t dihedral angle d
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_dihedral_angle_d
refine ls restr.number: 1550
refine ls restr.pdbx restraint function: SINUSOIDAL
refine ls restr.weight: 2.00

X-RAY DIFFRACTION,t trig c planes
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_trig_c_planes
refine ls restr.number: 111
refine ls restr.pdbx restraint function: HARMONIC
refine ls restr.weight: 2.00

X-RAY DIFFRACTION,t gen planes
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_gen_planes
refine ls restr.number: 657
refine ls restr.pdbx restraint function: HARMONIC
refine ls restr.weight: 5.00

X-RAY DIFFRACTION,t it
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_it
refine ls restr.number: 4575
refine ls restr.pdbx restraint function: HARMONIC
refine ls restr.weight: 20.00

X-RAY DIFFRACTION,t omega torsion
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_omega_torsion
refine ls restr.dev ideal: 2.51

X-RAY DIFFRACTION,t other torsion
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_other_torsion
refine ls restr.dev ideal: 17.04

X-RAY DIFFRACTION,t chiral improper torsion
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_chiral_improper_torsion
refine ls restr.number: 595
refine ls restr.pdbx restraint function: SEMIHARMONIC
refine ls restr.weight: 5.00

X-RAY DIFFRACTION,t ideal dist contact
type: refine ls restr
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls restr.pdbx refine id: X-RAY DIFFRACTION
refine ls restr.type: t_ideal_dist_contact
refine ls restr.number: 5151
refine ls restr.pdbx restraint function: SEMIHARMONIC
refine ls restr.weight: 4.00

2.03,X-RAY DIFFRACTION
type: refine ls shell
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
refine ls shell.d res high: 2.03
refine ls shell.pdbx refine id: X-RAY DIFFRACTION
refine ls shell.r factor r free: 0.2200
refine ls shell.r factor r work: 0.2173
refine ls shell.r factor all: 0.2175
refine ls shell.d res low: 2.09
refine ls shell.number reflns r free: 143
refine ls shell.number reflns r work: 2606
refine ls shell.number reflns all: 2749
refine ls shell.pdbx total number of bins used: 19
refine ls shell.percent reflns r free: 5.20
refine ls shell.percent reflns obs: 98.59

http://rdf.wwpdb.org/pdb/4G6J/reflns/1
type: reflns
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: 4G6J
reflns.pdbx ordinal: 1
reflns.b iso wilson estimate: 29.23
reflns.d resolution high: 2.0
reflns.d resolution low: 94.7
reflns.entry id: 4G6J
reflns.number all: 207933
reflns.number obs: 38275
reflns.observed criterion sigma f: 2.0
reflns.observed criterion sigma i: 2.0
reflns.pdbx rmerge i obs: 0.108
reflns.pdbx rsym value: 0.120
reflns.pdbx diffrn id: 1
reflns.pdbx net i over sigma i: 12.1
reflns.pdbx redundancy: 5.3
reflns.percent possible obs: 98.8

http://rdf.wwpdb.org/pdb/4G6J/reflns_shell/1
type: reflns shell
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reflns shell.pdbx ordinal: 1
reflns shell.rmerge i obs: 0.108
reflns shell.d res high: 2.0
reflns shell.d res low: 2.1
reflns shell.mean i over sig i obs: 2.3
reflns shell.number unique all: 37806
reflns shell.pdbx rsym value: 0.12
reflns shell.pdbx diffrn id: 1
reflns shell.pdbx redundancy: 5.3
reflns shell.percent possible all: 93.5

http://rdf.wwpdb.org/pdb/4G6J/software/1
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 1
software.classification: data scaling
software.name: XDS

http://rdf.wwpdb.org/pdb/4G6J/software/2
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 2
software.classification: data collection
software.name: AutoPROC

http://rdf.wwpdb.org/pdb/4G6J/software/3
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 3
software.classification: phasing
software.name: PHASER

http://rdf.wwpdb.org/pdb/4G6J/software/4
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 4
software.classification: refinement
software.name: BUSTER
software.version: 2.11.2

http://rdf.wwpdb.org/pdb/4G6J/software/5
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 5
software.classification: data reduction
software.name: XDS

http://rdf.wwpdb.org/pdb/4G6J/software/6
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 6
software.classification: data scaling
software.name: AutoPROC

http://rdf.wwpdb.org/pdb/4G6J/software/7
type: software
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
software.pdbx ordinal: 7
software.classification: data scaling
software.name: SCALA

4G6J
type: struct
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
struct.entry id: 4G6J
struct.pdbx descriptor: Interleukin-1 beta, heavy chain of antibody binding fragment of canakinumab, light chain of antibody binding fragment of canakinumab
struct.title: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/A
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/1
struct asym.id: A
struct asym.entity id: 1
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/B
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/2
struct asym.id: B
struct asym.entity id: 2
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/C
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/3
struct asym.id: C
struct asym.entity id: 3
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/D
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/4
struct asym.id: D
struct asym.entity id: 4
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/E
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/4
struct asym.id: E
struct asym.entity id: 4
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_asym/F
type: struct asym
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/4
struct asym.id: F
struct asym.entity id: 4
struct asym.pdbx blank PDB chainid flag: N
struct asym.pdbx modified: N

struct_asymUnique_1
type: struct asym

http://rdf.wwpdb.org/pdb/4G6J/struct_biol/2
type: struct biol
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct biol.id: 2

http://rdf.wwpdb.org/pdb/4G6J/struct_biol/3
type: struct biol
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct biol.id: 3

http://rdf.wwpdb.org/pdb/4G6J/struct_biol/1
type: struct biol
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct biol.id: 1

HELX P1
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P1
struct conf.beg auth asym id: A
struct conf.beg auth comp id: GLN
struct conf.beg auth seq id: 32
struct conf.beg label asym id: A
struct conf.beg label comp id: GLN
struct conf.beg label seq id: 33
struct conf.conf type id: HELX_P
struct conf.end auth asym id: A
struct conf.end auth comp id: GLN
struct conf.end auth seq id: 39
struct conf.end label asym id: A
struct conf.end label comp id: GLN
struct conf.end label seq id: 40
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 1
struct conf.pdbx PDB helix length: 8

HELX P
referenced by struct conf: HELX P1
referenced by struct conf: HELX P2
referenced by struct conf: HELX P3
referenced by struct conf: HELX P4
referenced by struct conf: HELX P5
referenced by struct conf: HELX P6
referenced by struct conf: HELX P7
referenced by struct conf: HELX P8
referenced by struct conf: HELX P9
referenced by struct conf: HELX P10
referenced by struct conf: HELX P11
type: struct conf type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct conf type.id: HELX_P

HELX P2
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P2
struct conf.beg auth asym id: A
struct conf.beg auth comp id: GLU
struct conf.beg auth seq id: 96
struct conf.beg label asym id: A
struct conf.beg label comp id: GLU
struct conf.beg label seq id: 97
struct conf.conf type id: HELX_P
struct conf.end auth asym id: A
struct conf.end auth comp id: ARG
struct conf.end auth seq id: 98
struct conf.end label asym id: A
struct conf.end label comp id: ARG
struct conf.end label seq id: 99
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 2
struct conf.pdbx PDB helix length: 3

HELX P3
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P3
struct conf.beg auth asym id: H
struct conf.beg auth comp id: THR
struct conf.beg auth seq id: 28
struct conf.beg label asym id: B
struct conf.beg label comp id: THR
struct conf.beg label seq id: 28
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: TYR
struct conf.end auth seq id: 32
struct conf.end label asym id: B
struct conf.end label comp id: TYR
struct conf.end label seq id: 32
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 3
struct conf.pdbx PDB helix length: 5

HELX P4
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P4
struct conf.beg auth asym id: H
struct conf.beg auth comp id: ARG
struct conf.beg auth seq id: 87
struct conf.beg label asym id: B
struct conf.beg label comp id: ARG
struct conf.beg label seq id: 87
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: THR
struct conf.end auth seq id: 91
struct conf.end label asym id: B
struct conf.end label comp id: THR
struct conf.end label seq id: 91
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 4
struct conf.pdbx PDB helix length: 5

HELX P5
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P5
struct conf.beg auth asym id: H
struct conf.beg auth comp id: SER
struct conf.beg auth seq id: 132
struct conf.beg label asym id: B
struct conf.beg label comp id: SER
struct conf.beg label seq id: 132
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: LYS
struct conf.end auth seq id: 134
struct conf.end label asym id: B
struct conf.end label comp id: LYS
struct conf.end label seq id: 134
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 5
struct conf.pdbx PDB helix length: 3

HELX P6
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P6
struct conf.beg auth asym id: H
struct conf.beg auth comp id: SER
struct conf.beg auth seq id: 161
struct conf.beg label asym id: B
struct conf.beg label comp id: SER
struct conf.beg label seq id: 161
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: ALA
struct conf.end auth seq id: 163
struct conf.end label asym id: B
struct conf.end label comp id: ALA
struct conf.end label seq id: 163
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 6
struct conf.pdbx PDB helix length: 3

HELX P7
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P7
struct conf.beg auth asym id: H
struct conf.beg auth comp id: SER
struct conf.beg auth seq id: 192
struct conf.beg label asym id: B
struct conf.beg label comp id: SER
struct conf.beg label seq id: 192
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: LEU
struct conf.end auth seq id: 194
struct conf.end label asym id: B
struct conf.end label comp id: LEU
struct conf.end label seq id: 194
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 7
struct conf.pdbx PDB helix length: 3

HELX P8
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P8
struct conf.beg auth asym id: H
struct conf.beg auth comp id: LYS
struct conf.beg auth seq id: 206
struct conf.beg label asym id: B
struct conf.beg label comp id: LYS
struct conf.beg label seq id: 206
struct conf.conf type id: HELX_P
struct conf.end auth asym id: H
struct conf.end auth comp id: ASN
struct conf.end auth seq id: 209
struct conf.end label asym id: B
struct conf.end label comp id: ASN
struct conf.end label seq id: 209
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 8
struct conf.pdbx PDB helix length: 4

HELX P9
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P9
struct conf.beg auth asym id: L
struct conf.beg auth comp id: GLU
struct conf.beg auth seq id: 79
struct conf.beg label asym id: C
struct conf.beg label comp id: GLU
struct conf.beg label seq id: 79
struct conf.conf type id: HELX_P
struct conf.end auth asym id: L
struct conf.end auth comp id: ALA
struct conf.end auth seq id: 83
struct conf.end label asym id: C
struct conf.end label comp id: ALA
struct conf.end label seq id: 83
struct conf.pdbx PDB helix class: 5
struct conf.pdbx PDB helix id: 9
struct conf.pdbx PDB helix length: 5

HELX P10
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P10
struct conf.beg auth asym id: L
struct conf.beg auth comp id: SER
struct conf.beg auth seq id: 121
struct conf.beg label asym id: C
struct conf.beg label comp id: SER
struct conf.beg label seq id: 121
struct conf.conf type id: HELX_P
struct conf.end auth asym id: L
struct conf.end auth comp id: SER
struct conf.end auth seq id: 127
struct conf.end label asym id: C
struct conf.end label comp id: SER
struct conf.end label seq id: 127
struct conf.pdbx PDB helix class: 1
struct conf.pdbx PDB helix id: 10
struct conf.pdbx PDB helix length: 7

HELX P11
type: struct conf
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conf type: HELX P
struct conf.id: HELX_P11
struct conf.beg auth asym id: L
struct conf.beg auth comp id: LYS
struct conf.beg auth seq id: 183
struct conf.beg label asym id: C
struct conf.beg label comp id: LYS
struct conf.beg label seq id: 183
struct conf.conf type id: HELX_P
struct conf.end auth asym id: L
struct conf.end auth comp id: HIS
struct conf.end auth seq id: 189
struct conf.end label asym id: C
struct conf.end label comp id: HIS
struct conf.end label seq id: 189
struct conf.pdbx PDB helix class: 1
struct conf.pdbx PDB helix id: 11
struct conf.pdbx PDB helix length: 7

disulf1
type: struct conn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conn type: disulf
struct conn.id: disulf1
struct conn.conn type id: disulf
struct conn.pdbx dist value: 2.032
struct conn.ptnr1 auth asym id: H
struct conn.ptnr1 auth comp id: CYS
struct conn.ptnr1 auth seq id: 22
struct conn.ptnr1 label asym id: B
struct conn.ptnr1 label atom id: SG
struct conn.ptnr1 label comp id: CYS
struct conn.ptnr1 label seq id: 22
struct conn.ptnr1 symmetry: 1_555
struct conn.ptnr2 auth asym id: H
struct conn.ptnr2 auth comp id: CYS
struct conn.ptnr2 auth seq id: 96
struct conn.ptnr2 label asym id: B
struct conn.ptnr2 label atom id: SG
struct conn.ptnr2 label comp id: CYS
struct conn.ptnr2 label seq id: 96
struct conn.ptnr2 symmetry: 1_555

disulf
referenced by struct conn: disulf1
referenced by struct conn: disulf2
referenced by struct conn: disulf3
referenced by struct conn: disulf4
type: struct conn type
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct conn type.id: disulf

disulf2
type: struct conn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conn type: disulf
struct conn.id: disulf2
struct conn.conn type id: disulf
struct conn.pdbx dist value: 2.036
struct conn.ptnr1 auth asym id: H
struct conn.ptnr1 auth comp id: CYS
struct conn.ptnr1 auth seq id: 145
struct conn.ptnr1 label asym id: B
struct conn.ptnr1 label atom id: SG
struct conn.ptnr1 label comp id: CYS
struct conn.ptnr1 label seq id: 145
struct conn.ptnr1 symmetry: 1_555
struct conn.ptnr2 auth asym id: H
struct conn.ptnr2 auth comp id: CYS
struct conn.ptnr2 auth seq id: 201
struct conn.ptnr2 label asym id: B
struct conn.ptnr2 label atom id: SG
struct conn.ptnr2 label comp id: CYS
struct conn.ptnr2 label seq id: 201
struct conn.ptnr2 symmetry: 1_555

disulf3
type: struct conn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conn type: disulf
struct conn.id: disulf3
struct conn.conn type id: disulf
struct conn.pdbx dist value: 2.037
struct conn.ptnr1 auth asym id: L
struct conn.ptnr1 auth comp id: CYS
struct conn.ptnr1 auth seq id: 23
struct conn.ptnr1 label asym id: C
struct conn.ptnr1 label atom id: SG
struct conn.ptnr1 label comp id: CYS
struct conn.ptnr1 label seq id: 23
struct conn.ptnr1 symmetry: 1_555
struct conn.ptnr2 auth asym id: L
struct conn.ptnr2 auth comp id: CYS
struct conn.ptnr2 auth seq id: 88
struct conn.ptnr2 label asym id: C
struct conn.ptnr2 label atom id: SG
struct conn.ptnr2 label comp id: CYS
struct conn.ptnr2 label seq id: 88
struct conn.ptnr2 symmetry: 1_555

disulf4
type: struct conn
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct conn type: disulf
struct conn.id: disulf4
struct conn.conn type id: disulf
struct conn.pdbx dist value: 2.040
struct conn.ptnr1 auth asym id: L
struct conn.ptnr1 auth comp id: CYS
struct conn.ptnr1 auth seq id: 134
struct conn.ptnr1 label asym id: C
struct conn.ptnr1 label atom id: SG
struct conn.ptnr1 label comp id: CYS
struct conn.ptnr1 label seq id: 134
struct conn.ptnr1 symmetry: 1_555
struct conn.ptnr2 auth asym id: L
struct conn.ptnr2 auth comp id: CYS
struct conn.ptnr2 auth seq id: 194
struct conn.ptnr2 label asym id: C
struct conn.ptnr2 label atom id: SG
struct conn.ptnr2 label comp id: CYS
struct conn.ptnr2 label seq id: 194
struct conn.ptnr2 symmetry: 1_555

4G6J
type: struct keywords
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
struct keywords.entry id: 4G6J
struct keywords.pdbx keywords: IMMUNE SYSTEM
struct keywords.text: immunglobulin fold, interleukin-1beta binding, IMMUNE SYSTEM

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/1
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 1
struct mon prot cis.auth asym id: A
struct mon prot cis.auth comp id: TYR
struct mon prot cis.auth seq id: 90
struct mon prot cis.label asym id: A
struct mon prot cis.label comp id: TYR
struct mon prot cis.label seq id: 91
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: A
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 91
struct mon prot cis.pdbx label asym id 2: A
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 92
struct mon prot cis.pdbx omega angle: 1.04

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/2
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 2
struct mon prot cis.auth asym id: H
struct mon prot cis.auth comp id: PHE
struct mon prot cis.auth seq id: 151
struct mon prot cis.label asym id: B
struct mon prot cis.label comp id: PHE
struct mon prot cis.label seq id: 151
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: H
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 152
struct mon prot cis.pdbx label asym id 2: B
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 152
struct mon prot cis.pdbx omega angle: -4.13

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/3
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 3
struct mon prot cis.auth asym id: H
struct mon prot cis.auth comp id: GLU
struct mon prot cis.auth seq id: 153
struct mon prot cis.label asym id: B
struct mon prot cis.label comp id: GLU
struct mon prot cis.label seq id: 153
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: H
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 154
struct mon prot cis.pdbx label asym id 2: B
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 154
struct mon prot cis.pdbx omega angle: 3.10

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/4
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 4
struct mon prot cis.auth asym id: L
struct mon prot cis.auth comp id: SER
struct mon prot cis.auth seq id: 7
struct mon prot cis.label asym id: C
struct mon prot cis.label comp id: SER
struct mon prot cis.label seq id: 7
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: L
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 8
struct mon prot cis.pdbx label asym id 2: C
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 8
struct mon prot cis.pdbx omega angle: -3.13

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/5
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 5
struct mon prot cis.auth asym id: L
struct mon prot cis.auth comp id: LEU
struct mon prot cis.auth seq id: 94
struct mon prot cis.label asym id: C
struct mon prot cis.label comp id: LEU
struct mon prot cis.label seq id: 94
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: L
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 95
struct mon prot cis.pdbx label asym id 2: C
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 95
struct mon prot cis.pdbx omega angle: -0.54

http://rdf.wwpdb.org/pdb/4G6J/struct_mon_prot_cis/6
type: struct mon prot cis
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct mon prot cis.pdbx id: 6
struct mon prot cis.auth asym id: L
struct mon prot cis.auth comp id: TYR
struct mon prot cis.auth seq id: 140
struct mon prot cis.label asym id: C
struct mon prot cis.label comp id: TYR
struct mon prot cis.label seq id: 140
struct mon prot cis.pdbx PDB model num: 1
struct mon prot cis.pdbx auth asym id 2: L
struct mon prot cis.pdbx auth comp id 2: PRO
struct mon prot cis.pdbx auth seq id 2: 141
struct mon prot cis.pdbx label asym id 2: C
struct mon prot cis.pdbx label comp id 2: PRO
struct mon prot cis.pdbx label seq id 2: 141
struct mon prot cis.pdbx omega angle: 0.01

http://rdf.wwpdb.org/pdb/4G6J/struct_ref/1
type: struct ref
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/1
struct ref.id: 1
struct ref.db code: IL1B_HUMAN
struct ref.db name: UNP
struct ref.entity id: 1
struct ref.pdbx align begin: 117
struct ref.pdbx db accession: P01584
struct ref.pdbx seq one letter code: APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS
link to uniprot: uniprot:P01584
referenced by struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1

uniprot:P01584

http://rdf.wwpdb.org/pdb/4G6J/struct_ref/2
type: struct ref
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/2
struct ref.id: 2
struct ref.db code: 4G6J
struct ref.db name: PDB
struct ref.entity id: 2
struct ref.pdbx db accession: 4G6J
referenced by struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/2

http://rdf.wwpdb.org/pdb/4G6J/struct_ref/3
type: struct ref
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entity: http://rdf.wwpdb.org/pdb/4G6J/entity/3
struct ref.id: 3
struct ref.db code: 4G6J
struct ref.db name: PDB
struct ref.entity id: 3
struct ref.pdbx db accession: 4G6J
referenced by struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/3

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
type: struct ref seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/1
struct ref seq.align id: 1
struct ref seq.db align beg: 117
struct ref seq.db align end: 269
struct ref seq.pdbx PDB id code: 4G6J
struct ref seq.pdbx auth seq align beg: 1
struct ref seq.pdbx auth seq align end: 153
struct ref seq.pdbx db accession: P01584
struct ref seq.pdbx strand id: A
struct ref seq.ref id: 1
struct ref seq.seq align beg: 2
struct ref seq.seq align end: 154
referenced by struct ref seq dif: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/1
referenced by struct ref seq dif: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/2
referenced by struct ref seq dif: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/3
referenced by struct ref seq dif: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/4
referenced by struct ref seq dif: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/5

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/2
type: struct ref seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/2
struct ref seq.align id: 2
struct ref seq.db align beg: 1
struct ref seq.db align end: 218
struct ref seq.pdbx PDB id code: 4G6J
struct ref seq.pdbx auth seq align beg: 1
struct ref seq.pdbx auth seq align end: 218
struct ref seq.pdbx db accession: 4G6J
struct ref seq.pdbx strand id: H
struct ref seq.ref id: 2
struct ref seq.seq align beg: 1
struct ref seq.seq align end: 218

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/3
type: struct ref seq
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref: http://rdf.wwpdb.org/pdb/4G6J/struct_ref/3
struct ref seq.align id: 3
struct ref seq.db align beg: 1
struct ref seq.db align end: 212
struct ref seq.pdbx PDB id code: 4G6J
struct ref seq.pdbx auth seq align beg: 1
struct ref seq.pdbx auth seq align end: 212
struct ref seq.pdbx db accession: 4G6J
struct ref seq.pdbx strand id: L
struct ref seq.ref id: 3
struct ref seq.seq align beg: 1
struct ref seq.seq align end: 212

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/1
type: struct ref seq dif
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
struct ref seq dif.pdbx ordinal: 1
struct ref seq dif.align id: 1
struct ref seq dif.details: EXPRESSION TAG
struct ref seq dif.mon id: MET
struct ref seq dif.pdbx auth seq num: 0
struct ref seq dif.pdbx pdb id code: 4G6J
struct ref seq dif.pdbx pdb strand id: A
struct ref seq dif.pdbx seq db accession code: P01584
struct ref seq dif.pdbx seq db name: UNP
struct ref seq dif.seq num: 1

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/2
type: struct ref seq dif
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
struct ref seq dif.pdbx ordinal: 2
struct ref seq dif.align id: 1
struct ref seq dif.details: EXPRESSION TAG
struct ref seq dif.mon id: LEU
struct ref seq dif.pdbx auth seq num: 154
struct ref seq dif.pdbx pdb id code: 4G6J
struct ref seq dif.pdbx pdb strand id: A
struct ref seq dif.pdbx seq db accession code: P01584
struct ref seq dif.pdbx seq db name: UNP
struct ref seq dif.seq num: 155

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/3
type: struct ref seq dif
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
struct ref seq dif.pdbx ordinal: 3
struct ref seq dif.align id: 1
struct ref seq dif.details: EXPRESSION TAG
struct ref seq dif.mon id: VAL
struct ref seq dif.pdbx auth seq num: 155
struct ref seq dif.pdbx pdb id code: 4G6J
struct ref seq dif.pdbx pdb strand id: A
struct ref seq dif.pdbx seq db accession code: P01584
struct ref seq dif.pdbx seq db name: UNP
struct ref seq dif.seq num: 156

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/4
type: struct ref seq dif
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
struct ref seq dif.pdbx ordinal: 4
struct ref seq dif.align id: 1
struct ref seq dif.details: EXPRESSION TAG
struct ref seq dif.mon id: PRO
struct ref seq dif.pdbx auth seq num: 156
struct ref seq dif.pdbx pdb id code: 4G6J
struct ref seq dif.pdbx pdb strand id: A
struct ref seq dif.pdbx seq db accession code: P01584
struct ref seq dif.pdbx seq db name: UNP
struct ref seq dif.seq num: 157

http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq_dif/5
type: struct ref seq dif
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct ref seq: http://rdf.wwpdb.org/pdb/4G6J/struct_ref_seq/1
struct ref seq dif.pdbx ordinal: 5
struct ref seq dif.align id: 1
struct ref seq dif.details: EXPRESSION TAG
struct ref seq dif.mon id: ARG
struct ref seq dif.pdbx auth seq num: 157
struct ref seq dif.pdbx pdb id code: 4G6J
struct ref seq dif.pdbx pdb strand id: A
struct ref seq dif.pdbx seq db accession code: P01584
struct ref seq dif.pdbx seq db name: UNP
struct ref seq dif.seq num: 158

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/A
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: A
struct sheet.number strands: 7

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/B
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: B
struct sheet.number strands: 3

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/C
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: C
struct sheet.number strands: 2

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/D
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: D
struct sheet.number strands: 2

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/E
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: E
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/F
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: F
struct sheet.number strands: 6

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/G
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: G
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/H
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: H
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/I
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: I
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/J
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: J
struct sheet.number strands: 3

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/K
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: K
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/L
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: L
struct sheet.number strands: 6

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/M
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: M
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/N
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: N
struct sheet.number strands: 4

http://rdf.wwpdb.org/pdb/4G6J/struct_sheet/O
type: struct sheet
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
struct sheet.id: O
struct sheet.number strands: 4

1,2,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

2,3,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

3,4,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

4,5,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 4
struct sheet order.range id 2: 5
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

5,6,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 5
struct sheet order.range id 2: 6
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

6,7,A
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 6
struct sheet order.range id 2: 7
struct sheet order.sheet id: A
struct sheet order.sense: anti-parallel

1,2,B
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: B
struct sheet order.sense: anti-parallel

2,3,B
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: B
struct sheet order.sense: anti-parallel

1,2,C
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: C
struct sheet order.sense: anti-parallel

1,2,D
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: D
struct sheet order.sense: anti-parallel

1,2,E
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: E
struct sheet order.sense: anti-parallel

2,3,E
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: E
struct sheet order.sense: anti-parallel

3,4,E
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: E
struct sheet order.sense: anti-parallel

1,2,F
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: F
struct sheet order.sense: parallel

2,3,F
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: F
struct sheet order.sense: anti-parallel

3,4,F
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: F
struct sheet order.sense: anti-parallel

4,5,F
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 4
struct sheet order.range id 2: 5
struct sheet order.sheet id: F
struct sheet order.sense: anti-parallel

5,6,F
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 5
struct sheet order.range id 2: 6
struct sheet order.sheet id: F
struct sheet order.sense: anti-parallel

1,2,G
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: G
struct sheet order.sense: parallel

2,3,G
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: G
struct sheet order.sense: anti-parallel

3,4,G
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: G
struct sheet order.sense: anti-parallel

1,2,H
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: H
struct sheet order.sense: anti-parallel

2,3,H
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: H
struct sheet order.sense: anti-parallel

3,4,H
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: H
struct sheet order.sense: anti-parallel

1,2,I
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: I
struct sheet order.sense: anti-parallel

2,3,I
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: I
struct sheet order.sense: anti-parallel

3,4,I
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: I
struct sheet order.sense: anti-parallel

1,2,J
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: J
struct sheet order.sense: anti-parallel

2,3,J
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: J
struct sheet order.sense: anti-parallel

1,2,K
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: K
struct sheet order.sense: anti-parallel

2,3,K
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: K
struct sheet order.sense: anti-parallel

3,4,K
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: K
struct sheet order.sense: anti-parallel

1,2,L
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: L
struct sheet order.sense: parallel

2,3,L
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: L
struct sheet order.sense: anti-parallel

3,4,L
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: L
struct sheet order.sense: anti-parallel

4,5,L
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 4
struct sheet order.range id 2: 5
struct sheet order.sheet id: L
struct sheet order.sense: anti-parallel

5,6,L
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 5
struct sheet order.range id 2: 6
struct sheet order.sheet id: L
struct sheet order.sense: anti-parallel

1,2,M
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: M
struct sheet order.sense: parallel

2,3,M
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: M
struct sheet order.sense: anti-parallel

3,4,M
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: M
struct sheet order.sense: anti-parallel

1,2,N
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: N
struct sheet order.sense: anti-parallel

2,3,N
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: N
struct sheet order.sense: anti-parallel

3,4,N
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: N
struct sheet order.sense: anti-parallel

1,2,O
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 1
struct sheet order.range id 2: 2
struct sheet order.sheet id: O
struct sheet order.sense: anti-parallel

2,3,O
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 2
struct sheet order.range id 2: 3
struct sheet order.sheet id: O
struct sheet order.sense: anti-parallel

3,4,O
type: struct sheet order
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet order.range id 1: 3
struct sheet order.range id 2: 4
struct sheet order.sheet id: O
struct sheet order.sense: anti-parallel

1,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 5
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 6
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: ASP
struct sheet range.end auth seq id: 12
struct sheet range.end label asym id: A
struct sheet range.end label comp id: ASP
struct sheet range.end label seq id: 13

2,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 42
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 43
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: PHE
struct sheet range.end auth seq id: 46
struct sheet range.end label asym id: A
struct sheet range.end label comp id: PHE
struct sheet range.end label seq id: 47

3,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: LYS
struct sheet range.beg auth seq id: 55
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: LYS
struct sheet range.beg label seq id: 56
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: GLY
struct sheet range.end auth seq id: 61
struct sheet range.end label asym id: A
struct sheet range.end label comp id: GLY
struct sheet range.end label seq id: 62

4,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: VAL
struct sheet range.beg auth seq id: 100
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: VAL
struct sheet range.beg label seq id: 101
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: GLU
struct sheet range.end auth seq id: 105
struct sheet range.end label asym id: A
struct sheet range.end label comp id: GLU
struct sheet range.end label seq id: 106

5,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 5
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: LEU
struct sheet range.beg auth seq id: 110
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: LEU
struct sheet range.beg label seq id: 111
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 114
struct sheet range.end label asym id: A
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 115

6,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 6
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 146
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 147
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: PHE
struct sheet range.end auth seq id: 150
struct sheet range.end label asym id: A
struct sheet range.end label comp id: PHE
struct sheet range.end label seq id: 151

7,A
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 7
struct sheet range.sheet id: A
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 5
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 6
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: ASP
struct sheet range.end auth seq id: 12
struct sheet range.end label asym id: A
struct sheet range.end label comp id: ASP
struct sheet range.end label seq id: 13

1,B
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: B
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 17
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 18
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: GLY
struct sheet range.end auth seq id: 22
struct sheet range.end label asym id: A
struct sheet range.end label comp id: GLY
struct sheet range.end label seq id: 23

2,B
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: B
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: GLU
struct sheet range.beg auth seq id: 25
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: GLU
struct sheet range.beg label seq id: 26
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: LEU
struct sheet range.end auth seq id: 29
struct sheet range.end label asym id: A
struct sheet range.end label comp id: LEU
struct sheet range.end label seq id: 30

3,B
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: B
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: MET
struct sheet range.beg auth seq id: 130
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: MET
struct sheet range.beg label seq id: 131
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: PRO
struct sheet range.end auth seq id: 131
struct sheet range.end label asym id: A
struct sheet range.end label comp id: PRO
struct sheet range.end label seq id: 132

1,C
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: C
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: LEU
struct sheet range.beg auth seq id: 67
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: LEU
struct sheet range.beg label seq id: 68
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: LYS
struct sheet range.end auth seq id: 74
struct sheet range.end label asym id: A
struct sheet range.end label comp id: LYS
struct sheet range.end label seq id: 75

2,C
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: C
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: LYS
struct sheet range.beg auth seq id: 77
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: LYS
struct sheet range.beg label seq id: 78
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 84
struct sheet range.end label asym id: A
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 85

1,D
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: D
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: TYR
struct sheet range.beg auth seq id: 121
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: TYR
struct sheet range.beg label seq id: 122
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 123
struct sheet range.end label asym id: A
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 124

2,D
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: D
struct sheet range.beg auth asym id: A
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 133
struct sheet range.beg label asym id: A
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 134
struct sheet range.end auth asym id: A
struct sheet range.end auth comp id: GLY
struct sheet range.end auth seq id: 135
struct sheet range.end label asym id: A
struct sheet range.end label comp id: GLY
struct sheet range.end label seq id: 136

1,E
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: E
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: GLN
struct sheet range.beg auth seq id: 3
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: GLN
struct sheet range.beg label seq id: 3
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 7
struct sheet range.end label asym id: B
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 7

2,E
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: E
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: LEU
struct sheet range.beg auth seq id: 18
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: LEU
struct sheet range.beg label seq id: 18
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 25
struct sheet range.end label asym id: B
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 25

3,E
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: E
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 78
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 78
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: MET
struct sheet range.end auth seq id: 83
struct sheet range.end label asym id: B
struct sheet range.end label comp id: MET
struct sheet range.end label seq id: 83

4,E
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: E
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 68
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 68
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: ASP
struct sheet range.end auth seq id: 73
struct sheet range.end label asym id: B
struct sheet range.end label comp id: ASP
struct sheet range.end label seq id: 73

1,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: GLY
struct sheet range.beg auth seq id: 10
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: GLY
struct sheet range.beg label seq id: 10
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 12
struct sheet range.end label asym id: B
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 12

2,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 112
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 112
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 116
struct sheet range.end label asym id: B
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 116

3,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: ALA
struct sheet range.beg auth seq id: 92
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: ALA
struct sheet range.beg label seq id: 92
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: ASP
struct sheet range.end auth seq id: 99
struct sheet range.end label asym id: B
struct sheet range.end label comp id: ASP
struct sheet range.end label seq id: 99

4,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: MET
struct sheet range.beg auth seq id: 34
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: MET
struct sheet range.beg label seq id: 34
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: GLN
struct sheet range.end auth seq id: 39
struct sheet range.end label asym id: B
struct sheet range.end label comp id: GLN
struct sheet range.end label seq id: 39

5,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 5
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: GLU
struct sheet range.beg auth seq id: 46
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: GLU
struct sheet range.beg label seq id: 46
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: ILE
struct sheet range.end auth seq id: 51
struct sheet range.end label asym id: B
struct sheet range.end label comp id: ILE
struct sheet range.end label seq id: 51

6,F
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 6
struct sheet range.sheet id: F
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: GLN
struct sheet range.beg auth seq id: 58
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: GLN
struct sheet range.beg label seq id: 58
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: TYR
struct sheet range.end auth seq id: 60
struct sheet range.end label asym id: B
struct sheet range.end label comp id: TYR
struct sheet range.end label seq id: 60

1,G
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: G
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: GLY
struct sheet range.beg auth seq id: 10
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: GLY
struct sheet range.beg label seq id: 10
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 12
struct sheet range.end label asym id: B
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 12

2,G
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: G
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 112
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 112
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 116
struct sheet range.end label asym id: B
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 116

3,G
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: G
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: ALA
struct sheet range.beg auth seq id: 92
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: ALA
struct sheet range.beg label seq id: 92
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: ASP
struct sheet range.end auth seq id: 99
struct sheet range.end label asym id: B
struct sheet range.end label comp id: ASP
struct sheet range.end label seq id: 99

4,G
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: G
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 105
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 105
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: TRP
struct sheet range.end auth seq id: 108
struct sheet range.end label asym id: B
struct sheet range.end label comp id: TRP
struct sheet range.end label seq id: 108

1,H
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: H
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 125
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 125
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: LEU
struct sheet range.end auth seq id: 129
struct sheet range.end label asym id: B
struct sheet range.end label comp id: LEU
struct sheet range.end label seq id: 129

2,H
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: H
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 140
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 140
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: TYR
struct sheet range.end auth seq id: 150
struct sheet range.end label asym id: B
struct sheet range.end label comp id: TYR
struct sheet range.end label seq id: 150

3,H
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: H
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: TYR
struct sheet range.beg auth seq id: 181
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: TYR
struct sheet range.beg label seq id: 181
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: PRO
struct sheet range.end auth seq id: 190
struct sheet range.end label asym id: B
struct sheet range.end label comp id: PRO
struct sheet range.end label seq id: 190

4,H
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: H
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: HIS
struct sheet range.beg auth seq id: 169
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: HIS
struct sheet range.beg label seq id: 169
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: THR
struct sheet range.end auth seq id: 170
struct sheet range.end label asym id: B
struct sheet range.end label comp id: THR
struct sheet range.end label seq id: 170

1,I
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: I
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 136
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 136
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 137
struct sheet range.end label asym id: B
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 137

2,I
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: I
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 140
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 140
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: TYR
struct sheet range.end auth seq id: 150
struct sheet range.end label asym id: B
struct sheet range.end label comp id: TYR
struct sheet range.end label seq id: 150

3,I
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: I
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: TYR
struct sheet range.beg auth seq id: 181
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: TYR
struct sheet range.beg label seq id: 181
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: PRO
struct sheet range.end auth seq id: 190
struct sheet range.end label asym id: B
struct sheet range.end label comp id: PRO
struct sheet range.end label seq id: 190

4,I
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: I
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: VAL
struct sheet range.beg auth seq id: 174
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: VAL
struct sheet range.beg label seq id: 174
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: LEU
struct sheet range.end auth seq id: 175
struct sheet range.end label asym id: B
struct sheet range.end label comp id: LEU
struct sheet range.end label seq id: 175

1,J
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: J
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 156
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 156
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: TRP
struct sheet range.end auth seq id: 159
struct sheet range.end label asym id: B
struct sheet range.end label comp id: TRP
struct sheet range.end label seq id: 159

2,J
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: J
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: ILE
struct sheet range.beg auth seq id: 200
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: ILE
struct sheet range.beg label seq id: 200
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: HIS
struct sheet range.end auth seq id: 205
struct sheet range.end label asym id: B
struct sheet range.end label comp id: HIS
struct sheet range.end label seq id: 205

3,J
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: J
struct sheet range.beg auth asym id: H
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 210
struct sheet range.beg label asym id: B
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 210
struct sheet range.end auth asym id: H
struct sheet range.end auth comp id: ARG
struct sheet range.end auth seq id: 215
struct sheet range.end label asym id: B
struct sheet range.end label comp id: ARG
struct sheet range.end label seq id: 215

1,K
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: K
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: LEU
struct sheet range.beg auth seq id: 4
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: LEU
struct sheet range.beg label seq id: 4
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 7
struct sheet range.end label asym id: C
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 7

2,K
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: K
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: VAL
struct sheet range.beg auth seq id: 19
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: VAL
struct sheet range.beg label seq id: 19
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: ALA
struct sheet range.end auth seq id: 25
struct sheet range.end label asym id: C
struct sheet range.end label comp id: ALA
struct sheet range.end label seq id: 25

3,K
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: K
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: ASP
struct sheet range.beg auth seq id: 70
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: ASP
struct sheet range.beg label seq id: 70
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: ILE
struct sheet range.end auth seq id: 75
struct sheet range.end label asym id: C
struct sheet range.end label comp id: ILE
struct sheet range.end label seq id: 75

4,K
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: K
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 62
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 62
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 67
struct sheet range.end label asym id: C
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 67

1,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 10
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 10
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 13
struct sheet range.end label asym id: C
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 13

2,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 102
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 102
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: ILE
struct sheet range.end auth seq id: 106
struct sheet range.end label asym id: C
struct sheet range.end label comp id: ILE
struct sheet range.end label seq id: 106

3,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: ALA
struct sheet range.beg auth seq id: 85
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: ALA
struct sheet range.beg label seq id: 85
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: GLN
struct sheet range.end auth seq id: 90
struct sheet range.end label asym id: C
struct sheet range.end label comp id: GLN
struct sheet range.end label seq id: 90

4,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: LEU
struct sheet range.beg auth seq id: 33
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: LEU
struct sheet range.beg label seq id: 33
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: GLN
struct sheet range.end auth seq id: 38
struct sheet range.end label asym id: C
struct sheet range.end label comp id: GLN
struct sheet range.end label seq id: 38

5,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 5
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: LYS
struct sheet range.beg auth seq id: 45
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: LYS
struct sheet range.beg label seq id: 45
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: LYS
struct sheet range.end auth seq id: 49
struct sheet range.end label asym id: C
struct sheet range.end label comp id: LYS
struct sheet range.end label seq id: 49

6,L
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 6
struct sheet range.sheet id: L
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: GLN
struct sheet range.beg auth seq id: 53
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: GLN
struct sheet range.beg label seq id: 53
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 54
struct sheet range.end label asym id: C
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 54

1,M
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: M
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: PHE
struct sheet range.beg auth seq id: 10
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: PHE
struct sheet range.beg label seq id: 10
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 13
struct sheet range.end label asym id: C
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 13

2,M
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: M
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 102
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 102
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: ILE
struct sheet range.end auth seq id: 106
struct sheet range.end label asym id: C
struct sheet range.end label comp id: ILE
struct sheet range.end label seq id: 106

3,M
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: M
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: ALA
struct sheet range.beg auth seq id: 85
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: ALA
struct sheet range.beg label seq id: 85
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: GLN
struct sheet range.end auth seq id: 90
struct sheet range.end label asym id: C
struct sheet range.end label comp id: GLN
struct sheet range.end label seq id: 90

4,M
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: M
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 97
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 97
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: PHE
struct sheet range.end auth seq id: 98
struct sheet range.end label asym id: C
struct sheet range.end label comp id: PHE
struct sheet range.end label seq id: 98

1,N
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: N
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 114
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 114
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: PHE
struct sheet range.end auth seq id: 118
struct sheet range.end label asym id: C
struct sheet range.end label comp id: PHE
struct sheet range.end label seq id: 118

2,N
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: N
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: THR
struct sheet range.beg auth seq id: 129
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: THR
struct sheet range.beg label seq id: 129
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: PHE
struct sheet range.end auth seq id: 139
struct sheet range.end label asym id: C
struct sheet range.end label comp id: PHE
struct sheet range.end label seq id: 139

3,N
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: N
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: TYR
struct sheet range.beg auth seq id: 173
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: TYR
struct sheet range.beg label seq id: 173
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: SER
struct sheet range.end auth seq id: 182
struct sheet range.end label asym id: C
struct sheet range.end label comp id: SER
struct sheet range.end label seq id: 182

4,N
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: N
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: SER
struct sheet range.beg auth seq id: 159
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: SER
struct sheet range.beg label seq id: 159
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 163
struct sheet range.end label asym id: C
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 163

1,O
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 1
struct sheet range.sheet id: O
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: ALA
struct sheet range.beg auth seq id: 153
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: ALA
struct sheet range.beg label seq id: 153
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: LEU
struct sheet range.end auth seq id: 154
struct sheet range.end label asym id: C
struct sheet range.end label comp id: LEU
struct sheet range.end label seq id: 154

2,O
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 2
struct sheet range.sheet id: O
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: LYS
struct sheet range.beg auth seq id: 145
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: LYS
struct sheet range.beg label seq id: 145
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: VAL
struct sheet range.end auth seq id: 150
struct sheet range.end label asym id: C
struct sheet range.end label comp id: VAL
struct sheet range.end label seq id: 150

3,O
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 3
struct sheet range.sheet id: O
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: VAL
struct sheet range.beg auth seq id: 191
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: VAL
struct sheet range.beg label seq id: 191
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: THR
struct sheet range.end auth seq id: 197
struct sheet range.end label asym id: C
struct sheet range.end label comp id: THR
struct sheet range.end label seq id: 197

4,O
type: struct sheet range
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct sheet: struct sheet
struct sheet range.id: 4
struct sheet range.sheet id: O
struct sheet range.beg auth asym id: L
struct sheet range.beg auth comp id: VAL
struct sheet range.beg auth seq id: 205
struct sheet range.beg label asym id: C
struct sheet range.beg label comp id: VAL
struct sheet range.beg label seq id: 205
struct sheet range.end auth asym id: L
struct sheet range.end auth comp id: ASN
struct sheet range.end auth seq id: 210
struct sheet range.end label asym id: C
struct sheet range.end label comp id: ASN
struct sheet range.end label seq id: 210

4G6J
type: symmetry
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to entry: entry
symmetry.entry id: 4G6J
symmetry.int tables number: 19
symmetry.space group name H-M: P 21 21 21

A,1,1,2,P01584
type: pdbx sifts unp segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts unp segments.entity id: 1
pdbx sifts unp segments.asym id: A
pdbx sifts unp segments.unp acc: P01584
pdbx sifts unp segments.segment id: 2
pdbx sifts unp segments.instance id: 1
link to uniprot: uniprot:P01584
pdbx sifts unp segments.unp start: 117
pdbx sifts unp segments.unp end: 269
pdbx sifts unp segments.seq id start: 2
pdbx sifts unp segments.seq id end: 154
pdbx sifts unp segments.best mapping: Y
pdbx sifts unp segments.identity: 1.000

A,1,1,2,154,85,Ensembl,ENSG00000125538
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: Ensembl
pdbx sifts xref db segments.xref db acc: ENSG00000125538
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 1
pdbx sifts xref db segments.seq id start: 85
pdbx sifts xref db segments.seq id end: 154
link to ensembl: ensembl:ENSG00000125538

ensembl:ENSG00000125538

A,1,2,2,84,41,Ensembl,ENSG00000125538
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: Ensembl
pdbx sifts xref db segments.xref db acc: ENSG00000125538
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 2
pdbx sifts xref db segments.seq id start: 41
pdbx sifts xref db segments.seq id end: 84
link to ensembl: ensembl:ENSG00000125538

A,1,3,2,41,2,Ensembl,ENSG00000125538
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: Ensembl
pdbx sifts xref db segments.xref db acc: ENSG00000125538
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 3
pdbx sifts xref db segments.seq id start: 2
pdbx sifts xref db segments.seq id end: 41
link to ensembl: ensembl:ENSG00000125538

A,1,4,2,152,3,InterPro,IPR000975
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR000975
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 4
pdbx sifts xref db segments.seq id start: 3
pdbx sifts xref db segments.seq id end: 152
link to interpro: interpro:IPR000975

interpro:IPR000975

A,1,5,2,109,96,InterPro,IPR000975
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR000975
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 5
pdbx sifts xref db segments.seq id start: 96
pdbx sifts xref db segments.seq id end: 109
link to interpro: interpro:IPR000975

A,1,6,2,77,57,InterPro,IPR000975
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR000975
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 6
pdbx sifts xref db segments.seq id start: 57
pdbx sifts xref db segments.seq id end: 77
link to interpro: interpro:IPR000975

A,1,7,2,125,110,InterPro,IPR000975
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR000975
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 7
pdbx sifts xref db segments.seq id start: 110
pdbx sifts xref db segments.seq id end: 125
link to interpro: interpro:IPR000975

A,1,8,2,133,113,InterPro,IPR020877
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR020877
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 8
pdbx sifts xref db segments.seq id start: 113
pdbx sifts xref db segments.seq id end: 133
link to interpro: interpro:IPR020877

interpro:IPR020877

A,1,9,2,149,32,InterPro,IPR000975
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR000975
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 9
pdbx sifts xref db segments.seq id start: 32
pdbx sifts xref db segments.seq id end: 149
link to interpro: interpro:IPR000975

A,1,10,2,151,7,InterPro,IPR008996
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR008996
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 10
pdbx sifts xref db segments.seq id start: 7
pdbx sifts xref db segments.seq id end: 151
link to interpro: interpro:IPR008996

interpro:IPR008996

A,1,11,2,153,5,CATH,2.80.10.50
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: CATH
pdbx sifts xref db segments.xref db acc: 2.80.10.50
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 11
pdbx sifts xref db segments.seq id start: 5
pdbx sifts xref db segments.seq id end: 153
link to cath: cath:2.80.10.50

cath:2.80.10.50

A,1,12,2,153,5,SCOP2B,8043267
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: SCOP2B
pdbx sifts xref db segments.xref db acc: 8043267
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 12
pdbx sifts xref db segments.seq id start: 5
pdbx sifts xref db segments.seq id end: 153
link to scop: scop2:8043267

A,1,13,2,149,32,Pfam,PF00340
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 1
pdbx sifts xref db segments.asym id: A
pdbx sifts xref db segments.xref db: Pfam
pdbx sifts xref db segments.xref db acc: PF00340
pdbx sifts xref db segments.segment id: 2
pdbx sifts xref db segments.instance id: 13
pdbx sifts xref db segments.seq id start: 32
pdbx sifts xref db segments.seq id end: 149
link to pfam: pfam:PF00340

pfam:PF00340

B,2,1,1,218,122,InterPro,IPR013783
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013783
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 1
pdbx sifts xref db segments.seq id start: 122
pdbx sifts xref db segments.seq id end: 218
link to interpro: interpro:IPR013783

interpro:IPR013783

B,2,2,1,121,1,InterPro,IPR013783
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013783
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 2
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 121
link to interpro: interpro:IPR013783

B,2,3,1,217,124,InterPro,IPR007110
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR007110
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 3
pdbx sifts xref db segments.seq id start: 124
pdbx sifts xref db segments.seq id end: 217
link to interpro: interpro:IPR007110

interpro:IPR007110

B,2,4,1,96,1,InterPro,IPR007110
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR007110
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 4
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 96
link to interpro: interpro:IPR007110

B,2,5,1,206,126,InterPro,IPR003597
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003597
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 5
pdbx sifts xref db segments.seq id start: 126
pdbx sifts xref db segments.seq id end: 206
link to interpro: interpro:IPR003597

interpro:IPR003597

B,2,6,1,116,12,InterPro,IPR013106
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013106
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 6
pdbx sifts xref db segments.seq id start: 12
pdbx sifts xref db segments.seq id end: 116
link to interpro: interpro:IPR013106

interpro:IPR013106

B,2,7,1,98,17,InterPro,IPR013106
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013106
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 7
pdbx sifts xref db segments.seq id start: 17
pdbx sifts xref db segments.seq id end: 98
link to interpro: interpro:IPR013106

B,2,8,1,211,140,InterPro,IPR003597
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003597
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 8
pdbx sifts xref db segments.seq id start: 140
pdbx sifts xref db segments.seq id end: 211
link to interpro: interpro:IPR003597

B,2,9,1,117,7,InterPro,IPR003599
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003599
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 9
pdbx sifts xref db segments.seq id start: 7
pdbx sifts xref db segments.seq id end: 117
link to interpro: interpro:IPR003599

interpro:IPR003599

B,2,10,1,118,1,InterPro,IPR036179
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR036179
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 10
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 118
link to interpro: interpro:IPR036179

interpro:IPR036179

B,2,11,1,216,124,InterPro,IPR036179
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR036179
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 11
pdbx sifts xref db segments.seq id start: 124
pdbx sifts xref db segments.seq id end: 216
link to interpro: interpro:IPR036179

B,2,12,1,118,1,CATH,2.60.40.10
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: CATH
pdbx sifts xref db segments.xref db acc: 2.60.40.10
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 12
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 118
link to cath: cath:2.60.40.10

cath:2.60.40.10

B,2,13,1,218,119,CATH,2.60.40.10
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 2
pdbx sifts xref db segments.asym id: B
pdbx sifts xref db segments.xref db: CATH
pdbx sifts xref db segments.xref db acc: 2.60.40.10
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 13
pdbx sifts xref db segments.seq id start: 119
pdbx sifts xref db segments.seq id end: 218
link to cath: cath:2.60.40.10

C,3,1,1,212,113,InterPro,IPR013783
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013783
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 1
pdbx sifts xref db segments.seq id start: 113
pdbx sifts xref db segments.seq id end: 212
link to interpro: interpro:IPR013783

C,3,2,1,112,1,InterPro,IPR013783
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013783
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 2
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 112
link to interpro: interpro:IPR013783

C,3,3,1,198,192,InterPro,IPR003006
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003006
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 3
pdbx sifts xref db segments.seq id start: 192
pdbx sifts xref db segments.seq id end: 198
link to interpro: interpro:IPR003006

interpro:IPR003006

C,3,4,1,210,113,InterPro,IPR007110
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR007110
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 4
pdbx sifts xref db segments.seq id start: 113
pdbx sifts xref db segments.seq id end: 210
link to interpro: interpro:IPR007110

C,3,5,1,88,1,InterPro,IPR007110
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR007110
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 5
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 88
link to interpro: interpro:IPR007110

C,3,6,1,105,8,InterPro,IPR013106
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013106
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 6
pdbx sifts xref db segments.seq id start: 8
pdbx sifts xref db segments.seq id end: 105
link to interpro: interpro:IPR013106

C,3,7,1,201,115,InterPro,IPR003597
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003597
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 7
pdbx sifts xref db segments.seq id start: 115
pdbx sifts xref db segments.seq id end: 201
link to interpro: interpro:IPR003597

C,3,8,1,204,129,InterPro,IPR003597
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003597
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 8
pdbx sifts xref db segments.seq id start: 129
pdbx sifts xref db segments.seq id end: 204
link to interpro: interpro:IPR003597

C,3,9,1,107,8,InterPro,IPR003599
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003599
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 9
pdbx sifts xref db segments.seq id start: 8
pdbx sifts xref db segments.seq id end: 107
link to interpro: interpro:IPR003599

C,3,10,1,210,119,InterPro,IPR003599
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR003599
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 10
pdbx sifts xref db segments.seq id start: 119
pdbx sifts xref db segments.seq id end: 210
link to interpro: interpro:IPR003599

C,3,11,1,90,18,InterPro,IPR013106
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR013106
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 11
pdbx sifts xref db segments.seq id start: 18
pdbx sifts xref db segments.seq id end: 90
link to interpro: interpro:IPR013106

C,3,12,1,211,110,InterPro,IPR036179
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR036179
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 12
pdbx sifts xref db segments.seq id start: 110
pdbx sifts xref db segments.seq id end: 211
link to interpro: interpro:IPR036179

C,3,13,1,106,2,InterPro,IPR036179
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: InterPro
pdbx sifts xref db segments.xref db acc: IPR036179
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 13
pdbx sifts xref db segments.seq id start: 2
pdbx sifts xref db segments.seq id end: 106
link to interpro: interpro:IPR036179

C,3,14,1,211,108,CATH,2.60.40.10
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: CATH
pdbx sifts xref db segments.xref db acc: 2.60.40.10
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 14
pdbx sifts xref db segments.seq id start: 108
pdbx sifts xref db segments.seq id end: 211
link to cath: cath:2.60.40.10

C,3,15,1,107,1,CATH,2.60.40.10
type: pdbx sifts xref db segments
of datablock: Crystal structure of human IL-1beta in complex with the therapeutic antibody binding fragment of canakinumab
reference to struct asym: struct asym
pdbx sifts xref db segments.entity id: 3
pdbx sifts xref db segments.asym id: C
pdbx sifts xref db segments.xref db: CATH
pdbx sifts xref db segments.xref db acc: 2.60.40.10
pdbx sifts xref db segments.segment id: 1
pdbx sifts xref db segments.instance id: 15
pdbx sifts xref db segments.seq id start: 1
pdbx sifts xref db segments.seq id end: 107
link to cath: cath:2.60.40.10